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THE

JEFFERSON

COMMITMENT

"Ours is a medically-oriented University, and as a University is characterized
by its commitment to an intellectual life
of inquiry and transmission of knowledge-research is an endeavor ranking
with education." So spoke President Peter A. Herbut in a report on Universit y
policies and their impact on research at
the December, 1975 meeting of the
Board of Trustees.
His report was an outcome of a series
of studies which began followin g the
publication in December, 1972 of the Report of the Master Planning Committee
of the Board of Trustees. At that time,
members of the faculty noted that the
Master Planning Report, while spelling
out in detail the status and future needs of
our educational and patient care programs , did not emphasize the role of research in our University. In response , Mr.
Frederic L. Ballard, Trustee Chairman
of the Committee, appointed a Task
Force on Research chaired by Trustee
James W . Stratton to study the matter.
The members of the Task Force were :
Trustee Dr. Orville H. Bullitt, andfaculty members Drs. Robert C. Baldridge, Robert L. Brent, Stephen I. Bulova, Joseph S.Gonnella, George F. Kalf,
Simon Kramer, Hyman Menduk e, Abraham E. Rakoff,Jussi I. Saukkonen and
Martin Wingate.
The Task Force, meeting monthly for
over a year, reviewed the organization

Dr. Baldridg e (center): an increasing emphasis on research in the basic sciences
at TJU. Trustee Orvill e H. Bullitt is at left.
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Dr. Baldridg e was appointed Dean of
the College of Graduate Studies in
March, 1970. He is an honorary member
of Jefferson 's Alumni Association.

TO

BIOMEDICAL

RESEARCH

by Robert C. Baldridge, Ph.D.

for and administration of research, the
University commitment to research, the
role of students in research and the
available methods for evaluation of research. The report of the Task Force,
including a series of recommendations,
was discussed and debated at several
meetings of the Master Planning Committee, and as an outcome, a series of
recommendations were transmitted to
the Board of Trustees.
Following is a summary of the resolution based on the recommendations that
was approved by the Board at its June,
1975 meeting.
1. The Medical College Committee and
the College of Graduate Studies Committee should accept increased responsibilitiesfor research. The members of
these Board Committees are urged to
devise procedures, with the assistance
of the appropriate Deans, to become
more informed and aware of the research activities of the University. The
Executive Committee at its meetings
will receive reports of these two committees and share appropriate reports
with the full Board.
2. The members of the Finance Committee and of the Resources Committeeshould determine the feasibility
of allocating internally derived funds
and of raising additional funds from external sources for intramural research.
3. Th e President should be urged to ap point a University faculty advisory
committee on research to assist him
in presenting annually at a meeting of
the full Board of Trustees, a report of
the status of research in the University and the impact of University pol-

icies on the research ac tivi ties of the
faculty. This rep or t wou ld include a
summary of steps taken to enhance
the research ca pabilities of the University. The report should also inclu de a review of fed eral policies regarding the funding of research
grants and resea rch training grants.
Steps are being taken to implement
these resolutions: members of the faculty are meeting with the Board Committee to describe their ongo ing research projects; and the Resources
Committee of the Board will consider
the feasibili ty of including funds especially earmarked for research as one of
the goa ls of Phase II of the Sesquicentennial Campaign.
In his report, Dr. Herbut noted that
nationally, federal funding of research
via the National Institutes of Health
(NIH), has leve led off over the past five
years in terms of constant dollars. The
funding of direct costs of sponsored research (mainly NIH research grants and
contracts) at Jefferson was some 40%
greater in 1974-1975 than that in 19711972, and has at least paralleled and
perhaps slightly exceeded the increased
costs of research. The number of funded
research projects has held fairly steady
the past three yea rs. Members of the
faculty in most departments have been
diligent in preparing detailed proposals
for research support.
University policies have been developed to maximize opportunities for faculty members to compete for extramural
funding. The creation of physical facilities for research such as laboratory and
officespace and animal quarters and spec-

Vice-Presid ent f or Plannin g and Research
Task Force member George M. Norwood.
Mr. No rwood has been app ointed Int erim
Presid ent of Tj U f ol/owin g the death of Dr.
Peter A. llerbut (see page 48).

3

James W. Stratton .was Chairman of the Task Force on Research, Master
Planning Committee, Board of Trustees. The College also has a Standing
Committee on Research of which Dr. Paul A. Liberti is presently Chairman.

cialized equipment such as ele ctron microscopes and computer terminals, are
taken as institutional responsibilities, although the funding for equipment is often obtained via proposals initiated by individual members of the faculty. A recent
example is the University 's expenditures
in support of research facilities for the
Cardeza Foundation. The new facilities
in the Curtis Clinic are a vast improvement over the old.
Currently, patient care activities are
being moved out of the Curtis Clinic to
provide additional space for the expansion of clinical departments and allow
for increased research activities. Among
the expanded facilities are those recently developed for the Departments
of Surgery, Neurosurgery, Orthopaedic
Surgery and Medicine. Others will be
completed as funds become available.
This expansion, coupled with the facilities available to the basic scientists in
Jefferson Alumni Hall, will place Jefferson in the enviable position among medical schools of having adequate research
space for both basic and clinical departmental research.
Productive scholarly activity is expected of each member of the faculty.
Nowhere is this idea more clearly expressed than in the criteria for appoint4

ment and promotion of faculty members of Jefferson Medical College.
Research accomplishment, as evidenced
by scholarly publications, is required for
promotion at all steps, with increasing
productivity at each level.
A University policy affecting research
output, vis-a-vis that of other institutions, is that we shall have a relatively
large medical student body with a relatively small number of full-time faculty.
Jefferson ranks in the lowest quarter of
American medical colleges in terms of
the full-time faculty/ student ratio. Essentially all members of the volunteer
faculty generate their income from private practice and hence have limited
time to conduct research projects.
A related policy is dictated by the necessity to replace our obsolete clinical facilities. At this time our resources are
being severely taxed to accommodate
the need for capital funds for the new
Hospital. Although it is regrettable that
we could not reach the ultimate goal of
the Sesquicentennial Campaign within
the two-year period the funds that have
been collected make possible the freeing
of some space for expanded clinical research by moving patients to the newly
acquired Health Sciences Center at Ninth
and Sansom Streets. Just as the avail -

ability of Jefferson Alumni Ha ll has
made possible the acquisitio n and retention of research oriented basic scien tists
the completion of our reno vation and
building programs will enhance the potential for clinical resear ch. Ho pefully ,
budgetary limitations will not delay
these renovations of the Curtis Clinic.
Also the lack of a clini cal research center
is indeed a deficiency. How ever , the policy of maintaining fiscal stability requires
that we cannot operate such a high cost
facility in the absence of extramural
funding. Rapidly rising costs inclu ding
such items as fuel, elec tricity and wage s
of service personnel cause additional difficultie s for researchers. Th ese are troubled times for all institutions of higher
learning especially those privat e universities conducting sizeable research programs. Inflationary pressures that impinge on all colleges and universities
especially affect medi cal centers. The
lack of intramural or University funds for
new faculty members also is a limiting
factor. Thus item two of the Board resolution is most heartening.
Th ere has been an increasing emphasis on resear ch in the basic sciences in
the past few decades at Jefferson. Examples of resear ch activities in these departments follow :
Anatomy: cyto physiology; comparative
anatomy; comparative, experimental
and reproductive endocrinology ; neuroendocrinology; lip id me tabolism ; experimental embryology and terat ology;
fetal and perinatal anat omy; experimental neuroanatomy; tissue culture.
Biochemistry : immunochemistry (nature of antigen-antibody interaction; genetic control of immune respo nse); enzymology; cell biology; metabolism of
amino acids , carbohydrat es, lipids, nucleic acids , and vitamin B-12.
Microbiology: microbial physiology and
genetics; virolo gy, mycology; parasitology ; pathogenesis of infecti ous disease; immunology; and clini cal
microbiology.
Pathology: renal pathology; radiation
patholo!,ry; cytochemi cal and ult rastructural studies of the nucleolus; regu lation of cellular growth; use of enzymes to control tumor growth.
Pharmacology: toxicology (including
biochemical toxicology); dru g metabo-

lism; neuropharmacology; psychopharmacology.
Physiology: neurophysiology of slee p
and gast rointestinal function; physiology of renal failure; physiology of
edema; cardiovascular physiology and
shock; metabolic effects of ischem ia;
contractile processes in smooth muscle.
In the documentation provided to
President Herbut, the University Advisory Committee on Research concluded
by noting that a true university must rank
research with teaching and public service including patient care. Attainment of
excellence in research requires great effort by all parts of the institution. The
possible leveling off of support for research and the lossof major federal grants
in support of medical education portend
difficult times ahead. Present facilities
must be built up and supplemented as
new education programs and responsibilities evolve. The specter of having to
freeze unfilled positions and impose additional teaching and service responsibilities is difficult to contemplate. Ways
must be found to continue to attain a cri tical mass of productive researchers and to
promote an environment conducive to
cr eative scholarship.
Finally on the national scene it should
be noted that the Congress recently
overrode the Pr esident's veto of a bill
appropriating increased funds for biomedical research. Our elected representatives undoubtedly were impressed by
the stand of Organized Medicine. Following are paragraphs from a recent
resolution regarding the matter passed
by the American Medical Association:
o The support of biomedical research is the responsibility of both government and private resources. The federal governme nt, for its part, must
sustain, with high priority, major appropriations to all federal agencies that
have responsibility for the support of
biomedical research, including training
for thi s research. Such support is warranted not only for humanitarian but
also for economic reasons. The cost benefits of medical research are dramatically illustrated by the investments
made in virus research that led to several effective vaccines against infectious
disease. At today's hospital costs, for example, the nation saves $2 billion per

year because of the vaccine against
poliomyeli tis. Equally large savings
have result ed from chem otherapy for
tub erculosis. Indee d it has been suggeste d that one dollar invested in research saves man y dollars in subsequen t
medical ca re costs.
o Inflation and inc reasingly soph isticated technology have increased medical research costs dramatically. It is
inapprop riate to compare today's research expenditures with those of an
earlier period in absolute dollar
amounts. Government appropriations
and au tho riza tion for b iomedical research and training must take these factors into account; at a minimum, support for research an d training shou ld be
established and sustained at a level that
will bear some consistent relation to the
nation's total expenditure for health.
o Federal appropriations to promote research in specifically designated
disease categories shou ld be limited and
made cautiously. Concentrating research funds in one disease area, such as
cancer, may no t be beneficial either to
the total biomedical research effort or

even to cancer research itself.
o Funds should be specifically appro priated to train personnel in biomedical research. Without adequate
numbers of pe rsonnel trained in both
bas ic and applied biomedical resear ch,
new discoveries for the prevention and
care of disease wili be unlikely. Indentured service or financial or othe r penalties that encumber the use of resear ch
training funds by either institutional or
individual awardees, ar e und esirabl e.
o The American Medical Association will accept responsibility for informing the public on the relevance of
basic and clinical research to the delivery of quality medical care. It is important that the public be familiar with the
goals and methods of biom edi cal science
so that the people and their representative s can effect sound scientific policy.
In closing I should like to urge that
each member of the medi cal community keep in contact with our elected
representatives and assure them that resources allocated for biomedical research represents a sound investment in
the health of the American people.

Hi storic Research and Modem Science
A recent abstract by members of
the Cardeza Institute in the Department of Medicine serves to illuminate the historic relationship
between the basic sciences and
modern clinical research. The paper, entitled, "The Effect of In
Vitro Carbamylation on Red
Blood Cell Function," by T. A.
Lane and E. R. Burka, appeared in
Clinical Research, 22 :701A (1974).
The initial work on which this
study was based began in the ye ar
of Jefferson's founding. In that
year, 1824, Frederick Wohler , in
Germany, first synthesized an "organic compound" (urea) from an
"inorganic compound" (silver
cyanate), and thus founded the science of Organic Chemistry, a cornerstone in modern biomedical research. Some 148 years later urea
was tested as a possible therapeutic agent for the treatment of
sickle ce ll anemia. It was noted

subsequently that cyanate ions are
pr esent in aqueous solutions of
urea, and that cyanate is an effective carbamylating agent; it reacts
with the N-terminal amino aci ds
of the ,a-chains of sickle cell hemoglobin and prevents aggr egation, the cause of the devastati ng
clinical picture. Sodium cyanate
now is being tested clini call y as a
possible th erapeuti c agent, and
the study conducted at the Ca rdeza Foundation is one of those
concerned with det ermining its effects on enzyme syste ms in the red
blood cell.
It is of interest that W ohler 's
work of a century and a half ago
was performed in his " teac hing
laboratory" in Cettingen, just as
biomedical research is conduc ted
today in the teaching laborat ories
of Thomas Jefferson University
and other academic medical centers throughout the world.
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T JU Research: Activity and Productivity
Jefferson scientists detailcurrent
projects in five representative
research areas.
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Using Polymers of Amino Acids
to Study Genetic Control
of the Immune Response
by Paul H. Maurer, Ph.D.

For the past 20 years or so we have employed synt he tic polym ers of amino
acids as molecular models for proteins
to study many paramet ers of the immune response. Th e synthe tic polym ers
that hav e been used have contained one
to thr ee and sometimes four amino
acids, eithe r polym er ized in random
fashion or most recently as sequential
polymers of amino acids wh erein we
know the exact sequences of the three
to four am ino ac ids repeated in the
polymeric chain. Th e initial emphasis
for this resear ch was to study some of
the paramet ers responsible for th e property of immunogenicity, i.e. the ability
of macromolecules which had the size
of proteins, to elicit an immune response in many different species. Associated with thi s was the goal to develop a
protein-like mat erial that could serve as
a synthe tic plasma volume expa nder
and not elici t immune responses. Although this goa l was not reached , man y
othe r studies in our own laboratories, as
well as in several oth ers throughout the
world , have yielded information about
many of the molecul ar properties of
macromolecules whi ch contribute to
the enhancement or the depression of
imm une responses.
Duri ng our studies with expe rimenta l
animals it becam e obv ious that one of the
major components respon sible for the
ability of a host to respond immunologically was associated with the "gene tic
ba ckground of the individual." Since
then many studies with random and inbred spec ies such as mice, guinea pigs,
rats and monkeys have indicat ed that the
capacity to form speci fic immun e responses is gove rned by the product of individual dominant (termed im mune response [Ir]) genes locat ed in the genome
Dr. Maur er is Professor of Biochemistry
and Chairman of the Department.

in close relationship with the gen es coding for the molecules responsible for the
histocompatibility specificities.
Th e major advantage of using synthetic polypeptides for immunological
studies is that we have been able to
pr esent the host with a protein-like
molecule having "limited structural heterogeneity." As is known, proteins are
complicated molecules and a host can
usuall y respond against man y different
ar eas on the macromolecule. However ,
by employing the synthetic polyp eptides and measuring the immune responses by a variety of techniques it has
been possible, in a relatively short time,
to demonstrate that the responses to a
wide variety of antigens are under the
control of what is now call ed dominant
histocompatibility-linked immune response genes. Because of the exceedingly complex nature of the immune response and the immune phenomena,
this kind of finding was a surprise to us
and other immunologists.
Before proceeding furth er , it is important to recognize that man y of th e
studies ar e collaborative in nature. Although the ea rliest observations wer e
mad e with the lat e Dr. Paul Pin chuck ,
who was associated with us at Jefferson
for a short tim e, during the past seven
years oth er faculty, such as Dr. Carmen
F . Mer ryman and Dr. Allen R. Zeiger ,
and a number of postdoctoral and predoctoral stude nts here at Jefferson have
contributed greatly to the fi eld. Th e collaborative effor ts of many ar e necessary
because of our multifaceted approach.
In ord er to und erstand the subsequ ent
discussion, it is necessary to know a littl e
abo ut the pr esent conce pt of the immune
response. It is acknowledge d that ther e is
a conside rable complexity in the cellular
eve nts associat ed with an antibody response to an antigen. Th e humoral (antibody) response must involve at least two ,

and probably th ree, cell populations; the
B cell lymphocyt es deriv ed from the
bone marrow, the T cell lymphocyt es of
thymus origin , and the macrophages. The
B cell can manufacture antibody after it
has come in appropriate contac t with
some determinants on the specific antigen. It is now well established tha t this
event does not occur in isolation but isdependent on some kind of signal emi tted
only if there is a recognition of "carrier"
det erminants on the anti gen by the T cell
or a T cell product. Whil e the role of the
macrophage has not been clearly defined, it appear s to be act ing by acquiring
a sur face receptor from the T cell so that
it combines antige n for presentation to
the B cell. This has been refer red to as the
collaboration between these three cells,
the T cell, the Bcell and the macrophage,
in eliciting an immune response.
Generally, in all of our studies we use
several different paramet ers to measure
the immune response. First and foremost, we measure the amou nt of specific antibody in the serum employing
radioactively labelled antigens and
some standa rd radioimmunoassay
pro cedures. This humoral response measures the B cell functi on. However, depending up on the spec ies being studied,
we also measure othe r parameters of the
immune response, such as the presence
of sensitized T cells. In the guinea pig,
we employ skin testing of the animal
with the antigen and look for a delayed
reaction as a measure of T cell response.
However , in the mouse, rat and guinea
pig studies we also isolat e the T cells
and measure the ability of the T cells to
respond in tissue culture to antigen as
an indirect measur e of the state of those
T cells in th e immunized animal.
As mentioned before, our initia l findings with polym ers of amino acids indicated that ther e must be some genetic
component associated with the responses again st the fairly simple " proteins." With a number of the polymers,
such as those conta ining glutamic acid
and lysine (G L), gluta mic acid , alanine
and tyrosine (GAT), glutamic acid, lysine and alanine (G LA) and glutamic
acid, lysine and phenylalanine (GLp) , as
well as a number of the seque ntial polymers of amino acids, it is appa ren t that
one can divid e any population of a spe-
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cies studied into "responders" and "nonresponders" to the specific immunogen.
One of our major goals is to learn why
some animals are responders and others
nonresponders. We also are interested in
the nature of the receptors on T cells and
on B cells responsible for the interaction
with the antigen and in what kinds of molecular changes might occur during the
interaction of antigen with antibody either in vitro or in vivo. Much of the in
vitro research in the Department is conducted by Drs. Paul A. Liberti and Hugh
J. Callahan who are studying how antibodies interact with antigens and what
kinds of conformational changes might
be occurring in the interacting molecules
at the cellular level. The interacting
molecules are responsible for the transmission of "signals" to the appropriate
lymphoid cells to proliferate and to recognize more antigen.
Although not all of the questions about
the immune response genes work have
been answered, we,as well as many oth ers,ar e clarifying some aspects of the
genes' mechanism of action, and at the
same time are uncovering many other unsolved problems in immunology.
Our earliest studies involved the randomly bred Hartley guinea pig. Although there were genetic clues, in order
to prove more conclusively that there in-

deed was a genetic component associated with the immune response, we
eventually had to use inbred strains of
guinea pigs. However, there are available in the world only two highly inbred
strains of guinea pigs, the strain 2 or the
strain 13 guinea pig. The remarkable
findings observed then and which are still
being uncovered today with a number of
our polymers is the tremendous difference in response patterns of these two inbred strains of guinea pigs against some
of our polymers. For instance, the random polymers of glutamic acid and lysine (GL) and glutamic acid and alanine
(GA) can elicit responses only in the inbred strain 2 guinea pigs. In contrast to
this, the polymer of glutamic acid and
tyrosine (GT) can elicit responses only in
the strain 13 guinea pigs. The exquisit e
sensitivity of the animal's recognition
mechanism to subtle changes in structure
of a polymer has been shown in our laboratory with the sequential polymers synthesized by Dr. Allen R. Zeiger. A polymer having the repeating sequence of
tyrosine, glutamic acid, alanine and glycine elicits responses only in the strain 13
guinea pig, whereas the polymer of tyrosine, alanine, glutamic acid and glycine
elicits responses only in the strain 2
guinea pig.
Since these earl y studies with guinea

pigs, we and other int ernational investigators have contributed information
which indicates that there must be at least
30-40 immune respon se genes controlling
responses in the mouse, guinea pig, rat,
monkey and man .Th ese genes are dominant and they determine both the cellu lar
and humoral immune responses.
In studying the immune response pat terns of inbred mice against a numb er of
the polymers, how ever , we made the remarkable observation that the responses
were not only und er genetic control,
but they also wer e linked to ano ther
group of antigens, the complex of histocompatibility antigens. Th ese histocompatibility antigens are located on
the surfaces of cells and although their
normal fun ctions ar e unknown, it is
known that th ey are the antigens most
responsible for the rejecti on of transplanted organs. Th e major initial advantage of using the mouse in study ing the
immune responses was the availability
of man y different strains. Th e development of these man y highly inbred
strains took place because of the growth
of another branch of imm unology dealing with elucidation of the mechanisms
of the graft vs. host ph enomena (transplantation immunology). It was shown
that in every species ther e are important histocompatibility genes and gene

Dr. Paul H. Maur er: basic studies revealing many of the param eters of immrlll ogenicity.
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products, known as the antigens, which
are the basis for immunological individuality and determine whether an individual will reject a graft as foreign. During the past ten years, based upon the
chance observation made initially by
Dr. McDevitt of Stanford, we have
learned not only that the immune response is under genetic control, but that
the ability to respond or not to respond
is linked to the nature of the major histocompatibility complex of the mouse.
This also has proven the case in studies
using many other species. The concept
of genetic linkage means that the genes,
such as those governing immune responses and those responsible for the expression of histocompatibility antigens,
are transmitted together from parent to
progeny; therefore both of these genes
are likely to be close together on the
same chromosome. Employing what are
now the tools of a new area in immunology, immunogenetics, we have been
able to " map" the area in the chromosome responsible for the recognition of
the antigen. The mouse has truly been
the most rewarding species for the study
of the se histocompatibility-linked immune response genes both because of
the number of inbred strains developed
by the students of tissue transplantation,
and because we have available specific
lines of mice which have slight differences in this histocompatibility complex
(H-2). By studying the response patterns
of many similar mice it has been possible to determine the chromosomal segment in the gene complex responsible
for these responses, which immunologists have termed the 'I region:
In an area of research which moves as
rapidly as the fields of immunology, immunochemistry and immunogenetics,
surprise findings are occurring all the
time, that suggest future research.
We were puzzled, for instance, when
our observations in determining the location on the mouse chromosome of the
gene controlling the response against
the polymer of glutamic acid, lysine and
phenylalanine were incompatible with
our previous findings and those of others studying a similar system. Upon further investigation it became apparent
that with this polymer the responses
were controlled by at least two genes

acting in a complementary fashion
rather than by a single gene. In other
words, it appears that two genes are
needed to control responses (multigenic
control) against some of the polymers, a
finding that has been corroborated with
different kinds of polymers by several
laboratories throughout the world.
From our research it has become
clear that the responses specified by
these immune response genes involve
the activities of the T lymphocytes. As
indicated before, there are two major
classes of lymphocytes which participate in the immune responses. The B
cells are the precursors of the antibody
secreting cells and are responsible for
humoral immunity. The T cells are the
effectors of cellular immunity and may
act directly to destroy foreign antigens
including transplanted organs. They
also regulate antibody production either
by helping or suppressing B cell activities. It therefore appears that the immune response genes to which we have
been referring are expressed mainly on
the T lymphocytes and actually may be
involved with the receptors for the antigen. In other words, one of the important mechanisms we know today is that
the T cells which recognize antigen
help the B cell produce the humoral immune response.
The explanation that we and others
had offered a number of years ago (to
explain responsiveness and nonresponsiveness) was that the inability to respond against a specific immunogen was
related to a defect in the T cell recognition of the antigen. That is, nonresponders were lacking T cells that could
help the B cells. However, a few years
ago in collaboration with Dr. Richard
Gershon of Yale University we were
able to show that the nonresponding animals could also " recognize" the antigen even at the T cell level, but that this
recognition involved interaction with
another class of cells now termed suppressor T cells. It is now apparent that
associated with the complexity of the
immune system is the importance not
just of T cells, but of different kinds of T
cells-those that can help the B cell,
those that can suppress the B cell.
An important part of our studies is
therefore to separate the various popu-

lations of lymphoid cells within an an imal for in vitro tissue culture studies.
Dr. David J. Ganfield in our resea rch
group is attempting to fractionate lymphoid cells and isolate the T cells from
an immunized animal and employ them
in tissue culture techniques to determine the response s of the T cells to
challenge with antigen. W e an d others
have demonstrated that responder T
cells can reco gnize the antigen in vitro,
proliferate and eventually characterize
the nature of this receptor.
Although there is little contro versy
about the nature of the reco gn ition
molecules for antigens (rece pto rs) on
the B cell (they are antibody molecules),
the question of the identity of the receptors for the antigen on T cell is in
considerable dispute. Some investigator s believe that the T cells ha ve receptor s consistin g of the imm uno globulin
(antibody) molecules, and othe rs can
find no evide nce for their p resence. We
are involved in a great effort to isolate
from the sur faces of T cells macromolecul es which might be responsible for the
in vivo reco gnition of the antigen. This
is literally more difficult than looking
for a needl e in a haystack ; even after
one finds th e needle, one must determine wheth er this needl e (receptor) has
come from the T ce lls or from some
oth er lymphoid cell.
Although almo st all of our research
can be considered basic and has involved laboratory animals, there are important implications of our resear ch
which may contribute to a bett er und erstanding of human diseases. Although
we have found that th e responses
against a number of antigens are controlled by gene s which ar e closely
link ed with th e major histocompatibilit y complex in a number of species, the
all important qu estion is: " Does this
have any relevance to man?" First of
all, in animals, associations have been
shown between the nature of H an tigens
and diseases such as autoimmune thyroiditis in mice , the susce ptibility of rat s
to experimental allergic ence phalomyelitis, and the susceptibility of mice
to the pathogeneic effects of lymphocytic choriomeningitis virus . Wh at about
man? A number of investigators have
been showing associations between a
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number of human diseases and the specific histocompatibility antigens of man
(HLA). Most of the diseases are associated with defective or aberrant immune
responses and many are thought to be of
"autoimmune origin," i.e. they may be
caused by an immune system attack on
the body 's own tissues. They include ankylosing spondylitis, Reiter's disease,
psoriasis, Graves' disease, multiple sclerosis and ragweed fever. In addition,
there appears to be an important role
for these histocompatibility linked Ir
genes in the development of tumor immunity and tumor rejection, not only in
experimental animals but possibly also
in man. It is known that malignant neoplasms bear distinct and new tumor specific surface antigens which are responsible for the stimulation of tumor
immunity. The immune responses to tumor specific antigens are recognized as
being very complex, involving cellular
immunity, cytotoxic and blocking antibodies and the possible involvement of
the class of T cells we referred to before

Devel opmental Biology
and Radiation
Embryology at the
Stein Research Center
by
Robert L. Brent, M. D., Ph.D.

as suppressor cells. In fact, for reasons
unrelated to the study of tumor immunity per se, it has been shown that there
are genetic factors controlling the susceptibility to Gross virus leukemogenesis in inbred mouse strains and that
even in the mouse these genes are
. closely linked to the mouse H-2 genotype. Similarly, in mice, the susceptibility to Friend virus leukemia is also
linked to the H-2 complex.
Observations of this kind have led to
another collaborative study with Dr.
Dan Moore of the Institute for Medical
Research in Camden, who has been
studying the transmission of the breast
cancer virus from mother to offspring
via the milk in inbred strains of mice.
Dr. Merryman and I are now involved
with Dr. Moore in investigating the possible role of the H-2 complex of the
mouse in determining resistance or susceptibility of a mouse strain to murine
breast cancer. Again, the implications in
human breast cancer are great.
The possible relationship between tu-

mor susceptibility and HLA genotype
might be explained by the absence or
presence of the appropriate immune response genes in a susceptible individual
which could render the person incapable of developing an adequate immune response against the tumor specific antigen. In fact, the immune
system, which is a unique immune surveillance machinery, is believed to be
important in removing tumor cells.
What started about 25 years ago as a
study associated with an applied problem, the development of a synthetic
plasma expander, has moved through a
number of basic studies and revealed
many of the parameters of immunogenicity. By understanding the role of genes
in controlling immune responses, we
hope it will be possible to apply these
findings to the enhancement or depression of the immune response, depending
upon the specific problem at hand, i.e.,
to enhance the response to cancer antigens and to reduce the response to
transplantation antigens.

The Stein Research Center houses clinical research and teaching programs of
the Departments of Radiology and
Radiation Therapy. At present, there
are three major activities housed at the
center: 1) the Medical Physics Division
of the Radiology Departments; 2) a portion of the Radiation Biology section of
the Department of Radiation Therapy
and Nuclear Medicine and; 3) the Radiation Biology and Developmental Biology programs of the Radiation Biology
section of the Department of Radiology.
Actually three-quarters of the space and
personnel are devoted to programs in
developmental biology and radiation
embryology, and since I am intimately
involved in these programs, I shall concentrate on these activities.
The goals of the faculty and research
staff members are multifaceted. We
have always encouraged medical student participation in our research pro-

grams even when a student indicated he
just wanted a "taste" of research. It is
just as important for a medical student
to know that he is not suited for an investigative career as it is to know that
he wishes to devote the remainder of his
life to creative research. Predoctoral
candidates from the Departments of
Anatomy, Physiology, Biochemistry and
Pharmacology have conducted their investigative programs at the Stein Research Center as part of the requirement for the Doctor of Philosophy
degree. Postdoctoral candidates from
diverse fields such as pediatrics, obstetrics and gynecology, endocrinology,
pharmacology, anatomy. medical physics and biomedical engineering have
trained here.
The development of a research philosophy and the establishment of undergraduate and graduate research programs cannot be undertaken and cannot
be characterized as quality programs
without the presence of ongoing research programs conducted by the permanent staff at the Stein Center or any
research center.
The developmental biology and radi-

Dr. Brent is Professor of Pediatrics and
Chairman of the Department, Professor
of Radiology (Radiation Biology), Professor of Anatomy and Director of the
Stein Research Center .
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ation biology programs ar e supported by
outside govern mental agencies and nonprofit foundati ons. Research support for
pr esent and pa st programs has been obtain ed from Th e National Foundation",
Th e Royal Societ y of Medicine, The National Institute of Child Health·, The Fogarty International Center, The Atomic
Energy Commission, The Energy Resource and Development Agency" , Th e
ational Institute of Environm ental
Health Science" and Smith, Kline and
French Labor atori es.
Although the developmental biology
pro grams can be considered modest, the
total budget from outside agencies since
I came to Jefferson amounts to more
than three million dollars. Besides the
research fundin g, th e developm ental
biology pro grams at the Stein Center
receive othe r suppo rt. Without some
faculty support from th e Jefferson Medical Co llege th e Stein Center could
never have been developed . Th e ge nerous gift of Mr. and Mrs. Loui s Stein, the
Elean or Roosevelt Foundation and th e
NIH permitted the structur e to be built.
Dr. Philip J. Hodes, Em eritus Professor
of Radiology, spe nt much of his tim e
and ene rgy in conce iving and working
for th e crea tio n of a Radiolo gy Department resear ch institute. Ongoing unrestricted support has come from a group
of dedi cated donors such as the Harry
Bock Chari ties and th e League of th e
Harry Bock Charities. Th ese gro ups
hav e work ed tirelessly to support th e
prog ram at the Stein Center and, in
fact , th e developmental biochemistr y
laborat ories on th e second floor are
known as the Har ry Bock Laboratories.
Th e resea rch program s of the develop men tal biology gro ups include pr oblem s
in radiati on embryo logy, fetal ph ysiology, plac ental transport developmental
immunology, embryo culture, effects of
microwave radi ation, fetal endocrinology, teratol ogy and legal medicin e.
Studies in radiation embryology hav e
been con duc ted continuously at Jefferson since 1957. The results of th ese studies have clarified the qu ant itative aspect s of the effects of radi ati on on the
develop ing mammalian embryo . Some
"Present li] supporting research or ed ucational programs in developm ental biology and radiati on biology.

Dr. Robert L. Brent : Our radiation embryology studies haoe clarified quantitati ve aspects of tile effects of rad iation on tile develop ing embryo.

important conce pts that have developed from thi s research include:
1) Embryonic and fetal growth retardation are intimately associated with
malformations produced by radiation.
2) Th e embryo, whil e very sensitive to
radiation , also has sophistic ate d repair mechani sms whi ch ca n prevent
th e effec ts of radiation if the dose
rat e and dose are very low.
3) The pr eimplantation peri od of mam malian development is a stage that is
resistant to th e teratogeni c and
growth retarding effect s of radiation.
4) X-ray exposures below ten rads hav e
no ability to pr odu ce gross malforrnations in this mammalian e mb ryo.
Th ese and other radi ati on studies
have permitted the staff to become
quite sophisticated in the eva luatio n of
human radiation hazards to the pregnant wom an. As a result , our laboratory
is a ce nter for the evaluation of radi ation effects in exposed potentially

pr egnant or pr egnant women. We receive approximat ely 100 calls each year
from all over the United States pertaining to such radiation ha zards. Besides
ca lls about radiation hazards we receive
requests for information about drug and
che mica l hazard s during pregnancy.
Developmental immuno logy research
hasbeen co nduc ted by Marcela Jensen,
Dr.Christoph er C. K. Leung, Dr . Thomas
R. Koszalk a and Dr. Ronald P. Jensh for
man y year s. In 1961 we first reported the
production of conge nita l ma lfor mations
by injecting het erol ogous anti-rat kidney
anti serum into pre!:,rnant rats. Th iswas the
first rep ort that a specific immunoglobulin co uld be a potent ter atogen. While
othe r investigat ors had repor ted congenital malform ati ons Foll owing exposure to
foreig n a nt ibodies, none of the findings
was corrobo rated. This discovery led to
the reali zati on tha t the teratogenic antiserum was locali zed in th e yolk sac. Dr.
Koszalk a, Dr. Jensh, Dr. Leungand Ms.
11

Jensen have begun extensive investigations dealing wi th yolk sac function, placental transport, collagen synthesis in the
developing yolk sac and are attempting to
isolate yolk sac and kidney antigens. Since
the human hasa vestigial yolk sac when
compared to the rodent, this line of investigation has raised an interesting que stion. If the yolk sac isa critical organ in rat
teratogenesis, are rats or other rodents appropriate species to utilize for screening
drugs and chemicals for potential human
teratogenesis?
Dr. Koszalka, who is Professor of Radiology and Biochemistry and Director of
the Developmental Biochemistry Laboratories, works with all members of the
developmental biology staff and is involved in his own program of placental
transport and muscle biochemistry. He
has continued wi th his studies dealing
with the mechanism of creatinuria following X-irradiation and the fact that insulin can reverse the creatinuria of radiation injury. His expertise in creatine
metabolism has permitted us to study
normal and abnormal transport in placenta and the transport of agents which
result in transplacental carcinogenesis.
Dr. Jensh, whoisAssociate Professor of
Anatomy and Radiology, was the first
Ph.D .graduate supported by thedevelopmental biology program and has maintained his interest in teratology and developmental biology. In 19700ur
laboratory reported that high exposure
microwave radiation could cause interruption of pregnancy. Because of exper-

(right) Home: These enclosures of Dr.
Brent 's contrivance are fitt ed at the
top with inexpensiv e lab bottles,
allowing their experimental rat
inhabitants a ready and clean source
of wat er. (far right) Technicians in
Dr. Wh eelock 's lab remove mice
spleens. Transfer of spleen cells fr om
FL V infected mice in large numbers
to normal mice produ ces FL V
erythroleuk emia.
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point. Dr. E. Mar shall John son is Chairman of the Anatomy department and is
well-known in th e field of teratology.
He has been a long -term colleague of
mine . With his coming to Jefferson in
1972 and the creation of a solid contingent of dev elopmental biologists in the
Department of Anatomy, the Med ical
College now ha s one of the stro ngest
multidisciplinary programs in developmental biology in th e country. Furthermore, th e pro gram is now attracting the
interest of other faculty mem bers and
there is an excellent possibilit y that research programs will be init iated that
will cross departmental lines and be
able to answer the multitude of questions that pertain to th e myste ries of
embryoni c development. For those who
may consider ba sic embryology and teratology to be esote ric and far from
clinical medicine, let me point out tha t
congenital malformations, mental retardation and gen etics contribute an
inordinate burden to mankind. The cost
of custodial care for childre n and adu lts
with pr enatal disease is staggering. The
rec ent advances in genetic counseling,
cytogenetics, transplacental carcinogenesis, amniocentesis and perin at al ca re
make our efforts in th e developm ental
biology laboratory even more meaningful. Twent y yea rs ago no one could
have imagined that ther e would be so
many clinical advances in the field of
applied developmental bi ology, wh ich
is just another name for ped iatri cs and
obstetrics and gynecology,

tise in this area, Dr. Jensh received a grant
from the National Institute of Environmental Health Service to study the effects
of microwave radiation on the developing embryo. Dr. Wolfgang Vogel isan intimate partner in the areaof animal
psychological testing. Mr. Irvin Weinberg,a biomedical engineer, has designed
the anechoic chamber and microwave
equipmentfor the project (seecover).
Other contributions of the developmental biology program include:
1) The production of congenital malformations utilizing the technique of
uterine vascular clamping;
2) The report that the individual embryo was frequently an erroneous
sample in teratologic testing;
3) The preparation, at government
request, of a soon-to-be released
monograph entitled, "The Prevention of Embryonic Fetal and Perinatal Disease;"
4) The refocus of embryonic nutrition as
an important area for developmental
biologists for the next decade;
5) The analysis of the basis of malpractice litigation involving congenital
malformations and the development
of a national plan to decrease malpractice litigation;
6) The training of developmental biologists who have gone on to head
their own programs at other major
medical centers;
7) The attraction of other developmental biologists to Jefferson.
I would like to elaborate on the last
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Understanding the Tumor Dormant State
by E. Frederick Wheelock, M.D., Ph.D.

Current treatment of human cance r
co nsists of surgery, che mothe rapy, X-irradia tion, immunotherapy or co mbinations thereof. A co mmon measur e of
successful tr eatment is fi ve-year survival
witho ut recurren ce of tum or. All too often, however , tumor ce lls reappear eve n
after prolonged clini cal remission. Such
tum or ce lls hav e, by some as ye t unknown mechanism, escaped destruction
during the remission period despite
bein g held in chec k. To dat e, few if any
studies hav e dir ectl y addressed themselves to thi s qu estion of tumor dormancy. Thi s is sur prising, since it is th e
inability to er adica te residu al tum or
ce lls completely that often thwarts our
best attempts to achieve a can cer cure .
The present lack of knowledge with respec t to the forces involved in maintaining and breaking tumor dormancy
hind er s our ability to do mor e during
this cru cial period.
Th e principal objec tive of th e research conducted in my laboratory has
been to understand th is relati onship betw een host and dormant tumor ce lls and
manipulate it in favor of the host. W e
have developed two major expe rime ntal
animal model systems, one a virus induced leukemia of mice and the other a
chemically induced transplantable lyrn-

phoma of mice. These experime ntal
mod els ar e highly manipulatabl e and
will permit an anal ysis of th e tumordormant state .

Friend Leukemia Virus
Friend leuk emia virus (FLV) is one of
a number of antigenically relat ed leukemia viruses of mice. Infection of adult
inbred mic e with this virus produces
ery throleukem ia in 100% of mice charact erized by hepatosplenomegaly and
lar ge numbers of er ythroblasts in the
circulation within 21 days. All leuk emi c
mice ar e dead within ten weeks aft er infection. FLV infe cts man y ce ll typ es in
th e host , including lymphocyt es, and infecti on leads to a rapid suppression of
both humoral and cellular immunity.
Reasoning that the immunodepression
induced by FLV might be essential for
its leukemogenicity, we sought wa ys to
restore immune competen ce to FLV infect ed mic e and th ereb y permit th e host
to mount an immune response to th e
vir us.
W e found that 100% of DBA /2 mice
wer e vire mic and had lar ge numbers of
leuk emic cells in th eir splee ns by the
third day aft er virus inoculation. An exten sive search was made for a drug or
other biologic agent that could suppress

FLV ery throleukemia when administered three days after FLV inoculation.
Such an agent was found in an extract of
virus infected Penicillium stoloniferum
fungal cultures . Th is extract, called
stat olon, could, whe n combined with
another adjuvant, CO AM (chlo rite oxidiz ed oxyamy lose) suppress erythroleukemi a in 90% of FV infec ted mice . We
fou nd that COA M-statolon treatment
results in int erfero n production and a
transient suppression of FLV replication. Virus is cleared from the blood and
the mice produce an antibody which
neutrali zes th e virus an d kills leukemic
ce lls, in vitro. Sta tolon treat ed mice suppr ess their FLV infecti on and are clinically nor mal displaying no gross pathologic, clini cal , or hem at ologic manifestations of leuk emia for their entire twoyear lifespan. However , FLV emerges
spontaneously lat e in life in some of the
mice to produce charac teristic erythroleuk emi a indicat ing th at the virus was
present in a dormant sta te during the
prolonged clinical remi ssion. Attempts
to isolate infective FLV from the blood
or spleen of th ese mice during remission
hav e be en unsuccessful. However, trans fer of th eir splee n ce lls in large numbers
to normal mice pr odu ces FLV erythroleuk emi a indicat ing that the virus
and/ or leuk em ic ce lls were present in
th e clin icall y normal mice.
Th e persistence of F LV infected
spleen cells in clinica lly normal mice
for man y months co uld be explained by
tw o possible mechanisms.
1) Large numbers of spleen ce lls are
infect ed and co ntain th e genetic informati on for FLV int egr ated into their
ce llular 0 A. Random reactivation of
the virus may occ ur in dormantly infected ce lls resulti ng in virus replication
and pr odu cti on of new virus-induced
antigens on the surface of tra nsformed
ce lls. Fri end virus cy totoxic antibody
present in the extracellular fluid at sufficient levels recognizes these foreign
viral an tige ns and destroys the transforme d ce lls as they a re formed. Howeve r, as mice age, an tibody levels decl ine and F LV tra nsfo rmed cells br eak
th rough to prod uce overt leukemia.

Dr. W7l eelock is Prof essor of Microbiology.
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Dr. E. Frederick Wh eelock: The objective is to manipulate tile host-dormant tumor cell relationship in fa vor of the 1I0st.

Th ere is, however , one flaw in thi s
hypoth eti cal mech anism . Th e FV-specific antibody requires complement to
kill cells. In our in vitro assay we add
guinea pig compleme nt. How ever in
vivo the antibody cannot kill leuk emic
cells since the DBA/2 mouse is deficient
in complement components essential for
antibody mediated immune cy tolysis.
What then is the function of this antibody in the animal itself? Is it in some
way involved in sup pression of unc ontro lled leuk em ia cell division and establishme nt of the dorm ant sta te? Th e answer may be found in the ph en omenon
known as antige nic modulation, first report ed in 1963 by T. Boyse and L. Old
and subseque ntly dem onstr at ed in a
nu mber of immunolog ic syste ms. Antigeni c modulation is a phenom en on in
which phen otypi c expression of anti gen
at the cell surface is modulated by the
pr esen ce of spec ifi c antibody in the extracellular fluid. Old mad e the unexpect ed obse rva tion that mice immu nized and containing complement and
14

antibody against cell surface leukemic
antigen s were not resistant to out growth by those leuk emic ce lls. Th e
mechanism of escape of the leukemic
cells from the immune response was investigated. Old found that leukemic
cells existing in the presence of leukemia specific antibody lost their leukemia specific cell surface antigen so
that the cells were no longer susceptible
to attack by specific antibody. Removal
of the se modulated leuk emi c cells to a
non-antibody containing environme nt
result ed in reappearance of the leuk emic-specific sur face anti gen.
This phenomenon has recentl y been
impli cated in several human diseases. In
suba cute scler osing panenc eph alitls , this
mechanism may account for the escap e
of measles virus-infected cells from the
high titered Virus-specific antibody
pr esent in the blood for man y years.
Modulation of cell surface measles virus
antigen by virus-specific antibody has
been demonstrated in vitro and may account for virus persistance in this dis-

ease. It has also been implica ted in Burkitt lymphoma.
Because of the complement deficien cy in DBA / 2 mice, we have developed a second hypothesis for the dormant FLV model.
2) Thi s hypothesis states that the interaction of Virus-specific antibody with
newl y mad e virus antigen at the cell
membrane results in inhibiti on (antigenic modulation ) of the virus genome.
Dormant FLV infecte d cells may persist
with activation occurring at random
and viral cell surface anti gens being expressed and modulated until late in life
when antibody levels decl ine. At this
point, emergence of leukem ia occurs.
One of our graduate studen ts, Eugene
Genovesi, has in the past yea r demonstrate d antigenic modulation in the
Fri end virus system in vitro. Dr . Preston
A. Marx, Assistant Professor of Microbiolo gy and Rosema ry Marano, graduate stude nt, are analyz ing the FLV specific proteins on the surface of leukemic
cells in order to identify the proteins to
which a modulating humoral antibody
response is directed. Characterization of
the antibody which specifically suppr esses the FLV infecti on and development of ways to stimulate production of
this antibody to prevent eme rgence of
leuk emi a are major goals of this laborator y. Another graduate student, Julia
Wirth. is studying the host cellular imrnune mechanisms involved in leukemia
suppression and maintenance of dormant leukemia.

L5178Y Transplantable
Murine Lymphomas
Th e second experi mental model that
we are study ing consists of a chemically
induce d lymphoma of DBA / 2 origin.
Thi s tum or, designated L5178Y, can
consiste ntly grow out and kill DBA/ 2
mice following intr ap eri toneal implantation of as few as 20 viable tumor cells.
Its suitability for study as a model for
tumor dormancy is based pr incip ally on
the finding that DBA / 2 mice tha t have
been immunized with mitomycin Ctr eat ed L5178Y cells routinely resist tumor chall en ges that kill 100% of nonimmunized mice in less than 25 days.

However , exte nded observations of
these immunized and chall eng ed mice
revealed that about 40% of them develope d and succ umbed to asciti c tumors
within 18 months. Th e development of
ascitic tum ors in normal aged DBA / 2
mice has never been observ ed.
Dr. Lester Go ldste in, post-doctoral
Fellow, and Kent Weinhold, graduate
student, have been studying the mechanisms of tum or dormancy in thi s system.
One of our expe rime ntal approach es has
been to isolat e tumor cells from mice
while they are in the prolonged clini cally normal sta te. W e hav e succeed ed
in doing so by placing cells from various
organs of these mice into cell cultures in
vitro and have observed out growth of
tum or cells. Our curre nt efforts consist
of atte mpts to reconstruct in the cell
culture syste m the immune and non-irnmune compone nts of the dormant tumor mouse. Our aim is to und er stand
why tum or cells remain dormant in v ivo
but grow out rapidly in v itro. By adding
selec ted lymphoid cell populations and
rnacr oph ages and solubl e serum factors

Studying Cardiovascular
Physiology and
Function
by Allan M. Lefer, Ph.D.

from tumor dormant mice to the culture
syste m together with tumor cells, we
hop e to identify those factors or combination of factors that maintain the tumor cells in a dormant state in vivo. W e
do know that these tumor dormant mic e
contain an antibody that binds to but
doe s not destro y tumor cells. W e believe that maintenance of the tumor
dormant state may involve the loss of
exposed cell surface target s for host immune mechanisms. The most likely explanation for such loss is anti genic mod ulation. It is also possible that some
surface receptors responsible for regulation of cell division are usually concealed during tumor progression. These
receptors may become unmask ed dur ing antigenic modulation and lead to
the regaining of control of cell division
by the host. It is also possible that tumor
dormancy could be the result of the action of cyto static rather than cytolytic
host mechanisms. Walter Carney, graduate student, is studying this aspect of
the problem using L5178Y cells in
DBA /2 X C57 /B6-Fl hybrids .

Implicit in this line of research is the
hypothesis that modulation of both the
FLV leukemic cells and the L5178Y
lymphoma cells results in reestablishment of normal cell division. The tumor
cells can, however, survive attacks from
immune cells and antibody since they
no longer hav e tumor specific targe t antigens on their surfaces. In contrast with
other tumor systems, in whi ch ant igenic
modulation is view ed as a mechanism of
tumor cell escape from attack by the
immune syste m, we believe that antigenic modulation can lead to tumor
dormancy. The animal model system
which we ar e studying in our laboratory
will enable us to characterize the host
tumor intera ctions that lead to the establishment of the dormant tu mor state
and the events that subseque ntly occur
to break this dormancy and perm it tumor emergence . An und erstanding of
the interaction involved in tumor dormancy and emerge nce would greatly facilitate the development of methods of
prolonging the tumor dorman t period
and eradicating all residual tumor cells.

BeginninginJuly 1974 with the arrival of
several new staff members in the Department of Physiology, cardiovascular physiology became a major focus of research
on cardiovascular function in health and
disease stat es. These new staff members,
who are we ll trained in this area and have
established laboratory programs, are Dr.
Michael J. Rovetto and Dr. James A.
Spath, Jr., Assistant Professors. My own
appointment as Professor and Chairman
of the Department was effective that
July . Each has developed projects which
involve utilizing expertise and techniques in several areas.
Following is a bri ef description of the
typ e of research work conducted in
each laboratory, the professional researche rs leading each proj ect , and the
basic questions being asked by these investigative teams.

tion of toxic factors during hemorrha gic, septic, cardiogeni c, bowel ischemia, acute pancreatitis, and burn
shock. Efforts are being devoted to elucidation of the chemical structure of the
toxic peptide Myocardial Depressant
Factor (MDF), and of the key roles of
lysosomal hydrolases, prostaglandi ns
and kinin s in cardiovascular alterations
during shock and low flow sta tes. Studies are also conc ern ed with prot ease activation and proteolysis in the pan creas
and liver during ischemia and othe r
conditions simulating shock.
Additional studies ar e concerned with
pathophysiologic mechanisms of developm ent of myocardial infarcti on. The
subcellular mechanisms of the spread of
ischem ic dama ge during acu te myocardial infar cti on are being investigat ed.
Pharmacologic studies also are underway
in an effort to det ermine which agents are
useful in the preservation of myoca rdial
integrity during myocardial ischemia.

Ci rculatory Shoc k Resear ch
Hesearch in this laboratory centers
around pathophysiology and therapeutics of circulatory shock with particular
emphasis on the mechanisms of elabora-

Dr. L efer is Professor of Physiology an d
Chairman of the Department.
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Dr. Allan M. Lefer: Since 1974 cardiovascular physiology has been a
maior fo cus of research on cardiovascular fun ction in health and disease states.

One of the recent breakthroughs in
shock research has been the elucidation
of the role of shock factors, particularly
MDF, in the pathophysiology of shock.
Current activities thus include a systematic effort to determine the mechanisms of formation and the amino acid
sequence of this peptide. The work is
microchemical in nature as MDF concentration in the plasma of animals and
patients in shock is in the range of one
nanogram/ml and this involves
the cooperation of protein chemists at
other institutions, both in the United
States and abroad. The work is coordinated in Philadelphia by Frances Kuber,
a research technician specializing in
analytical chemical techniques, and me.
One of the new areas of research in
this laboratory concerns the role of the
prostaglandins in circulatory shock. Dr.
John T. Flynn, Research Associate, and
Mr. G. Alan Bridenbaugh, predoctoral
Fellow, are working with me in this
area. Part of the work is directed
toward the quantification of the synthesis and release of the major prostaglandins (e.g. PGE" PGE., PGF.a) in dif-
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ferent types of shock (e.g., hemorrhagic,
bowel ischemic, cardiogenic). These experiments involve the use of pharmacologic agents to block prostaglandin synthetase, the enzyme largely responsible
for prostaglandin synthesis by means of
appropriate drugs (e.g., indomethacin,
meclofenamate) to determine the effects occurring in the absence of released prostaglandins. Other experiments involve the infusion of archidonic
acid, the precursor of the bisenoic prostaglandins (i.e., PGE., PGF.a) to determine the effects of increased circulating
prostaglandin levels. In addition, the effects of exogenously administered prostaglandins are being studied in intact animals as well as in isolated organs (e.g.,
isolated perfused hearts and aortic strips).
When the results of these studies are integrated, it isanticipated that it will be possible to ascertain whether prostaglandins
are mediators of the shock state or
whether they induce compensatory actions beneficial to the survival of the animal or patient in shock .
The role of platelets in circulatory
shock is being investigated by determin-

ing the effects of toxic fact ors such as
MDF and lysosomal hyd rolases on the aggregability of platelets by use of a recording aggregom eter . Studi es are also in
progress to det ermine the role of platelets in obstructing the splanchnic microcirculation during shock and to determine the effect of removing platelets
prior to induction of shock on the development of the shock state. Th ese th rombocytopenic animals represent an interesting model in which to evaluate the
pathophysiologic mechanisms of shock.
One ar ea of great con cern is the functional status of the liver in shoc k. Richard Carlson, Research Associat e, and
Genevieve Deutch, a research technician specializing in metabolic methods, are working in my group on this
timely problem. They ar e study ing liver
performance in a multiplicit y of ways.
In addition to studying liver metabolisms(i.e., glucose metabolism), considerable emphasis isbein g placed on hepatic
integrity (i.e., both parenchymal and
Kupffer cells) and on reticuloendothelial
function (the latter by measurem ent of
clearance of colloidal suspensions of par-

ticles of known size). Although some of
the responses of the liver to circulatory
shock are studied in the intact animal,
many of the key experiments are conducted in the isolated perfused cat liver.
This preparation allows the study of the
effects on liver integrity and function of
ischemia, hypoxia and acidosis. If a
clear picture of the response of the liver
to shock can be determined, therapeutic
regimens to normalize the pathophysiologic changes can be designed. Some of
the findings were recently presented by
me at an international congress of emergency care medicine in Rio de Janeiro.
The other major area of interest in my
laboratory is the pathophysiology and
therapeutics of acute myocardial infarction . Two of the major questions being
asked are: (1) What are the early events
occurring in myocardial cells after the
onset of acute ischemia? and (2) How can
we preserve myocardial cell integrity after ischemia, and prevent either cardiac
failure or cardiogenic shock?
A recent breakthrough in this area
has been the realization that the ultimate size of the developing myocardial
infarct is not fixed or predetermined at
the onset , but can be modified with appropriate drug therapy. Recently, it was
found that synthetic glucocorticoids are
very effective in preventing the extension of infarct size. Tentative results indicate that the mechanism of this protective effect is stabilization of myocardial cell membranes (i.e., plasma
and lysosomal membranes).
Present studies underway with Dr.
Minoru Okuda, Research Associate on
leave from Defense Medical College in
Japan, focus on the mechanisms of myocardial cell uptake of glucocorticoids
using isotopically labelled glucocorticosteroids. He is being assisted by Mr.
George Osman, a research technician
who is a specialist in isolated cardiac
and vascular preparations. Work in this
area involves the use of cardiac tissue
slices, isolated perfused hearts, and intact animals. These studies indicate that
myocardial tissue passively takes up
large amounts of glucocorticoid. Using
cell fractionation techniques (i.e., density gradient separation coupled with
ultracentrifugation), most of the uptake
was found to be in the plasma and ly-

The effec ts of exogenously administered prostaglandi ns are being studied in
intact animals as well as in isolated organs such as aortic strips.

sosomal membrane fractions.
Clinical studies are also underway
with Dr. Leslie Wiener, Professor of
Medicine and Director of the Coronary
Care Unit, to determine the efficacy of
glucocorticoid therapy during myocardial infarction in clinical settings. This
study exemplifies the application of
physiologic investigation to future
patient care.
Other important work in progress in
the area of pathophysiology of myocardial infarction is devoted to determining
the early cellular and sub-cellular
events in acute myocardial ischemia.
These studies are in progress with the
help of Mr. Martin Ogletree, predoctoral Fellow, and Dr. Mario Feola, Assistant Professor of Surgery. This group has
developed a technique for sampling regional myocardial tissue and the coro-

nary venous effluent from ischem ic
ar eas. Thus, tissue and blood samples
can be studied for the release of lysosomal enzymes and pro stagland ins, two
markers for early cellular damage to the
myocardium. Outgrowths of th is work
involve the effect of anti-inflammatory
agents in the infarction process. Th ese
approaches have been very fruit ful in
the past two years, and are of great potential in unravelin g the mechanisms of
control of cardiac perform ance in ischemic states.

Myocardial Metabolism and
Myocardial Ischemia
The research pro grams in this laboratory ar e concerned with the way in
which the metabolism of the myocardium is controlled and can be modified
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by hormones and other agents. This also
involves studying the relationship of altered states of metabolism to the mechanical function of the myocardium. A
major interest is the effect of ischemia,
or reduced blood flow, on purine, carboh ydrate and fatty acid metabolism.
Agents are being studied which may
protect the myocardium from permanent damage during ischemia by preserving or increasing the metabolic ca. pacity of the heart.
A variety of experimental techniques
are used in these studies. Much of the research employs an isolated, perfused,
working-heart preparation which allows
the variables that influence mechanical
function and metabolism to be closely
controlled. Intact animal preparations
are also used in studies designed to test
potential therapeutic agents. These
preparations are coupled with many
analytic biochemical techniques which
include spectrophotometric and fluorometric enzyme assays, radioactive tracer
techniques for determining utilization
rates of substrates, and chromatographic
techniques for separation of metabolites
and intermediates of interest. These and
other related techniques are used to determine the rate-limiting steps in metabolic pathways and the factors which
control these pathways.
Dr. Rovetto is assisted in this work by
Diane Reibel , predoctoral Fellow, and
Diane Ubele, a research assistant who
specializes in isotopic biochemical
methods. Thi s group has recently been
abl e to separate the effects of hypoxia
and ischemia on myocardial metabolism. Surprisingly, hypoxia appears to
lead to an increase and ischemia, a decrease in the rate of anaerobic energy
production. These differences in the
rate of energy production are due to accumulation of metabolic products resulting from the low blood flow during
ischemia. The studies are of fundamental importance for the understanding of
the response of the heart to preinfarct
stress states. They also point out the role
of myocardial intracellular hydrogen
ions and other metabolic products as key
factors in the control of myocardial metabolism. These studies have prompted
Dr. Rovetto to investigate the influence
of these metabolic mechanisms on the
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coronary vasculature, a long neglected
aspect of the total control system .
Recently, Dr. Rovetto has teamed up
with Dr. Feola, of the Department of
Surgery, Dr. Wiener, of the Department of Medicine, and Dr. Raymond
Soriano, of the Department of Pathology, to study cardiac edema in myocardial ischemia. Using electron microscopy with special lanthanum staining
techniques, this fruitful collaborative
study has shown that edema is a real
phenomenon in acute myocardial ischemia. Moreover, this team has gone
one step further and showed that pharmacologic doses of glucocorticoids are
beneficial in limiting the edema, reducing the severity of cellular injury and
stabilizing myocardial cell membranes.
Dr. Rovetto is also engaged in relating the hormonal control systems to the
regulation of cardiac function and metabolism. In this area, he is currently investigating possible direct effects of thyroxine and long term stress, which
elevates a number of hormones, on various energy producing processes in the
heart. These studies are primarily concerned with trying to determine what
limits the rate of energy production
within a given pathway, how these rates
might be changed by hormonal mechanisms and the relationship between the
hormonally-induced changes in energy
production and myocardial mechanical
function. Understanding of these processes and relationships will prove valuable for developing interventions to
protect the energy deficient myocardium both during ischemia and failure.

Hemodynamics and Low Flow
States
The research activities in this laboratory involve studies of (1) pharmacologic mechanisms of maintaining cellular integrity within the heart tissue in
states of low blood flow (2) the pathophysiology of cardiogenic shock and
other low flow states and (3) factors or
mechanisms which regulate blood flow
within the organs of the body.
Research projects are designed to investigate normal and pathological mechanisms which may operate within the
circulatory system. The aim of each

study is to relate physiologic activities of
the total organ or organism to underlying activity at the cellular level.
Dr. Spath has designed some special
techniques in order to achieve these
goals. Recently, in this laboratory, a new
technique for studying pericardial tam ponade and sampling myocardial tissue
and pericardial fluid was devel op ed in
order to study the development of cardiogenic shock induced by pericardial
tamponade. Assisting Dr. Spa th in these
studies are Patricia Gwirtz, predoctoral
Fellow, and Ernest Rivers, American
Foundation for Negro Affairs stud ent .
Dr. Spath is also actively engaged in
studying the role of lysosomal hydrolases
in the pathophysiology of acut e myocardial infarction and in the transi tion from
myocardial ischemia to cardiogenic
shock. These studies have yielded funda mental insight into the cellular aspects of
ischemic damage and hav e called attention to the role of acid hydrolases in
propagating the spread of ischemi c damage from cell to cell after the initial ischemic insult. In this connection, lysosomal proteases appear to be particularly
important in mediating cellular disruption and ischemic damage. A ce rtain pr otease inhibitor has been administered in
experimental myocardial ischemia and
found to be effective in preventing the
sp read of ischemic damage in the hea rt .
This agent, aprotinin, is being studied
further for additional information on its
mechanism of action.
In an attempt to interrelate myoca rdial ischemia with pulmonary dysfunction, Dr. Spath is currently working with
Dr. Marlys Gee, Assistant Professor of
Physiology, on pulmonary edema in
acute myocardial ischemia. By the use of
microanalytical fluoresc ent techniques,
they are investigating the occurrenc e of
significant degrees of pulmonary edem a
formation in this condition. This is another example of bringing together two
important research areas.
As the cardiovascular physiology
group becomes well established, more
and more opportunities for interaction
will become apparent, and hopefully
others in the Jefferson community will
develop collaborative research studies
with the cardiovascular phy siology research team.

Hematologic
Research at the
Cardeza Foundation

by Allan J . Erslev, M.D.

In 1939, Thomas Drake Martinez Cardeza and his wife, Mary Racine Cardeza,
established the Cardeza Foundation as a
Hematologic Research Institute in th e
Department of Medicine of th e Jefferson Medi cal College.
Th e Charter of the Cardeza Founda.tion specifies that it shall serve as the
Divi sion of Hematology in the Department of Medi cin e and that its members
be teachers or clinicians as well as investigators. Its Director, The Thomas
Drake Martinez Cardeza Research Professor of Medicin e, is responsible for hematology teaching for all the affiliated
units of the Jefferson Medic al College of
the Th omas Jefferson University and he
reports dir ectl y to the Chairman of th e
Department of Medicine. How ever , th e
Cardeza Foundation, because of its
broad academic responsibility to hematolo gy, also serves the Blood Bank and
Blood Donor Cente r for the Hospi-

Dr. Allan ] . Erslev: Research at tile Cardeza Founda tion is primarily applied and clinically orien ted.

tal, as the D ivision of Hemat ology of
the Department of Pediatrics and as a
hematologic resource for the Departments of Bioch em istry, Physiology and
Pharmacolo gy. In short, it serves as an
int erdepartmental Blood Center at
Thomas Jeffer son University and its Director reports dir ectl y to the Board of
Trustees through an Advisory Board
mad e up by members of the Board of
Trustees, the Administrat ion and the
Executive Council.
Th e Cardeza Foundation under the
Trusteeship of J. Harry Wagner , Jr. Esq.
and the Fidelit y Bank provides approximately one -half millio n dollars a year
for salaries of key research personnel.
Th e University, whic h receives 20% indir ect cost allocati on by the foundation,
provides space and physical facilities.
On top of this "hard money" basis,
members of the Cardeza Foundation
bring in abo ut one million dollars a year
in research grants and contracts. There
has been a stea dy incr ease in research
support and activities over the years
and the Foundation personnel now consists of a staff of 16 fullt ime M.D.s and
Ph .Ds, five Fellows, two graduate students and about 60 non-professional
memb ers. In 1960 it moved from its
original quarters in the College Building
to a three-story building on Sansom
Str eet. After 15 years there it moved in
April 1975 into three completely renovat ed floors in the Curtis Building. Here
it is located next to the oth er divisions
of the Department of Medicine and the
beautifully red ecorated 16,000 square
feet of research space includes a small
library-conferenc e room , a photographic laborat ory, animal house and
op erating room, isot op e room s, work sho ps, offices and laboratories of individual investigators.
Th er e ar e spec ial quarters for rotating residents and for clinical and resea rch Fellows and also labora tories for
routine and sophistica ted hemat ologic
tests used by the staff in their clinical
consultative serv ice at the Thomas Jefferson Unive rsity Hospit al. The Cardeza
Hemophilia Center and the Cardeza
Dr. Erslev is the Thomas Drake Martin ez
Cardeza R esearch Prof essor of Medicin e
and Director of Hematology.
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Donor Center are temporarily located
on other floors in the Curtis Building
and the Cardeza Blood Bank and Tissue
Typing Laboratory are located in the
Hospital buildings.
Research conducted at the Cardeza
Foundation is primarily applied and
clinically oriented. In most instances, it
is work made relevant by exposure to
patients and stimulated by constant
feedback from students, housestaff and
Fellows. In other words, research is part
of the teaching and clinical responsibilities, a creative mixture only available in a medical university. Since hematology, as all medical specialties, has
become further sub-specialized, hematologic research of necessity is primarily
carried out within certain units. Nevertheless , the physicians on the Cardeza
staff are all general hematologists and
have clinical and research interests
spanning most of these units, while the
Ph.D.s have an interdisciplinary range
of interests which include physiology,
pharmacology, biochemistry, immunology and pathology.

The Thrombotic and Hemostasis
Disease Unit
Immunologic characterization of
clotting proteins has revealed that diseases formerly identified by a deficiency
in the biologic activity of such proteins
may be caused by many different genetic or acquired abnormalities in the
protein molecules. Hemophilia, for exampl e, with low to absent Factor VIII
activity, can be caused by either a genetic deletion of the Factor VIII mole cule or by numerous inherited changes
in its composition. Drs . Sandor S. Shapiro , Jose Martinez and associates have
been particularly interested in genetic
abnormalities of the prothrombin molecule and have been involved in the
functional and immunologic characterization of several prothrombin variants,
one of these aptly nam ed Prothrombin
Cardeza . Th ese studies have led to an
improved understanding of the activation of prothrombin to the clotting enzyme, thrombin, and its subsequent
inactivation. Drs. Martinez and Shapiro
have also worked on abnormal fibrinogens. Using a procedure developed by
Dr. Louis A. Kazal at Cardeza in 1963,
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they have isolated a new fibrinogen,
Fibrinogen Philadelphia, and used a variety of biochemical tools to dissect and
identify the biologically active fragments which appear during the transformation of fibrinogen to fibrin.
Of great importance to hemostasis
and thrombosis is the transformation of
a circulating " inert" platelet to a sticky
cell capable of arresting bleeding or inducing thrombosis. This platelet aggregation is initiated when blood vessels
are injured and it may be enhanced or
retarded by various drugs. The work of
Drs. Melvin J. Silver, J. Bryan Smith
and associates has demonstrated the importance of prostaglandin synthesis in
platelet aggregation. Dr. Smith's early
work has helped to explain why aspirin,
a prostaglandin inhibitor, is such a potent inhibitor of platelet aggregation.
Since both excessive bleeding and excessive thrombosis are life threatening
events, further elucidation of platelet
prostaglandin metabolism may have
wide reaching implications. The capabilities of Cardeza to undertake research into all aspects of hemostasis and
thrombosis will be enhanced by the addition of Dr. Scott Murphy who will
join the Cardeza Foundation in May
1976. Dr. Murphy is known for his
studies on platelet preservation and
platelet transfusion, and has been instrumental in developing the use of platelet
concentration in clinical medicine.
Through the tireless efforts of Dr.
Shapiro, a state and federally supported
Hemophilia Center has been established
at Jefferson. Thi s center, staffed by a full
time nurse , a social worker-coordinator,
and supported by clerical and laborator y facilities, provides comprehensive
medical, hematologic and social support
for about 120 patients with hemophilia
and for their familie s. Preventive management with medical, social and emotional restoration is attempted through
home therapy with Factor VIII concentrates, surgical correction of joint deformities and genetic and social counseling. The Hemophilia Center is also the
coordinating center and reference labo ratory for a national program aimed at
studying the natural history of hemophilia and its major complications, particularly the development of inhibitors

to Factor VIII. Thi s study will eventuall y include some 1500 pati ents.

The Red Blood Cell Unit
The effect of abnormal hemo globins,
such as sickle cell hemo globin,on normal
physiology, is being studied in a number of
way s in order to obtain information useful
for the treatment and pr event ion of these
effect s. Th e identification and characterization of abnormal hemoglobins have
been hallmarks of research don e by Miss
Jean Atwater , and several hemoglobins,
such as Hemoglobin Philadelphia were
first described and identified at Cardeza .
Studies of protein synthesis in reti culocytes have led Dr . Edward J. Burka to
propose that hemoglobin is produced by
ribosom es lying free in the cy toplasm
while membrane bound ribosomes are
mor e involv ed in the synthesisof enzyme
and oth er red cell proteins. Wit h Dr. Samir K. Ballas,he has studie d the effect of
membrane injury on lipid synthesisand
has described a close relati onship between lipid turnover and red cell surviva l.
Th e relationship between red cell enzym es and red cell survival in the newborn is the subject of a similar study by the
pediatric hematologist, Dr. Susan F.
Travis.
Th e Transfusion Unit ,dir ect ed by Dr.
Burka , is working on perfecting a blood
component preparation and treatm ent
and will shortly provide patients at
ThomasJefferson University Hospit al
with leukocytes as well as with plat elets,
red cells and plasma. In orde r to be ofbe nefi t, leuko cyt es have to be mat ched by tissue typing and mixed lymphocyte cultur e
testin g and thisservice is provided for
leuko cyt e recipi ent s as well as for kidney
transplant recipi ents by the tissue typing
laboratory directed by Dr. Bulova,
A Sickle Ce ll Ce nte r will be established
alon g the patterns of the Hemophilia
Cent er with emphasison treat ment, pre vention, counseling and research. Stud ies
of molecular adjustm ent of the sickle cell
hem oglobin by mean sof cyana te and
oth er che micals will be pursued.

The Immunology Unit
Th e lymphocytes, whi ch for years
wer e thou ght to be useless end-ce lls on
their way to finai elimination, have suddenl y become the most exciting cells in

the body. They carry the immunologic
knowl edge of the body and are capable
of transforming into antibody producing
cells or into cells directly fighting intruders and abnormal, esp ecially malignant, cells. Th e surveillance of the body
with these cells is imperative for survival and num erous hematologic and
non-hematologic disorders hav e been
related to eithe r over , under or dysfunction of these cells.
Dr. Stephen P. Hauptman and Dr.
Stephen I. Bulova are actively engaged
in the study of Band T cell function, antibody synthesis and the effect of drugs,
such as cortisone. Dr. Hauptman has
discover ed that albumin and antibody
of the IgA typ e ar e synth esized together
and rel eased as a complex. This complexing function of albumin may be of
great potential importance in th e immunul ogic hom eostasis in th e body.

The Leukemia and Lymphoma
Unit
Dr. Farid I. Haurani was one of the
early Directors of Acute Leukemia
Group B, a cooperative IH research
unit studying the management of
patien ts with leukemias and lymphomas. Currently, 125 patients in vari ous affiliated hospitals of the Thomas
Jefferson Univer sity are undergoing
protocol tr eatments under close supervision and observation. The studies of
this group hav e played a major role in
our present, far more optimistic outlook
on patients with leukemias and
lymphomas.
Certainly, a 95% remission rate in
childre n with acute leukemia and a
hopeful anticipation that about 50 % of
these children may be cured of their disease are results no one dared to dream
about 15 yea rs ago. Most of the clinical
memb ers of the Cardeza Foundation
both at Jefferson and at the affiliated
hospit als parti cipate in this research
program.

ropoietin. The int eraction of these factors in the bone marrow can explain the
pathogenesis of a number of anemias,
but more importantly ma y throw a
light on the control of normal and abnormal growth. In addition, the study of
th ese factors has led to the identification of a specific deficien cy syndrome, the anemia of chronic renal disease, an anemia caused in part by a lack
of erythropoietin and probably correc table by replacement therapy with this
hormone. Since it is anticipated that
within a few years, about 60,000
patients with chronic renal disease in
the U.S.A. will be kept alive by home
dialy sis, it is imperative to enhance the
quality of their lives by preventing the
anemia by replacement therapy.
The mechanism of erythropoietin
production of the kidney is studied by
Dr. Kazal, me and my associates. Although isolated perfused kidneys will
produce large amounts of erythropoietin , kidney extracts do not contain th is
hormone. It is hoped that this is not a
que stion of lack of storage, but rather
inactivation during the extraction period. A lipid inhibitor of erythropoietin
has been demonstrated in renal extracts
and it is bein g identifi ed in order to de velop a way by which it can be re-

moved and permit isolation and mass
production of erythropoietin for clini cal
use. Th e acti on of ery thropoietin on the
bon e mar row ste ms cells is being studied by Dr. Ruth Silver and me both in
vivo in pati ents and laboratory animals
and in vitro in cu ltures of normal and
abnormal bone mar row. Furtherm ore
the requ irem ent s of the bone marrow
for iron , vita min B1 2 and folic acid have
been studied by Dr . Haurani. Recentl y
he has demonstrat ed tha t vitamin B12
may ac t by producin g a key enzyme
(thy midy late synthe tase ) in folic acid
metabolism. Much dat a and many hypotheses ha ve been produced but still
only few facts.
Many othe r studies are being carried
out at the Ca rdeza Found ation, some
pilot studies aimed at prospecting new
ideas, some oppo rtunistic studies because of the cha nce availability of
patients with unusual clinical manifestatio ns and some long-term eva luations of
frequ entl y occ urring, but poorly und erstoo d clinical p roblems. In all of these
studies, and in all of the activities of
members of the Ca rdeza Foundation,
the common theme is a desi re to und erstand path oph ysiologic mechanisms and
make new information available to sick
pati ents and future physicians.

The Erythropoietic Unit
Elu cidation of the physiologic control
of red cell production is a major research aim at the Cardeza Foundation.
It is known that red cell production depends on the presence of a number of
minerals and co-enzymes, and that it is
controlled by a renal hormone, eryth-

Dr. Lo llis A. Kazal (riglit): stud ying
th e mechanism of eryth ropoietin produ ct ion of the kidn ey
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Extramural Jefferson Researchers
Alumni investigators are making
scientific contributions in a
variety ofdisciplines and settings.
by Joy Roff Mara
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Pharmacologic Studies
in an Institute Setting

In assessing possible sources for basic
science research fundin g on e would
probably think first of the Federal government and last, if at all, of private industry. With prominent exceptions like
Bell labs, indu stry-sponsored research
has been notoriously target ed and directl y self-serving. In 1967 Hoffman LaRoche ope ned the drug industry's first
indep end ent subsidized institute for fundam ent al research , with the practi ce of
good science the only stated aim and requirement for funding . One of the original staff members, Dr. Sidney Spector
(Ph.D. '56), reports that Hoffman LaRoche has kept its word and give n the
Roche Institute of Molecular Biology a
susta ined and adequ at e level of funding
with no int erfer ence and no quid pro
quo. Significantly, the test of good science has not been administered by the
compa ny. Peer review , by Institute associates and annually by a scie ntific advisory board made up of acade mics and
IH sta ff (including since 1967 six Nobel Laureat es), provides the scientific
qu alit y control.
W orking at the Institute has several
marked adva ntages, not the least of
which is freedom from want. Roche staff
me mbe rs are not permitted to receive
outside funding, and very few are sentimental abo ut their former involv em ents
with the grant applications process.
Set up much like NIH, the Institute
has a small nucleus of permanent members, with a larger complement of post
doct oral Fellows, visitors and scientists
on sabba tica l. Because most of th e permanent members like Dr. Spector hold
appointme nts at nearby Ne w York City
medical schoo ls an d universiti es, graduate students and resident s also parti cipate in Institute research project s. Currently, for example, Dr. Spector is
supervising a third year anesth esiology
resident on an optional rotation at

Roche from Columbia's College of Physicians and Surgeons wh ere Spe ctor is an
Adjunct Professor. "The int ernational
ba ckground of the scientists and the
frequent turnover of personnel makes
the Institute a very exciting place to
be," Dr. Spector notes , "and the constant influx of new ideas and enth usiasm
mak es a definite contribution to research productivity."
The physical am enities at the Institute also ar e enviable. All the laboratory
and support facilities needed ar e contained within an aesthetically pleasing,
modem design stru cture, including conference, symposium and library are as.
Th e building has clearly been designed
for laboratory people as well as laborator y animals, and Dr. Spector says staff
interaction and socializing add to the
pleasant atmosphere.
Dr. Spector's particular research inter ests ar e pharmacologic, and of his
three broad programs two ar e conce rned with hypertension. He has
worked extensively, for example, with
the neurotransmitter norepinephrine,
which is elaborated by the central nervous syste m. Studying the synthesis,
regulation of synthesis and the degradation of this mat erial in hyp ertensive animal models, Spector has follow ed the
neurotransmitter throughout the course
of hypertension, particularly in the
heart, th e blood vessels and the brain.
One of the results of this work has been
to dem onstrate the pr esence of nor epinephrine and the enzy matic machin ery
necessary for its production in isolat ed
brain microvessels. This provides addi tional evide nce for the neuronal regulation of ce rebral microcirculation.
Collagen pr odu cti on has been anothe r focus of Dr. Spector's work in hypertension. On the premise that hyp er tension is an insult to the body, it
seemed reasonable to posit that syn-

thesi s of the connec tive tissue protein,
collagen, might be indu ced during hypertension. Spector discover ed that extraordinary collagen producti on does
occur in hyp ertension, and because its
deposition in th e blood vessels produces
furth er impairment and rigidity, levels
of hypertension are thereby increased
and a self-pe rpe tuating cycle created.
On ce this cycle was understood, Dr.
Spector found that antihypertensive
dru gs can redu ce levels of new collagen
product ion, and he is now investigating
mechanisms to modify or remove the
tissue alr eady depo sited.
Immunopharmacology,specifically
generating antibodies to small molecular weight substances of ph armacologic
int erest, has been a third program of inter est for Dr. Spector. Some agents,
such as the endoge nous norep inephrine
and man y drugs, ar e too small in themselves to promote antibody production.
When conjugated ont o a ca rrie r of sufficient mass, however, they can attain
the critical size necessar y for antibody
development .
On ce antibodies ha ve bee n generated,
they ar e immediately useful in quantitative studi es employing the radioimmunoassay technique. Th eir production with regard to exogenous agents
op ens up the broader question of the possibility of modifying the phar macology of
dru gs. Dr. Spect or is curre ntly investigating antibodies that could be used therapeutically to reverse dru g toxicity in
cases, for example, of aller gy or overdose.
A corollary study is involved with the possibility of potentiating a drug or other
agent once an antibody has modified or inhibited its action.
Antibody production is also useful in
followin g the pharmokineti cs of a drug,
ascertaining where spec ifically in tissue
and subcellular regions a drug goes. Previously, radi oacti vity was used in such
det erminati ons, but th is has been an imperfect meth od. Because dru gs are metabolized during their course through
the bod y, the radioacti ve probe may be
att ached to what eve ntua lly becomes a
metabolit e. On ce antibodies are availabl e, however , immunofluorescent tech niqu es can be employed. Im munofluorescence is more sensitive and specific;
because it recognizes only the ant ibody,
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the course of the drug in question can
be more correctly and particularly followed. Antibodies have already been
successfully generated for opiate alkaloids, barbituric acids, catecholamines
and acetylcholine, among others.
A number of the permanent staff
members and the prime mover of the
Roche Institute are, like Dr. Spector,
alumni of the National Institutes of
Health. From 1956 to 1967 Spector
worked in the Laboratory of Chemical
Pharmacology at the National Heart Institute and the Laboratory of Experimental Therapeutics. He feels his close
work with clinicians and clinical problems during his stay at NIH has been of
lasting value and has made him wary of
losing perspective in work with animal
models. Some of the work he is doing
now had its inception at NIH.

Dr. Spector studied at Jefferson's inchoate Graduate School from 19521956 as the first student of Dr. Kwang
Soo Lee. Although his connections to
the rest of the institution were somewhat informal during those years, still
Dr. Spector has a strong feeling of allegiance to the new University. Dr. Lee
has since been proferred and accepted
another position, something which
seems to be endemic of the first rate scientist. For the proven researcher there
seems always to be that Circean " other
offer" to be considered along with one's
quotidian responsibilities. Dr. Spector is
no exception, having received his quantum of advances from other institutions.
For the moment, however, the Roche
Institute's own enticements seem at
least sufficient to make any such consideration a very difficult one.

Dr. Sidn ey Spector: specializing in tmmunopharmacologq and
the pharma cologq of hypertension
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Clinical
Investigations in
Cancer
Immunology
Dr. Carl M. Pin sky ' 64 is a clinical researcher at the Memorial Sloan- Kett ering Cancer Ce nte r who takes his clinical responsibiliti es as seriously as his
scientifi c. Mana gem ent of a cancer
patient, especially in the advanced
stages or"the disease, is emotionally difficult and , Dr. Pinsky feels, has been
poorly handled traditionall y. "Particularly in my early training years the
pati ents we worked with had been
shunted to the back war ds where the y
wer e largely abandoned. Even the language of the ca nce r patien t's medical
history typi cally began, '111is unfortunat e 53-year-old doomed man .. .' We 'r e
trying now to get away from the hopelessness fixation, in part by keep ing an
individual as an outpatient as long as is
feasibl e. I enco urage my pati ents to
make livin g as norm al a life as possible
their only conce rn and to let us worr y
about the disease."
Approaching cance r research immunologicall y, Dr. Pinsky says he chose
this spec ialty becau se it was a young field
with ground floor opportunities. His experience has since confirm ed that judgment; the two-man team with whic h he
began his tenure at Sloan has now grown
to a group of medi cal oncologists, a surgeon, Fell ows, nurses and a large staff of
support per sonnel. Pinsky a tt ributes this
in part to an administration, specificall y
Director Robert Goo d, President Lewis
Thomas and Dr. Pinsky's Service Director Dr. Herbert F. Oettgen , that sees
cancer immunology as a legitimate undertaking rather than as the stepchild it
has sometimes been regarded.
On e of Dr . Pinsky's ar eas of interest
has been immunodiagnosis, specificall y
the use of the carcinoe mbryonic ant igen (CE A) to det ermine the existenc e,
type and stage of ca ncer. In a test involving 1200 pati ents, 800 of whom had
some type of can cer , CE A levels wer e
prov en unreliable indicators of the exis-

tence of cancer; some patients with benign disease, for instance, had elevated
CEA levels, while levels remained normal in some with malignancies.
CEA levels have, however, been
shown to have prognostic value at later
stages of treatment. In a study of colon
cancer patients, for example, Dr. Oettgen's group, of which Dr. Pinsky is a
member, found that when the cancer is
surgically removed elevated CEA levels
invariably return to normal. The recurrence rate isalso closely tied to CEA level
elevation, a phenomenon which isespecially useful diagnostically because it often occurs before the recurrence can be
observed clinically. Dr. Pinsky has shown
additionally that CEA levels are less
likely to rise with local tumor recurrence
than they are when liver metastases have
occurred. Since there is some evidence
that early detection and removal of liver
metastases can prolong life, this study has
obvious clinical significance.
In as yet inconclusive studies, however, routine laboratory procedures like
liver function tests have been projected
to be as reliable in predicting the stage
or progression of colon cancer as the
CEA test has proven to be. Investigation is now underway to determine
whether an expensive procedure like
CEA measurement actually is needed.
Evaluating the immunocompetency
of patients for prognostic purposes has
been another thrust of Pinsky's work.
Using the skin-sensitizer DNCB (2,4-dinitrochlorobenzene) in a group of
patients with various types and stages of
cancer, it has been shown that those
who respond positively to D CB have a
significantly lower recurrence rate after
definitive cancer surgery than those
who failed to respond. When patients
are grouped by extent of disease , where
there are no metastases patients who are
D CB positive progress better clinically than those who are D CB negative. For the group in which metastases
have occurred, the trend still favors the
D CB positive patients, but Dr. Pinsky
feels that the evidence is less convincing. One explanation is that once metastases have begun, the biological action
of the tumor becomes more important
than the immune response, although
Pinsky notes that there are any number

Dr. Carl Pinsky: immunodiagnosis and immunotherapy

of other possible explanations as well. It
seems, however, that the prognosis for
patients who are DNCB negative with
no metastases is almost as bad as that for
patients in whom metastases have already occurred. Dr. Pinsky cautions
that from this study one cannot make
absolute conclusions applicable to all
types of cancer at all stages of progression . "There has been no evidence to the
contrary:' he says, 'out when we broke
our groups down by disease and extent
of disease, we did not feel the numbers
were statistically sufficient."
What Pinsky calls the Holy Grail of
cancer immunology, the consistently elusive human tumor specific antigen, isthe
subject of many studies despi te two decades of fruitless pursuit. Tumor specific
antigens, substances appearing only
when cancer or a specific type of cancer
is present, do exist in animals and are invaluable in analyzing tumor behavior.
Because techniques for finding spon taneous antigens in man are still crude, it

has been postulated that they might be
more profitably detected in patients
hyperimmunized with material from
their own tumors. This isknown as active
autologous immunization, a technique
that Dr. Pinsky feels will become increasingly important in immunology's future.
Because animal studies indicated that
immunotherapy was most successful
when tumor specific antigens were
present, oncologists proceeded on the
assumption that these antigens would
eventually be found in humans and undertook clinical trials with immunopotentiators which had previously been
used in animal work. As far back as the
turn of the century it was reasoned that
even non-specific immunostimulants
might be effective in cancer treatment.
In 1935 a forgotten researcher named
Holmgren first reported some success
using the tuberculosis vaccine BCG on
cancer patients, but he was largely ignored. Others have shown more recently that percutaneous BCG vaccina-
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tion prolongs che motherapy-induced
remission in patients with acute lymphoblastic leukemia.
Dr. Pinsky 's own studies have confirmed the valu e of BCG as a therapeutic agent. In treating malignant melanoma, he found that the intralesional
injection of BCG usually induces tumor
regression in injected tumors, though
rarely in non -injected ones. Respons e
rate is best if a patient is immunocompe tent and if the disease is confined
to the skin. To translat e the intralesional
success into a systemic effect, the group
injected BCG into the skin of melanoma
patients with lymph node metastases
from whom all tumors had been removed. In a random group the y found
that contrary to two oth er recent reports, BCG did not prevent tumor recurre nce in this high risk group. Differences in techniques and patient
population could account for the con flicting test results, but the question of
BCG's e fficacy in this situation remains
as yet unresolved.
Complicating the use of BCG are its
someti mes conside rable side effec ts and
even occasional life threatening toxicity. This has encouraged scientists to
look for oth er , non-living immunopotenti ators and has led the MSKCC
group to experiment with the use of Corynebacte rium parvum (C parvum ),
both intralesionall y and systemically.
While the systemic study is still ongo ing, intratumorally C parvum would appear to have no extraordinary advantages over BCG. MER, a BCG extract, is
also being studied, with some positive
results beginning to emerge. Dr. Pinsk y
stresses, however, that he has never seen
any of these agents cause regression in
advanced cancer in organ systems.
Immunotherapy trials have been
done empirically, and few efforts have
been made to determine optimal dose
and sche duling of the various agents. Although the permutations found in different studies are infinite, scientists hav e
begun trial s of specific agents to establish these parameters definitively. Th e
group at MSKCC is now conducting
phase I clinical trial s on C parvum and
Levamisol, an antihelminthic reported
useful in preventing recurrence in certain high risk cancer patients.
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In addition to active autologous immunization, Dr. Pinsky feels that synthesis or extraction of the active principle (s) from immunopotentiators to
minimize possible toxicit y will be a primary thrust of immunologic research in
the near future. He is also convinced
that multimodality studies, not don e
currently because the risks and benefits
involved ar e largely unknown, would be
invaluable both to researchers and
pati ents alike. '1' d like to see us take
non-terminal patients who are ordinarily consider ed inoperable, hav e a sur geon remove every bit of cance r he can,
and then begin chemotherapy and immunotherapy, taking into account the
immunologic effects of the combination
and timing the treatments accordingly.
Thi s is the direction in which I think
can cer research is going. "
While recent publications affectively
detailing the acrimony surr ounding the
discovery of DNA would lead one to expect otherwise, Dr. Pinsky describes
collaboration with peers nationally and
internationally as common, amiable and
open. Th e friendly association Pin sky
outlines may seem like a closed club,
but he insists it is more properly a network, running primarily from Sloan to
the NCI , to the M.D. Anderson Center ,
UCLA and Roswell Park , for the ear ly
and see mingly jealous y-free dissemination of information. He speaks enthusiastically and knowledgeably of the recent discoveries in all areas of cancer
research, uncompromised by the specialist's proclivity to ignore or denigrate
the successes of another approach.
When Carl Pinsky attended Jefferson
it was viewed primarily as a clinician's
school , with a good deal less emphasis
on research or academic medicine.
While the way in which JMC was per ceived was no advantage for graduates
inter ested in high pow er ed post-gradu ate research training pro grams, Dr. Pin sky feels strongly that the clinical emphasis was a plus for his research
competence. "Being able to interact
with patients as a clinician gives me an
advantage in the clinical research setting. If I'd had less clinical training and
exposure as a student, working with animal model s in the lab might hav e been
my only realistic option."

An Interdisciplinary
Approach to
Ophthalmologic
Research

Asking a resear cher to explain the process of scie ntific discovery is somewhat
like asking a poet to explain how a particularly apt phrase came about: hard
work and extensive pr ep arati on are always credited first, but at a cer tain
point ente rs the almost mystical concept of inspiratio n. Georgetown University Ophthalmology Professor Vernon
G. W ong '58, for example, was absentmindedly working on his backhand in a
tennis game with his son when the idea
for his most recent research project occurred to him. Wh en an experimental
model was develop ed in the lab, his initial proposition proved valid and has
since op ened up what promises to be at
least ten years of productive research.
In investigating retinal degeneration,
a common cause of blin dn ess, Dr. Wong
postulated that blindness might be
caused by the bod y's inability to deal in
ce rtain cases with the molecule rhodopsin, the major biochemi cal mediator of
vision in the eye . Working with primates, he immunized rhod opsin systemically in low conce ntrations. He found
that at these levels the molecule which in
essenc e allows us to see is the most potent retinal " poison" with which he has
ever worked ; and the blin dn ess produced
is irr eversible. Th e investigation is still in
its preliminary stages, but in its course
should involve many different disciplines
including biochem istr y, histopathology,
immunology and elec trophysiology.
Th e interdisciplinary approach has
be en some thing of a constant with Dr.
Wong, whose own background is well
suited to it. Initially int er ested in obstetrics and gynecology, W ong had a Fellowship from Johns Hopki ns while he
was a student at Jefferson, spending
week-ends in Baltim ore to study vitamins and intrinsic factor. Afte r an oph-

Dr. Vernon W ong: The maier
biochemical mediator of vision in
the eye can produce irreversible
blindness when immunized
systemically.

thalmology residency at the University
of Pennsylvania Graduate Hospital Dr.
Won g joined the full-tim e staff of the
Ophthalmology Branch of the National
Institutes of Health. One of his projects
there involv ed working with National
Cancer Institute researchers who were
studying the immune response and antitumor drugs in relation to the rejection phenomenon. Because some inflammatory eye diseases are related to
the immune disorders, he applied th e
findings of th e cancer study, particularly
the use of antimetabolites and immunosuppresive agents , to ophthalmology
and the treatment of inflammatory
blinding disease.
Anoth er research interest that has involved Dr . Wong with scientists from
oth er disciplines has been the study of
cystinosis. Thi s genetic disorder is a result of an amino acid abnormality in
wh ich insoluble cystine crystals are deposited throughout the body. The most
pernicious result of this process is eventual renal failure.
Because depo sits of these crystals also
occ ur in the eye, Dr. Wong was able to
contribute an ophthalmologic description of the disorder and to hel p improve
diagnostic methods. The earliest possible
and most reliable diagnostic procedure in
infants, in fact , is now an ophthalmologic
one . Wong stresses the team nature of the
effort, which has involved geneticists and

specialists from many other fields. The
group has made diagnosis of cystinosis in
utero through amniocentesis a reality,
and genetic counselling and screening
can now alert carriers to the risks before
the y conceive children. With kidney
transplants and dial ysis available, cystinosis is no longer invariably fatal. Dr.
Wong has found this project a particularly rewarding one , because he has been
involved in its progression from theory to
clini cal application.
Although members of the research
team are now located in different parts
of the country, the cystinosis study continues. In addition to attempting to unravel the basis of genetic biochemical
disorder, researchers are also investigating specific agents which might reduce
the cystine content in the tissue. Dr.
Wong is participating in this work, and
has also become a sought-after clinical
consultant when cystinosis is suspected,
often traveling to different parts of the
United States for diagnostic purposes.
As a practicing ophthalmologist, the
inflammatory condition known
as presumed ocular histoplasmosis interested Dr. Wong, and he has recently
made it a research interest as well.
Using rabbits and monkeys in attempts
to develop an experimental animal
model for ocular histoplasmosis, he
hopes to be able to study the mechanism of pathogenesis of the disease and

eventually a means of treat ment.
Although Dr . Wo ng's p rimary orien tation is research, he is hap py with the
mix of teaching and clinical exposure he
has at Georgetown. As a teacher he is
primarily involved with residents, and
as a clinician 30 to 40% of his work is
referral. He also enjoys the opportunity
to perform ophthalmic surgery.
Th e chance for variety and for a university atmosphe re was part of the reason Dr. Wong left NIH in 1972 after ten
product ive years. As a measure of his
NIH achi evements, when Congress
created the special National Eye Institute in 1970, Dr. Won g was chosen its
first clinical Director. "N IH was an exciting pla ce to work," explains Dr.
Wong, "b ut the conditions at Georgetown are optimal, and ther e is no question that quality research can be done
here." Dr . Wong also notes that he has
always found his Jefferson training to be
second to none .
Vernon Won g is a gentle and very private man whose enthusiasm for scientific
research consistently br eaks through his
person al reserve. Although he says he enjoys joggin g, photography and being with
his wife, who is a pharmacist, and his two
sons in their Rockville home, when he
mentions a desire to become involve d
some day in cancer resea rch, one can
somehow imagine that he will alsocontinu e to work on his backhand.
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Pioneering
in
Cardiothoracic
Research

W ith the escalating costs of biomedical research and the governme nt's increasingly grudgi ng allo cation of funds
for the purpose, attempts to economize
where feasible, by building one's own
equ ipment for example, are of necessity
becoming mor e common. Dr. William
W.L. Glenn '38, however, was making
contr ibutions to cardiothorac ic surgery
that wouldn't offend anyon e's sense of
budget long befor e budget was much of
an issue at all.
In 1948-50, for instance, Dr. Glenn , a
Professor of Surger y at Yale University
School of Medicin e, help ed build th e
first artificial heart with a pump to by-

pass one and subsequently both sides of
the heart. A prototype of the artificial
heart models currently being refined by
NIH and other investi gators, it featured
a rubber ventricle driven by compressed
air . The technique of the right heart bypass developed in this regard and reported in 1950 was the one lat er used in
the first successful open heart operation
in man , pulmonary valvulotomy. The
total materials cost of thi s significant
first step was $25 .00.
A surgical technique for mitral valvulotomy originated by D r. Glenn total ed a mat erials cost of only $.05. In
operations for mitral valvulotomy, surgeons had pr eviously int errupted th e
fused commissures with the blunt force
of a finger or the cutt ing force of a
knife. The accidental discovery of an
op en-ended tailor's thimble in a draw er
of a newl y-purchased antique ches t suggest ed to Glenn th e idea of delivering
the necessary blunt force through the
op en end of such a thimble, pri ced at
one nick el. Clinical trial subsequently
revealed that the sequential use of tailor 's thimbles of gradua ted sizes ensure d
a large valve orifice, and in 1969 Glenn
reported the use of the thimble valvulotom e in mor e th an 200 pati ents with
mitral stenosis.
Dr. Gl enn has devised several othe r
surgical techniques for various cardiothoracic conditions. In the pat ent

du ctus operati on, for instance, he contrived the techn ique of suturing the
ductus prior to division, which has improved the mort ality rate for this pro cedure. In lar ge artery surgery he began
delib erately lowering blood pressure
using hypot ensive drugs, making op erat ions on the aorta and its major
bran ches less hazardous. Dealing with
op en heart surgery, Glenn applied electri cit y to the heart to produce controll ed cardiac fibrillation. In many
op en heart ope ra tions, th is procedure
has proven useful in preventing air embolism, Seeking a better operative ap proach to the high-p ressured areas of
the blood vasculature system he initia ted the ap plication of a pro stheti c
tube or graft to extend the chambers of
the heart and lum en of the vessels. (Th e
prot otyp e for the fab ric dive rti culum
now used was a rubberized $.25 doll
stocking.) Th e use of the closed rubb er
diverti culum proved simpl er and safer
than previous methods of approach, and
as such enco uraged fur ther development of digit al intracardia c surge ry.
In addition to surgica l techniques, Dr.
Glenn and his associat es have also conceived orig inal ope rations. Since 1954,
when he first report ed success in dogs
with a superior vena cava -right pulm onary artery anas tomosis, Glenn has been
involved wi th this procedure, whi ch is
predi cat ed on the fact that the arte rial

Dr. William Glenn : Using radio
fr equency stimulation of excitable
tissue clini cally fo r cardiac and
diaphragm pacemakers
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pressure in the lungs is lower than in
any other part of the body, and is not
great enough to require a pulsating ventricle to produce blood flow. Glenn's interest in bypassing the right heart entirely stemmed from unsatisfactory
results with a systemic artery-to-pulmonary artery shun t performed on several
patients with tricuspid atresia. With the
traditional shunts, congestive failure or
partial to complete closing of the shunt
were frequent complications.
The cava-pulmonary artery shunt,
generally referred to as the Glenn operation, was first applied clinically in 1958
and has proven a highly successful palliative measure in numerous patients so
treated since that time. The shunt is
particularly well-suited in instances of
uncorrectable congenital malformations
of the right side of the heart and diminished blood flow to the lungs, the principal such condition being tricuspid atresia. In some cases, however, after a
number of years of clinical improvement following a cava-pulmonary artery shunt, symptoms of hypoxia recur.
To ameliorate this problem Dr. Glenn
made a carotid artery-jugular vein fistula on animals who had undergone the
SVC-RPA procedure some years earlier.
After good animal results the creation
of an arteriovenous fistula between the
right axillary artery and vein was performed on humans and has proven an
effective means of improving oxygenation in patients with SVC-RPA
anastomosis.
Perhaps Dr. Glenn 's most important
contributions have been in the area of
stimulation of excitable tissue from the
interior by radiofrequency transmission,
i.e., the pacemaker. The group at Yale
was the first to use radiofrequency stimulation clinically, and in 1959 his artificial cardiac pacemaker was the first
implanted unit to be used clinically in
the Western hemisphere. Since 1966
Dr. Glenn's group applied the principle
of electrical stimulation by RF transmission to long-term ventilatory support by phrenic nerve stimulation. This
diaphragm pacemaker has enabled
quadriplegics and patients with the rare
Ondine's Curse to function without a
respirator for up to 12 hours a day. The
longest time respiration has been sup-

ported by the pacemaker is five years
for the quadriplegic and seven years for
patients with Ondine's Curse. While
Dr. Glenn points out the cost value this
research has returned to t.he taxpayer by
getting quadriplegics out of $300-a-day
intensive care units, he mentions first
the rewarding personal aspect, the revolutionary improvement in the quality of
life for affected patients.
The pacemaker project, which has
been supported by the National Heart
and Lung Institute for 17 years, is now
investigating the application of radiofrequency stimulation to emphysema to
prevent nighttime build-up of CO 2 , Although more careful documentation still
is needed, the likelihood of benefit
seems good in emphysema patients with
hypoxia who also have good diaphragm
movement. The clinical use of radiofrequency has opened up possibilities
for the stimulation of many kinds of excitable tissue for medical purposes. Dr.
Glenn notes that the neural prosthesis
field might eventually become a billiondollar industry just as the cardiac pacemaker field has.
In 1971 when Dr. Glenn assumed the
Presidency of the American Heart Association he caused something of a stir
with his inaugural remarks, which suggested that bypass surgery for angina,
the subject of national publicity at the
time, should not prematurely be regarded as a panacea. He took this stand
in great measure because the number of
hospitals with proper cardiac operative
facilities was not nearly adequate for
the number of people suffering from
angina, should all of them demand bypass surgery. Although Dr. Glenn feels
that it will be another five or six years
before an authoritative evaluation can
be made, he says it has become clear
that the procedure does provide symptomatic relief from angina; there is,
however, no evidence as yet that longevity is prolonged thereby except in
cases where partial or complete occlusions of the left main artery have occurred. He expects that the operation
will be clinically indicated for left main
lesions and intractable angina, but probably not for the majority of angina variations, and he plans to write a follow-up
when more conclusive facts are in.

Dr. Glenn, who received Jefferson's
Alumni Achievement Award in 1972,
has served as President of the International Surgi cal Group, the Co nnecticut Society for Medi cal Research , the
Connecticut Society of the Ame rica n
Board of Surgeons and the Yale Medical
Society. Certified by the Ame rican
Board of Surgeons and the American
Board of Thoracic Surgeons, he is a
member of many organizations, the
American Surgical Association, the Society of Univer sity Surgeons and the
American Association for Thoraci c Surgery among them. He has published extensively in both journals and books.
Although animal research has been an
important facet of his work, D r. Glenn
stresses that for him the most exciting
part of medicine is working out solutions in a clinical se tting. In addi tion to
believing, as one would assum e most do,
that there must be a reasonable chance
of good and little chance of ha rm for a
clinical researcher to und ertake a project, Dr. Glenn feels strongly that results
of every proj ect should be rep orted and
that follow-up studies should be done,
without exception. "It is oft en 25 years
before we can appreciate all the ramifications of a new procedure," he notes.
"As a matter of fact , it has been more
than 200 years since electrical stimulation of tissue was employed therap eutically, and we are just now beginning
to realize how useful it can be."
Spending a day with Dr. Glenn it
soon becomes apparent that he is a
teacher and a physician as we ll as a researcher. As the Charles W . Ohse Professor of Surgery Dr. Glenn supe rvises
Fellows, residents and groups of medical students rotating through his service.
His referral patient roster is international in composition, though his qu ietly friendl y manner with pati ent s has
overtones of the famil y physician as
well as the specialist. Teachi ng consultationsare frequ ent. As Dr. Glenn points
out, "Anyone who writes a textbook has
to enjoy teaching." Glenn is the co-author of Thoracic and Cardiovascular
Surgery with R elated Pathology, now in
its third edition. He not es that their major competition is a text originally written by another Jefferson surg eon, D r.
John H. Gibbon, Jr.
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The Type C
RNA Tumor
Viruses and
Acute
Myelogenous
Leukemia

The National Institutes of Health have
been the center of a great deal of controversy in recent years, some of which
has been more political than scientific.
Dr. Robert C. Gallo '63, who has been a
staff member at the ational Cancer Institute since 1965, an era that is now
considered to have been something of a
golden age for the NIH, has not felt any
effects personally from what some feel
is an increasingly political atmosphere
brought to the Institutes during the
Nixon administration when the NIH Director became a presidential appointee.
Gallo was a member of the search committee for the Scientific Director of
Cancer Treatment for the CI, for example, and the man suggested by the
committee was appointed, seemingly
without political complications. This is
not to say he feels politicization is without hazard, however.
As might be expected, Dr. Gallo does
not view the aggrandization of the NCI
under the National Cancer Act with the
same dismay many critics voiced at its
inception. "The public interest in cancer and the timeliness of the problem
make it reasonable to channel more
funds into cancer research than in some
other areas," he says. "It has already
produced better clinical care and will
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prove its worth in research findings as
well. Those who say that the so-called
'War on Cancer' is excessive research
targeting are probably partly right, but
in the long run cancer research is really
basic science research. Those making efforts for funding should keep this in
mind. With the public attitude towards
science and research at this time, I think
it is a mistake to believe that money
now allotted NCI would otherwise have
been parcelled out equally to the different disciplines. If it weren't given for
cancer studies, it probably would not
have been spent for biomedical research
at all."
Dr. Gallo is now Chief, Laboratory of
Tumor Cell Biology, Experimental
Therapeutics; his primary interest is in
acute myelogenous leukemia, and he is
investigating in this connection the
group of RNA tumor viruses classified
morphologically as type C.
Of the many possible approaches to
studying the etiology and pathogenesis
of the disease, Dr. Gallo chose to work
with the RNA tumor viruses for several
reasons. They are known, first of all, to
be a primary etiologic agent in the natural production of leukemia in mice,
cats, cows, sub-human primates and
chickens. It has also proven possible to
study them in the laboratory, where leukemia has been produced in species
other than the original virus carriers.
Additionally, the very nature of all viruses seemed to oblige the study of type
C RNA tumor virus involvement in leukogenesis: if it were infectious, perhaps
it could also be manageable.
Investigation has, in fact , shown that
the viruses can be infectious agents,
sometimes, as with cats and sub-human
primates, exogenous in the classic
manner. In other instances, for example
in the mouse, the virus is endogenous,
remaining in the animal's genetic information and in this way transmitted to
progeny. But this duality has made the
RNA tumor viruses more rather than
less formidable to deal with, as has their
tendency to be slow viruses, difficult to
trace and characterize in the lab.
More importantly, not every animal
who is infected by virus contracts leukemia. It has thus become clear that
while the viruses are involved in the

leukogenic process, they may not be by
themselves sufficient to produce the disease. Other factors such as chance (what
cell they "hit," what chromosome etc.),
genetic predisposition, environmental
insult or any combination thereof would
seem to be additionally required.
Although the viruses are complex
mechanisms, progress has been made in
their definition, and Dr. Gallo 's own
work has been some of the most significant. In 1970 shortly after Temin and
Mizutani reported the discovery of
RNA-directed DNA polymerase (reverse transcriptase) in RNA tumor viruses, Gallo and his associates identified
reverse transcriptase in human leukemic
cells, the first demonstration of reverse
transcriptase in any cell. Dr. Gallo refers to discoveries like these as footprints, traces suggesting to the scientist
that he is on the right course, but always
demanding additional evidence and new
links.
Some new traces began to accumulate in 1972-74 when Gallo's lab, using
immunologic techniques, demonstrated
that the reverse transcriptase identified
in human acute myelogenous cells had
biochemical properties indistinguishable from reverse transcriptase found in
certain mammalian type C viruses, specifically related to the two known oncogenic primate type C viruses, the
woolly monkey and gibbon ape viruses.
The direction in which these footprints seemed to be pointing was, of
course, the involvement of the RNA tumor viruses in human leukemia. Attempts to isolate any human tumor virus
have been frustrating and controversial,
with many virologists prematurely reporting positive isolations that were
eventually compromised in some way .
Dr. Gallo attributes the difficulty to the
fact that cancers in man including leukemias are not virus productive diseases. If and when virus is released it is a
rare event and the virus may be defective. In 1975 Gallo and his associate
Robert Gallagher reported isolating a
human tumor virus from one patient
with acute myelogenous leukemia; as
would have been expected the virus
contained reverse transcriptase and
group specific antigen specifically related to the oncogenic primate type C

viruses, some of which have caused neoplasias in primates under natural conditions. Additionally, a second virus was
found which was closely related to the
endoge nous type C virus of baboons.
Th e isolation was made possible by the
discovery of new conditioned culture
media, produced from a strain of human embryo cells. For reasons unknown, the isolation has not been successfully rep eated with cells from other
pati en ts, though it was completed several tim es over a 14-month int erval
with cells from the same pati ent. Presumably, this may be because of unusual
genetics in the one patient or a coincidental environme ntal effect, e.g., th e
presence of two viru ses Simultaneously.
Dr. Ga llo was able subsequently to
carry the process one step further.
Through molecular hybridization techniques he has found unambiguous proof
that the genetic information for a typ e
C RNA tumor virus was pr esent in the
primary tissue of the same patient, as
present ed in the April , 1976 issue of the
Proceedings of the ational Academ y
of Science.
Becau se every new development in
the study of type C RNA tumor viruses
seems to pose more qu estions than it an swe rs, Dr. Gall o is also involved in
studyi ng the det ails of the virus life
cycle, particularly in gibbon ape leukemia, a disease very similar to human
acute myelogenous leukemia. Primate

viruses have only been isolated since
1971, so there is still a good deal of basic information to be compiled that
could have interdisciplinary importance
as well as pertinence to Gallo 's particular work. While the subject could of
course have endless permutations, the
scientist's present goal with this proj ect
is to establish to his own satisfaction
that the primary genetic information
for human acute myelogenous leukemia
may involve information derived from
primate type C viruses.
As a staff member at IH , Gallo has
institutional responsibilities like grant
and contract review, and as a respected
scientist he is inundated with manuscripts and socie ty applications to
judge. Adding thes e tasks to his 160
published papers and numerous papers
presented at meetings and myriad editorial involvements mentioned earlier, it
is not surprising he does not feel he can
spe nd as much time as he would like to
in th e lab. But frequent visits to other
laboratories allow him to keep up with
the new techniques and other changes
from which it is dangerous to becom e
too far removed, and he insists he has
not become an administrator. "My day
is primarily spent discussing experiments and meeting with scientists. Call
me a lab worker without a pipette."
Although postal rates mak e it impossible to list all of Dr. Gallo 's societies
and accomplishments, a small sampling

includes his having presented the Bryan
Priestman Memorial Lecture at the
University of New Brunswi ck, his having rec eived the Dameshek Award from
the American Society of Hematology,
his Honorary Doctor of Science from
Providence Coll ege and his membership
on five scientific editorial boards including the Yearbook of Can cer. He is a
member of the Scientific Board of
Trustees of th e Leukemia Society of
Ame rica, Co nsultant at Roswell Park
Memo rial Institute and at the M.D. Anderson Hospital and Tumor Institute,
and is a member of such learned societies as the American Socie ty of Clinical Inv estigation and the American Socie ty of Biological Ch emists.
Gallo's enthus iasm for research was
evide nt even in his Jefferson days when
he admits slipping out the side door during fra cture clini cs to spe nd extra time
at Cardeza. But the rigors of a successful scie ntist's schedule have not been
without consequence for his family.
" Fo r the first eight years of both of my
SOrIS' lives I was rar ely home from the
lab when they were awak e. It's different
now , I'm making sure that it is." Still,
amidst describing his enjoyme nt of a
new hom e in Bethesda, tr avel and good
food, a certain single-mindedness inev itabl y eme rges. " I sta rted skiing with the
kids, and I expe ct to do a lot of skiing this
season . I tend, " he explains, "to pursue
things fanatically for awhil e."

Dr. Robert Gallo: In 1975 lie and his
associat es reported the isolat ion ofa
III/man tumor virus f rom one pati ent
with acut e myelogenous leukemia .
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the
jefferson
scene

interim president
At a special meeting of th e full Board of
Trustees on Monday, AprilS, Mr.
George M. Norwood, Jr. was named Interim President of Thom as Jeffer son
University. The appointment was made
following the unexpected death of Dr.
Peter A. Herbut th e previous week (see
page 48).
Mr. Norwood, who ca me to Jefferson
in 1965 from th e University of North
Carolina, served first as Vice -Presid ent
for Busin ess and Finance and since 1970
as the Vice-President for Planning. In
that position he has been largely responsib le for devising and th en implem enting Jefferson 's Mast er Development
Program. Prior to his Jefferson appointments, Mr . Norwood was th e Chi ef
Business Officer of th e Di vision of
Health Affairs at th e Univ ersity of
North Carolina. He is a Trustee of th e
Phil ad elphia Magee Mem orial Reh abil itation Center in Philadelphia and
serve d as National Chairman of th e
Planning Coordinators G roup of th e Association of Ame rican Medi cal C olleges
in 1973.
A resident of Society Hill in Philadelphia, Mr. Norwood is married and
has four children.

new trustee
Don ald E. Meads, Chairman and Chief
Executive of Certa in-Teed Produ ct s
Corporati on, was elec ted to membership on th e Board of Trustees of Th omas
Jeffer son Unive rsity on March 1. In ad dition to Mr. Meads ' new po sition he
also serves as a Trustee of International
House, the Penn sylv ani a Acade my of
the Fine Arts and th e National Planni ng
Assoc iation and is a Board Member of
th e W orld Affairs Counci l.
At age 55 Mr. Meads is a di rect or of
eight other major cor porations including th e Insurance Co mpa ny of Nor th
Ame rica, Western Savin gs Funds Society, Singer Company and th e Qu aker
Oats Company.
A gradua te of Staunton Milit ary
Academ y and Dartmouth Co llege Mr.
Meads receiv ed a Masters degree in
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business administration from Har vard
University .
Cha irman of th e Board William W.
Bodine in an nouncing the elec tion
stated, "Our goa ls in medical edu cation,
health care and research are certa in to
be fur the red with th e help of such an
outsta nding business and community
leader."
Mr. Meads will serv e three yea rs as a
Term Trustee.

alumni president
At th e Alumni Association's Annual Business Meeting on Feb ruary 26, a special bice nte nnial ga thering preceded by cocktail sat th e Penn Mutual Tower and
followed by a perfor man ce of the Benjamin Rush players, D r. John Y. Templeton,
III took over the Presidency of the Association from Dr. Frederick B. Wagner, Jr.
D r. T empleton, whose father was a Jefferson gradua te, received his degr ee in
1941. He took his internship at Jefferson,
an d, after a four -yea r tour of duty in the
army, he ret urned to Jefferson for a residen cy in general and thoracic surge ry,
workin g with D r. John J. DeTuerk und er
Dr. John H . Gibbon, Jr. After various Fellowships and staff appointments at Jefferson, D r. T emp let on became a Clinical
Professor of Surgery here in 1957. He was
a Professor of Surgery at the University of
Pennsylvani a Schoo l of Medicine from
1964 to 1967 but returned to Jefferson
in 1967 with the ran k of Pro fessor. He is
curre ntly a cons ulta nt in general surgery at Chestn ut Hill Hospital and Lanken au Hospital, a cons ultant in th oracic
surgery at W ilmingto n Medical Cent er ,
and attending physician at Jefferson.
As a ph ysician , Dr. T empleton perform s primaril y ca rdiac surgery, although his group has a broad general
surgica l pr acti ce. His teachi ng responsibilities are mainl y cl inical , as is his cur rent research , in whic h he is working
with medi cal ca rdiologists to det ermine
optima l methods of management for
th ose having or ab out to hav e myoca rdial infar cti ons.
D r. T emplet on has held office in
man y professional societies. Past President of th e Philadelphia Academy of

Surgery, the Philadelphia County Medical Society and the Laennec Society of
Philadelphia, he has also been Governor
from Pennsylvania for the American
College of Surgeons. He is a member of
the American Surgical Associa tion,
the International Society of
Surgery, the American Association for
Thoracic Surgery and the American
College of Surgeons, among many others. Dr. Templeton is certified by the
American Board of Surgery and the
American Board of Thoracic Surgery.
In Jefferson's Alumni Association, he
has been a Vice-President, a member of
the Executive Committee since 1954, and
a class agent for the Annual Giving Fund.
He says he thinks being elected Alumni
President isan honor, but that he does not
feel it is appropriate to try to put his personal mark on the Association while he is
in office; he hopes simply to continue the
Association's traditional role.

Other officers electe d for a one year
term are: Go nza lo E. Aponte '52, Pr esident-elect;John N. Lin dquis t '43, Pe ter
A. Th eodos '35, J. Woodrow Savacool '38,
Thomas B. Mervine '40, Vice-Presidents;
Samu el S. Conly.]r, 'S44, T reasurer; and
Norman J. Quinn, Jr. '48, Secretary. Dr.
Aponte is Pathology Chairman.

honored
Standing ovations greeted Martin J.
Sokoloff '20 and 1. Charles Lintgen '25
as they accepted engraved clocks at the
Annual Business Meeting of the Alumni
Association on February 26. The Executive Committee had elected to honor
them and colleagues Reynold S. Griffith
'18 and David R. Morgan '16 for their
many years of distinguished teaching
service to Jefferson. Dr. Griffith and Dr.
Morgan were unable to attend.
Dr. Morgan was appointed to the Jef-

ferson faculty in 1922 and was promoted through the ranks to full Professor in 1955. In addition to his teaching
duties in the Department of Pathology
Dr. Morgan also served as cura tor of the
museum. He was a member of ma ny
professional organizations incl uding the
American Society of Clinical Pathologists, the American Societ y of Bacte riologists and Pathologists and the
American College of Pathologists. Dr.
Morgan, the author of over 20 pap ers,
presently is residing with a nephew in
Edwardsville, Illinois.
Dr. Griffith also has spent his entire
professional career at Jefferson. In replying to President Wagner 's letter of
invitation he stated, "Incide ntally, this
is my 63rd year at Jefferson. In the
event you attempt to figure the extra
year, 1913-1914 , I was a pre-medical
student in the first such class at Jefferson. I am presuming you did not know

Dr. Templeton : Continuing the Alumni Associa tion 's tradit ional role
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that Jefferson had a pre-medical course.
As I recall it was short lived, one or two
ye ars only. This honor from the Alumni
is a suitable climax to my medical career ." Dr . Griffith , an internist, has offices in Philadelphia and holds the rank
of Honorary Clinical Assistant Professor
of Medicine.
Dr. Sokoloff , an Honorary Clinical
Professor of Medicine at Jefferson, began his professional career at White
Ha ven Sanatorium in 1922. He remained ther e as Visiting Physician and
lat er served as Medical Director, a position he held to 1956. In 1951 he was appointed Director of the Barton Memorial Division of Jefferson Hospital and
has served as consultant in pulmonary
diseases at several Philadelphia area
hospitals. Dr. Sokoloff has held office in
num erous organizations including the
Presiden cy of the Penns ylvania Thoracic Societ y, the Laennec Society of
Philadelphia, the Pennsylvania Chapter
of the American College of Chest Physicians and in 1956 the Alumni Association of Jefferson.
Dr. Lintgen at 84 still sees patients several days a week at his center city office.
Pr esentl y he is Honorary Clinical Professor of Obstetrics and Gynecology. Dr.
Lintgen was promoted to full Professor in
1952 and served in this position until his
retirement in 1965. He also is a member
of num erous professional organizations
including the American College of Surgeons , the American Board of Obstetrics
and Gynecology and the American College of Obstetricians and Gynecologists.
His son, Arthur, Jefferson '66, is an internist practicing in Abington.

parents'day 1976
Thi s year's traditional Parents ' Day at
Jefferson, sponsored by the Alumni Association in conjunction with the Dean's
Office, brought more than 200 mothers
and fath ers to the campus for guided
tours, lectures and a lunch hosted by
Dean William F. Kellow. The morning
program included presentations in both
the clinical and pr e-clinical departments in addition to a showing of the
Sesquicente nnial film " Of Light and
Learning." Dr. John Y. Templeton, III ,
'4 1, Professor of Surgery, gav e the after34

noon slide lecture on " Emergency Surgery for Heart Attack Patients." As
Alumni President, Dr. Templeton also
brought greetings from the Association.
The sophomore class each year selects a facu lty mem ber to address them
at the Dean's Luncheon. This year's
well-received speaker was Dr. Laird G.
Jackson, Associate Professor of Medicine, Obstetrics and Gynecology and
Pediatrics and Director of the Division
of Genetics.
Speaker for the sophomore class was
Mr. Duncan Salmon. Dr. Warren R.
Lang, '43 , Chairman of the Parents'
Day Committee, served as toastmaster,

black and blue ball
Jefferson's social fraternity, Kappa Beta
Phi, will sponsor its annual Black and
Blue Ball on Saturday, May 29 beginning at 9 P.M. in Jefferson Alumni Hall.
Tickets for alumni are priced at $15.00
per couple and at $8.00 per couple for
students and house staff . All proceeds go
to the KB$ Student Loan Fund.
Music for the evening will be provided
by the Brian Pastor Orchestra. Each year
Kappa Beta Phi selects a favorite professor to be their guest of honor. This year
they cho se Dr. Edward H. McGehee, Professor of Family Medicine. For tickets and
information, contact Dick Buza , 1025
Spruce St., W A8-0739.

alumni trustee
Ballots for the election of the Alumni
Trustee wer e mailed to the entire membership on May 4. Ch airman of the
Alumni Trustee Committee, Dr. Paul A.
Bowers, '37, not ed in his message that
Dr. Joe Henry Coley, '34, has served the
University extraordina rily well during
his first term of office. Th e committee,
followin g lengthy discussion, recommended to the Association 's Executive
Committee that he be nominat ed for reelection to a three-year term. The Com mittee endorsed this recom menda tion at
the April meeting.
Serving with Dr. Coley, whose term
will expire in June , are Dr. Robert L.
Evans , '52 and Dr. Thomas F. Nealon,
Jr ., 'S44.
Results of the balloti ng will be announced in the summer issue of the
Alumni Bulletin.

faculty changes
Dr. Norman N. Cohen promoted to
Clinical Professor of Medicine (MCMC)
Dr. Lawrence W. Davis appointed Professor of Radiation Therapy and Nuclear Medicine
Dr. George F. McInness promoted to
Professor of Surgery (W ilmington)
Dr. Diran O. Mikaelian promoted to
Professor of Otolaryngology
Dr. Dewey A. elson promoted to Professor of Neurology (W ilmington)
Dr. Frances C. Schaeffer appointed
Clinical Professor of Obstetrics and Gynecology (Daroff)
Dr. William E. Stass, Jr. promoted to
Clinical Professor of Rehabilitation
Medicine

Dr . Coley

class notes

class notes
1913
D r.J. WaIl ac e Hurff, 45 Woodland Ave.,
Summit, N.J., retired in 1972. He is85 years
old.

1915
Dr. Joseph Aspel, 409 Maplewood Ave.,
Merion, Pa ., w rit es th at he has not practiced since 197 1.
Dr. Warren S. Reese, 2118 Locu st St.,
Philadelphia, writ es th at he was honored by
th e Athl etic Club of Philadelphia as one of
its surviving founders and because he wa s a
pioneer in intraocul ar implant sur gery in
th e Unite d Stat es.

1917
D r. William G. Flickinger, Foxcroft Apts.,
Jenkintown, Pa., writes, " My famil y gan ged
up on me and mad e me retire. This is what
I never advised my patients."

1919
Dr. Samuel R. Lu ster, 169 S. Form osa Ave .,
Los Ange les, is semi-retire d, still see ing
patients at his home. He sends regards to all
his class ma tes .

1920
Dr. Edward W. Schoenheit, 25 Eastwood
Rd., Ashe ville , N.C., has retired. An int er nist with a spe cialty in car diology, Dr.
Schoe nhei t is a form er Presid ent of th e
North Carolina and Buncombe County
Medi cal Soci eti es. He is a FeIlow of th e
Ame rican CoIlege of Physician s and th e
American Co Ilege of Ches t Physician s.

1923
Dr. Benjamin HaskeIl, 1427 Spruce St.,
Phil ad elphia and Mrs. HaskeIl, spe nt th e
week of the Nobe l Pri ze pr esentations in
Stoc kho lm. This was at th e invit ati on of Dr.
Howard Tem in, a long ti me friend and now
Professor of Virology at th e University of
Wisconsin, wh o had been named laureat e
in medicine and ph ysiology. " It was a t ruly
me mo rable expe rience" Dr. Haskell sta ted
upo n h is return. " We we re include d in all
activities, even th e an nual ball sponsored
by th e med ical stude nts, who were by th e
way ext re mely hospitabl e."
Class Historia n Dr. Ernest L. Noone forwarde d the following abou t his c lassma tes,

"Dr. W . Emory Burn e tt expecte d to host
Dr. George J. W illa uer at a joint four c ity
sur gical meeting in Philadelphia last
March. Emory forgot th e date altogeth er
and George, waiting for Emory, saw five
inches of fresh snow instead, winced a nd
reached for his overcoat. Em ory enjoye d a
Florida winter and visits with his Alabama
kinsfolk. Geor ge, who se culinary skill is
well known, also occupies his spare tim e
making soap. 'First' says George, 'take
thirty pounds of fat .. .' "

1924
Dr. Lawerence Shinabery,212 Three River s
N., Ft. Wayn e, In. , spent Christmas in In diana but most of th e winter in the Florida
Keys.

1925
Dr. Sigmond J. Shapiro, 550 Butl er Rd.,
Warren , Oh ., was honored by th e Ohio
Stat e Medi cal Associ ation for 50 years of
servi ce in medicine. Dr . Shapiro was a gene ral practitioner in Warren and delivered
hundreds of babies in th e ar ea. He spe nt
some yea rs running th e Anesth esia Department at St. Joseph's Hospital and is now
semi-reti red, spe ndi ng three aft ernoons a
week specializing in all ergy . His son, Rich a rd, is an ophthalmologist in Warren and
his son, Mark, is an ophthalmology resident
at Jefferson .

1926
D r. Philip B. Davis, 807 Fl orham St., Hi gh
Point, N.C. , retired in Jun e, 1967. He and
his wife spe nd th e winters in Florida and
summe rs in Hi gh Point. Th ey hope to attend th e 50th reunion in Jun e.
Dr. James H . Tate, 1174 Hilltop Rd., Eri e,
Pa., retired from gene ral practice in 1971.
He and his wife of 40 years hav e three ch ildr en , all college gradua tes , and both boys
hav e th eir master s degrees. Th ey spe nd th e
winters in Fl orida.
Dr. Max L. Weimann, 10 First Ave., Had don Height s, N.J., ha s retired from his pr actice of med icine.

1927
Dr. Samuel M. Dodek, 5480 W isconsin
Ave., W ashin gton , D.C ., has had his portrait pr esented to th e Library .of th e Schoo l
of Health Sciences of Geo rge W ashin gt on
University, along with th e first tocodynamomet er used in th e W estern Hemi sph ere.
Th e instrument was devised , and used by

him in 1930 to study hum an myom etrial physiology and th e effec t of ce rtain dru gs and
agents up on ut erine con traction s during labor. It also became th e prot otype of exte rnal
tocodynamomet ers used today to monitor labor and th e oxytoci n cha llenge test.
D r. Dodek is Professor Em eri tus of Clinical
Ob st etrics and Gynecology at G.W. U.
Dr. L. Paul Ralph, 11223 N.I03rd Ave., Sun
City, Az., is in his seco nd year of retirement
aft er 43 ye ars of pr actice as a cardiologist in
Grand Rapids, Michi gan . He and his wife
have a surnme r hom e near there bu t resid e in
Sun Ci ty six months of the year.

1928
Dr. Charles W. Lighthizer , McCauslen
Man or, Steube nv ille , Oh., had join ed a group
of six " re tired ph ysician s" in May of 1969 to
man th e Em ergen cy Dep artment of th e Oh io
Valley Hosp ital. "We may be reti red but we
tr eat ed 40,000 pat ient s last year ." Last Jun e
he rece ived th e "O utsta nding Ohi o Tea m
Physician Awa rd ," pr esented by th e Ohi o
Sta te Med ical Socie ty and the Ohi o High
Sch ool Athletic Associa tion .

1929
Dr. Joseph C. Hudson, 11608 Balboa Dr.,
Sun City , Az., is a member of th e Th eod ore
Roosevelt Co unc il of the Boy Scouts and
each summe r goes to camp as physician to
th e Scouts. He also has joine d th e sheriff's
posse of Sun Ci ty .
Dr. James P. Ward, 320 Lemoyne Dr. , Pass
Christian, Ms., and his wife drov e through
Mexico and Ce nt ral Ame rica to the Panama
Ca na l last Oct ober. T hey flew hom e and
shippe d th e car. Th e t rip wa s 3500 miles
from th e U.S. bord er.

1930
Dr. Leon L. Berns, 1300 Knox Rd., W ynn ewood, Pa., has been promoted to Clinica l
Professor of Ana tomy at Jefferson.

1931
Dr. Edward Gipstein , 181 Broad St., P.O. Box
3 10, New Lond on, Ct. , is practici ng clin ical
ca rd iology on a semi- retired basis. He is still
Cha irma n oft he Dep artm ent of Medicine
and th e Div ision of Med ical Education at Memorial Hospitals in ew London.
Dr. William H. Newman , 251 E. Grove
Ave., Cla rks Sum mit, Pa., and his wife are
looking forw ard to th eir reunion in Jun e
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and hop e to travel to Europe with the
alumni tr ip.
Dr. Nathan Ralph, 2047 Spruce St., Philade lph ia, isserv ing as chai rman for th e 45th reun ion. "I am lookin g forward to a big
tu rnout."

1932
Dr. Nathan S. Schlezinger, 8378 Glen Road ,
Elkins Pa rk, Pa., and Mrs. Schl ezinger were
gues ts at th e New Delhi wedding of the
grandson of Dr. Amar D. Matta '31. The
Schlez ingers wer e on a round the world trip
inco rpo rati ng med ical meetings and lectur es wi th pleasure.
Dr. Burchard E. Wright, Old Orchard Estat e, Ijam sville, Md., retired in July, 1975
from th e Food and Drug Administr ation afte r 11 yea rs as th e Agency's senior biostatistician a nd epide miologist in th e Bureau of
Dru gs. He rece ntly returned from th e Andean highlands of Peru visiting th e ar cheological ruins at Lima, Cu zco , Macchu
Pichu and othe r sites .

1933
Dr. Richard I. Barstow, Th e Village Green,
Norfolk, C t., has begun his 40th year of
prac tice , associa ting with an oth er ph ysician . He is enjoying cross country skiing
and curling and hop es to join th e Jeffer son
tr ip to Euro pe in April.

1935
Dr. Albert J. Blair , Sr., 409 Franklin Heights
Dr., Monroevill e, Pa., has retired as Chi ef
Medi cal Direct or ofConsolidated Natural
Gas Co mpany. He has been th ere since 1956,
pri or to which he had a priv at e practi ce in
W aynesburg. He is past Presid ent of th e
Gree ne Co un ty Mem ori al Hospital and th e
Gree ne Co unty Med ical Socie ty. He is also
past Direct or of th e Amer ican Occupational
Med ical Associati on. He and his wife, Hel en ,
have thr ee children.
Dr. R. Marvel Keagy, 35 10 Bak er Blvd., Altoo na, Pa., is pract icing ped iatrics with two
junior partners, Rodney L. Sponsler '62 and
John L. Berardinelli '68. He is now Emeri tus Cha irman of th e Dep artment of Pediatrics at th e Altoona Hospital , an d Dr . Sponsler is Chairman .

1936
Dr. Edmund J . Brogan , 1020 Ce dar Grove
Rd., Wynnewood, Pa., has ret ired as Med ical Direct or of Provident Mutual Life Insurance Com pany of Philadel phia. Dr. Brogan will con tinue his privat e practi ce.
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Dr. Amar D. Matta '3 1 (far right) attended the wedd ing ofhis grandson (center) in New Delhi,
1ndia. Dr. Nathan S. Schlezinger '32 (lef t) and his wife we re also wedd ing guests.

Dr. Oliver E. Turner, 825 Eisenhower Dr.,
Pittsburgh, and his wife plan to attend th e
reunion in June. He has just completed a
three-year research project correlating glucose tolerance versus insulin assay techniques for diagnosis of diabetes, obesity , hypoglycem ia, etc.

1937

1944J
Dr. John H. Bland, Uppe r Valley Rd., Cam bridge, Vt., is an Associa te Professor of
Medicine at th e University of Vermont. He
and Dr. Leon Sokoloff, a Professor of Path ology at th e Sta te Unive rsity of New
York, Stonyb rook, have pu blished a book,
The Musculoskeletal System.

Dr. Carl G. Whitbeck, Box 177, RD 2, Hudson,
.Y., gave up his private practice in 1970.
He now works for th e State of New York
and parttime as Medical Director of a nursing hom e.

Dr. John A. Martin, 2037 Crys tal Spring
Ave., S.W ., Roan oke, Va., has been elected
alte rna te delegat e to th e AMA from Virginia. He is a Clin ical Professor of Radiology at th e Universi ty of Virginia Medical
School.

1940

Dr. Arthur B. Van Gundy,843 N. Columbus
St., Lan caster, Oh., writes tha t his second son,
Gr eg, is now a sophomore at Jefferson.

Dr. Rogcr B. Thomas, 8 Vining La., Wil mington, De., writes that his son, Roger, [r.,
is a pra cticing int erni st in \Vilmingt on and
is married with two children . His son, Robe rt, is a tax law yer in Wilmington, marri ed
with no childre n.

1941
Dr. Louis C. Blaum, 244 Scott St., Wilk esBarre, Pa., writes that his son, Louis Jr., is a
th ird-year reside nt in surgery at Jeffer son.
" If any of th e class has occasion to visit Jeff,
look him up and say hello."
Dr. Clyde C. Greene, jr., 140 ew Mont gomery, San Francisco, wr ites th at he was
sorry to miss th e recent Ameri can Co llege
of Surgeons Jefferson reception, but he is
"s till laid up by th e neu rosur geons. Hope to
be ambulatory and able to attend th e 1976
reunion...

19448
Dr. Charles V. Dolan, 128 . Mill St., Birdsboro, Pa., has been accep ted for membership
in the Berks Co un ty Med ical Societ y. He
pract ices family medicine an d is an emergency room physician at Ephrata Hospital.

1945
Dr. J. Elder Bryan , Jr. , 7926 3rd St.,
Down ey, Ca. , is th e princip al au thor of HR
10562, a bill for basic health insuran ce and
tax c redit.
Dr. John J . Cox, SOl Haddon Ave., Had donfield , .J., writes that his eldest son,
Jonathan , has been acce pted at Jefferson
and will begin in Septe mber, 1976.

1946
Dr. Charles E. Bickham, Jr., 5920 Searl
T er. , Washington, D.C ., ha s been appointed
Chairman of Suburban Hospital Department of Radiology. Prior to thi s appointment he was Chairman of the Department
at Doctors Hospital. He is a Fellow of the
Ameri can College of Radiology and a member of numerous societ ies.
Dr. F. William Henderson, 135 Oak Ave .,
Lak e City, FI., still has two children in college. Hopes to attend reunion in June.

1947
Dr. Lewis E. Jones, 1752 Morris Landers
Dr., Atlanta, has been promoted to Assistant Professor of Medicine at Emory University . He is Chief of Staff at th e Atlanta Veterans Administration Hospital.
Dr. John A. Koltes, 530 Spring La. , Philad elphia, complete d two yea rs as President
of th e Medi cal Staff of Chestnut Hill Hospital and one year as the first physician appointed to the Board of Trustees of the
sam e hospital.
Dr. Martin M. Mandel, Benson Manor, Ste.
110, Jenkintown, Pa ., has been elected the
91st President of the Philadelphia Neurological Societ y for 1976. Many other Jefferson neurologists have held this position. He
is also chief of the Department of Neurology and Director of the Electrodiagnostic
Laboratory at Jeanes Hospital.
Dr. Laurance A. Mosier, 10510 Chapman
Ave ., Garden Grove, Ca. , spent an evening
with Gail Li '47 and his wife, ani, during
th e recent AMA meeting in Honolulu. " H e
is well and prospering."
Dr. Leonard Rosen,5 Arthur Ci. , Wallingford, Pa., ha s contrib uted his services to
th e fre e care of indigent patients in Chester.
He has been praised by the community for
thi s effort, notes cla ssmate Martin Mandel.
Dr. Samuel Younger, 5109 Genesta Ave. ,
Encino. Ca. , writes that his son, Joel , is a
second year student at Jefferson.

1948
Dr. Velio E. Berardis, 632 Prospect Ave. ,
Scranton, Pa .• writes that he enjoyed himself a t th e 27th reunion at Skytop. He is
looking forward to th e next one. His son,
John, is a freshman at Jefferson.
Dr. Ralph Lev , 4 Ren ee C t., Edi son, T.J.,
was recently elec te d to th e Board of Direc tors of the American Committee for the
W eizmann Institute of Science at Rehovot,
Israel. He is also C hairman of th e Physicians Co mmittee for th e Institute. Dr. Lev

is practicing cardiovascular and thoracic surgery in Edison and is a Clinical Associate
Professor of Surgery at the New Jersey
Medical School.

1949
Dr. John E. Mills, 123 Congress sr., Pasadena, Ca.• announces the birth of a son, Peter Thomas, on November 24, 1975.
Dr. She ldon Rudansky, 520 Franklin Ave .,
Garden City, N.Y., writes that he visited Israel in the summer of 1975 and presented a
paper at the Ichilov Hospital in Tel Aviv.
"Quite pleased that my son, Max, is a freshman at Jefferson."

1950
Dr. Charles L. Saunders, 523 Wildwood La.,
Burlington, .C., writes that after 20
years he has started limiting his practice to
gynecology.

1951
Dr. Douglas F. Brady, 160 McLaughlin Dr.,
ew Kensington, Pa., is practicing solo general surgery and is on the staff at Citizens'
General Hospital and Allegheny Valley
Hospital. He has two boys, John, a senior in
high school, and James, a pre-med student
at the University of Pittsburgh.
Dr. Victor F. Greco, Greco Memorial Medical Arts Bldg., R.D . Drums, Pa ., has been
appointed Medical Consultant for the Comprehensive Health Planning for the State of
Pennsylvania. His oldest son , Vic, is a student at Philadelphia School of Optometry,
hoping to get into medical school. His oldest daughter is studying to become an operating room technician and his second son is
in his first year of pre-med. " W e have three
more children coming up , all of whom have
an interest in medicine."

1952
Dr. Nelson P. Aspen, 633 N. Church St., West
Chester, Pa. , writes that his five children have
become eight by marriage, "and six grandchildren bring us to middle age. " He is Chief
of Orthopaedics at Paoli Hospital.
Dr. Jerome I. Brody, 3300 Henry Ave.,
Philadelphia, is a Professor of Medicine at
the Medical College of Pennsylvania.
Dr. Raymond L. Cunneff, 30 Alston Ct.,
Red Bank , N.J., is President of th e ew Jersey Orthopaedic Society, Director of Orthopaedics at Riverview Hospital in Red Bank,
and Associate Attending at New York Orthopaedic Hospital. He continues as surgeon to the ew York Giants.

Dr. Robert L. Evans, 144 Sherburne C i.,
Weston, Ma. , will receive the M.S.M. degree from M.I.T. in May, 1976 after completing the Alfred P. Sloan Fellowship in
management science. He receiv ed th e Joh n
C . Leonard Award for contributions to
medical education at the Congress on Med ical Education in Chicago in January.
Dr. Howard Fugate, Jr., 633 Maple Ave.,
DuBois, Pa. , is practicing internal med icine. His oldest son is a senior at Philadelphia Osteopathy School and h is other
three sons are pre-med at Penn Stat e. He
and his wife have four grandchildren .
Dr. George C. Godfrey, 112 Glen sid e Ave.,
Linwood, .J., practices gene ral surgery at
Shore Memorial Hospital and has an office
in Somers Point. He recently saw classmates James Carroll and James Comerford
at a meeting of the American Coll ege of
Surgeons. Dr. Carroll is a urologist in th e
Oakland area and Dr. Comerford an anesthesiologist in San Jose .
Dr. Jerome J. Lebovitz, 5650 Aylesboro
Ave., Pittsburgh, writes that his son, Mark ,
is a freshman at Jefferson . He is Vice-Pr esident of the Southwest Chapter of Je fferson
Alumni. His second son will start a pre-med
program in September.
Dr. Herbert A. Saltzman, Duke University
Medical Center, Box 2904, Durham, N.C ., is
well and busy. He has one ch ild in college
and two still at home.
Dr. Robert M. Zweig, 2936 McAll ister St.,
Riverside, Ca ., is studying hydrogen as an
alternate fuel and has presented pap er s in
connection with this topic.

1953
D r. Franz Goldstein, 707 Arlington Rd.,
Penn Valle y, Pa., has been named th e Humanitarian Doctor of the Year by th e Philadelphia Chapter of the ational Foundation for Ileitis and Colitis, Inc. He is Chi ef
of Gastroenterology at Lankenau Hospital
and Professor of Medicine at Jeffer son.
Dr. August F. Herff, Jr., 8711 Village Dr. ,
San Antonio, Tx., writes that his eldes t

Phi Alpha Sigma
Cordially Invites its Alumn i
to a
COCKTAIL PARTY
4 P.M. Jun e 9th
3 13 S. 10th St.
Alumni planning to attend their cla ss reunion ar e invit ed to sto p by and ha ve a
drink, me et th e new brother s, see the
hou se, and reminisce.
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child graduated from Texas University and
is working. The second child is in 10th
grade and seems to want to attend the Naval Academy.
Dr. Willard S. Krabill, 120 Carter, Goshen,
In., is college physician at Goshen College,
Medical Director of the High Park Clinic
and Medical Staff representative to the
Board of Trustees of Goshen General
Hospital.
Dr. Robert M. Mead, 3015 El Corte Way,
Erie, Pa ., writes that two children in college at the same time are keeping him
"hopping financially."
Dr. Robert Poole, 419 N. Franklin si., West
Chester, Pa., is Chief of Staff of Chester
County Hospital. He is President of the
Board of Health of Chester County, and
Chairman of the Council on Professional
Relations and Services for the Pennsylvania
Medical Society. One daughter has finished
college and is working as a probation officer; two daughters are in college; and one
daughter in high school.
Dr. Raymond P. Seckinger, 4285 Tilghman
St., Allentown, Pa., is practicing psychiatry
utilizing the team approach with correlative
therapy. Treatment is coordinated to the
client's needs utilizing psychoanalyticallyoriented psychotherapy as the core
technique.

1954
Dr. Thomas Aceto, Jr., McKenna Hospital,
Sioux Fal1s, S.D., has been appointed Chairman of th e Department of Pediatrics at th e
University of South Dakota School of Medicine. A pediatric endocrinologist, Dr . Aceto

had been Professor of Pediatrics and Deputy Chairman of the Department at the
University of Virginia. From 1962 to 1974
he was affiliated with Buffalo Children's
Hospital as Director of Pediatric Endocrinology and Director of Postgraduate Education, and he was also an Associate Professor of Pediatrics at the State University of
New York at Buffalo. He is Board certified
in pediatrics and a member of the Society
for Pediatric Research, the Endocrine Society and the American Federation for
Clinical Research. Dr. Aceto was also Acting Director of the National Pituitary
Agency in Baltimore and Director of a collaborative project on the effects of human
growth hormone from 1965 to 1974. He has
many scientific publications to his credit.

1955
Dr. William A. Anthony, Jr., 1016 Charleston Ci., Roseville , Ca. , writes that he and
Paul Dugan '56 continue to be employees
of a five-man family practice corporation.
"W e soon plan to enlarge to seven men ."
Dr. Burton S. Benovitz, 425 Tioga Ave.,
Kingston, Pa. , writes that "Madge is now a
member of the Pennsylvania State Board of
Education, while my daughter, Jane , is a
sophomore at Brown ."
Dr. Frederick Lytel, 117 E. Fourth Ave., Con shohocken, Pa., is an Assistant Professor of
Family Medicine at Jefferson. "It's a great
program and I'm pleased to be part ofit. "

1956
Dr. Joseph L. Magrath, Ashby Rd. & Chestnut St., Upper Darby, Pa ., is an Assistant
Profes sor of Surgery at Jefferson.
Dr. Wallace B. O. Wong, 1354 McBain
Ave., Campbell , Ca. , is Chairman of th e
Ob-Cyn Department at Santa Teresa Hospital in San Jose. His eld est child, Gregor y,
is attending Northwestern Universit y. " In
th e case of classmates travelling in California , stop by."

1957
Dr. T. Clark Corson, 10 Penn si., Bloomsburg, Pa., is still in the private pra ctice of obI
gyn. He is Pre sident of th e Board of Edu cation
at th e Central Columbia School District.
Dr. Stephen J. Kendra, Box 143 aval Sta tion , San Diego, Ca ., is Commanding Officer of th e Navy Environmental and Prev en tive Medicine Unit #5 in San Diego. His
son, Stephen, Jr., is a sophomore in pre-med
at Notre Dame.
Dr. A ceto
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Dr. Ronald M. Match, 10 Medical Plaza,
Glen Cov e, N.Y., writ es that he enjoyed at -

tending the Jefferson Orthopaedic Society
Meeting in De cember and presen tin g two
papers. He is a member of th e American Society for Surgery of th e Hand.
Dr. Sanford M. Miller, 6BO W. End Ave.,
New York, is an Assistant Professor of
Anesthesiology at New York University
Medical Center. " Marcia and the two boys
(now 12 and nine) are all fine."
Dr. Joseph F. Rodgers, 1723 Sylvan Ln.,
Gladwyne, Pa. , was install ed as President of
the Volunteer Faculty at Jefferson at th e
Annual Meeting in January. A Clinical Assistant Professor of Medicin e, he succeeds
Dr. Paul J. Poin sard '41.
Dr. Rohert H . Schwab, 632 Montgomery
School Ln ., Wynnewood , Pa., has two children,Jennifer , age four , and Daniel, age two.

1958
Dr. Edwin R. Concors, 5009 Oxford Ave.,
Philadelphia, has joined with several other
phy sicians to op en a group pract ice of pediatrics. Dr. Concors is affiliat ed with Fran kford
and Nazareth Hospit als and is a Clinica l Associate Professor of Pediatricsat Hahn emann.
Dr. Carter N. Davison, Oxford Ci rcle, Tamaqua, Pa ., ha s op ened an office for general
practice in Hom et own , Pen nsylvania. He
practi ced pr eviously in Mah anoy City.
Dr. Donald N. Dubrow, 6536 Crestmere St.,
Dallas, writes that despite th e rigors of inter nal medi cin e pra cti ce, "we harvested a
bountiful c rop ofcom, beans, summer squash,
cucumbe rs, melon s and tom at oes. We live for
thewinterl Nancy and I continue to breedboxers-and show th em. Dau ght ers Fran,
Eve, Karen busy with piano, school, soccer. I
hav e been recertified by th e American Board
ofInternal Medicine."
Dr. Edward Fine,43 Kings Highway W.,
Haddonfield , N.J., is Director of Medica l Education for Our Lady of Lourdes Hospital in
Camden, one ofJefferson 's affiliates. Dr. Fine
is a Clinical Assistant Professor of Obstetrics
and Gynecology at Jefferson.
Dr. Marvin Z. Rotman, 59 E. BOth St., New
York, is Professor of Rad iology and Director
of Radiation Th erapy at New York Medical
Col1ege.
Dr. William J. Warren, RRl , Box 149, Furlong, Pa., has form ed th e W ar ren Medica l
Lab orat ori es, Inc., locat ed in Lansdale,
Pennsylvania. Full services are offered.

1959
Dr. TrevorD.Glenn, 5072 N. Van Ness Blvd.,
Fr esno, Ca., is a memb er of th e American College of Physicians, and on its Advisory Panel
on Nati onal Heal th Insur ance.

Dr. William A. Steinbach, 1120 Northeastern Bank Bldg., Scranto n, Pa., is an orthopaedi c and hand surgeon. He is Assistant
Chief of Surgery at th e Community Medical Ce nte r.
Dr. Samuel L. Stover, Box 435, Helena, AI.,
is Professor of Rehabilitation Medicine and
Associate Professor of Pediatrics at the University of Alabama School of Medicine.

1960
Dr. William R. Fair, 4960 Audubon Ave., St.
Louis, Mo., isa Professor of Surgery and
Chairman, D ivision of Urology, at Washington University School of Medicine and Urologist-in-Chi ef, Barnes and Allied Hospitals.
He isalso a memb er of the Scien tific Advisory
Board of the National Kidney Foundation.

1961
Dr. Lewi s H. Dennis, 13809 Vintage La., Silver Sprin g, Md., has taken an associate into
his pra cti ce ofhemat ology and oncology. He
continues on the Executive Committee of th e
Washington Adventist Hospital.
Dr. Paul G. Pentz, 42 Kenneth Dr ., Glastonbury, Ct. , is a staff psychiatrist and Direct or of Student Mental Health at the Institute of Livin g in Hartford.

D r. Robert M. Glazer, 1358 Drayton La .,
Wynnewood, Pa., is on the faculty of the
University of Pennsylvania School of Medicine in Orthopaedic Surgery. In addition to
a private practice at HUP , he is Acting
Chief of Orthopaedics at the Philadelphia
Veterans Administration Hospital.
Dr. LouisE. Levinson, 515 Westbank Expy.,
Gretna, La., is pra cticing obstetrics and gyne cology. " Phyllis,Tracy and Dara are all well.
Tracy is a freshman in high school. Give us a
call when you visit New Orleans."
Dr. Robert J. eviaser, 14620 Sene ca Rd.,
Germantown, Md., received tenure at
George Washington University School of
Medicine as an Associate Professor. He will
be promoted, effective July 1, 1976 to Professor of Orthopaedic Surgery.
Dr. William E. Staas, Jr., 323 Mimosa Dr. ,
Ch erry Hill , N.J., has been promoted to
Clinical Professor of Rehabilitation Medicine at Jefferson.

1963

Dr. Philip R. Hirsh, Jr., received consulting
privil eges in psychiatry at Memorial Hospital in Easton, Maryland, and has begun a
practice in Easton as well .
Dr. Stephen C. Kauffman, 3301 Goldsboro
Ct. , Falls Church , Va., has added two more
men to his group in family practice. He writes
that he is looking forward to seeing those who
visit W ashin gton for th e bicentennial.
Dr. Harvey M. Tucker, 3292 Havel Dr .,
Beachwood, Oh ., is Professor and Chairman
of the Department of Otol aryngology and
Communicative Disorders at the Cleveland
Clinic Foundation.

1965
Dr. Merrill A. Anderson, 731 Conestoga
Rd., Rosemont , Pa., is the Associate Director of th e Family Pract ice Residency Program at Bryn Mawr Hospital.

Dr . Thomas S. Patricoski, 12210 S. 86th
Ave., Palos Park , II., writes that a daughter ,
Joy Marie, was born on November 8, 1975.
She has five brothers and three sisters.

Dr . Edward R. Corcoran, j-, 4211 La Dega
Ct ., Tampa, Fl., and his wife grea tly enjoyed
seeing old friends and new buildings at the reunion last Jun e. He is in a pathology residency
at the UniversityofSouth Florida.

1964

Dr. James R. Dingfelder, 2003 Fireside Dr.,
Chapel Hill, N.C., is Assistant Professor of
Obstetrics and Gynecology at the University of North Ca rolina. He has presented
papers rece ntly in Kuala Lu mpur, Malaysia; Buenos Aires; Las Vegas; Daytona
Beach , and othe rs. He is married and has
three sons, ages six, seven and 11.

Dr. John G. Starr, 326 E. 2nd Ave., #3, Anchorage , AI., is establish ing a small pediatrics practi ce in Anchorage , and hop es to
continue his public health work as well.

Dr. James C. Barton, Rte. 1, Chambersburg,
Pa ., writes that h is wife , Anne , and childre n
Beth , Leah and Sarah are enjo ying life and
working on famil y projects. " Our four-man
family practi ce is doin g well. "

1962

Dr. AlfredJ. Cooke, Jr., 650 Church St.,
Landisville, Pa., is practicing orthopaedics in
Lancaster, andhe and his partner recently
took on two new associates. He and his wife
have three sons, ages 10,eight and seven.

Dr . George A. Blewitt, 21 Patriot Ci. , Devon, Pa., has returned to the east to become
Associate Dir ector of Clinical Servic es, Nephrology, at th e Smith , Kline Corporation
in Phil adelphia.

Joan, recently re turne d to her social work
caree r parttime in his family practice group
as a psych iatric social worker.

Dr. William A. Freeman, P.O. Box 130,
Shippensburg, Pa., writes that his wife ,

D r. Jay M. Grodin, 104-D8Great Arbor Dr.,
Potomac, Md., has been ele ct ed President of
the D.C. chapter of the Jefferson Alumni
Association.
D r. Will iam F. Pharr, R.D. 5, Dan ville, Pa.,
has joined the medical staff of Geisinger

Jefferson Art Show
Since its inaugurati on in 1967 the Annual Art
Show by the Fa cult y Wive s Club of Jefferson
Medical College has become one of the anticip at ed events ofeach school year. Open to
all members of the University including Medical School alumni and their famili es the show
con tinues to draw entries from across the
country incl ud ing theSOth state, Hawaii. Th e
nin th exhibition isscheduled again this year
to coinci de with reun ion activities. Dates:
May26 through June9.
Everyone and eve rything qualifi es. Media
entries range from oils to watercolors to ceramic s, sculptures, photographs, graphics,

metallics, carvings and even needlepoint. It
is a noncompetitive, non-judged exhibit and
serves as FWC's annual gift to Jefferson.
Out of town entries may be mailed to the
Alumni Office, Jefferson Alumni Hall, 1020
Locust Street, Philadelphia, 19107, by May
24. FWC will return them toyou by June 14.
Please be sure to include information such as
yourreturn address, title of work , class or
affiliation.
Exhibitors are invited to a special reception the aft ernoon of June 2.
Mrs. John H. Hodges, Chairma n
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LifeinJerusalem is Remarkably Normal

Dr. Gordon: A new life
in the same lifetime

40

It is difficult for most Americans to envision
life in a country where the continued existence of the nation as a political entity is a
matter of everyday concern. Yet Dr. Milton
H. Cordon '37, a recent emigre to Israel,
says that day-to-day life in that beleaguered
area of the world is remarkably normal, perhaps intentionally removed from the cataclysmic issues debated in Ceneva and ew
York. And despite the frequent incidence of
terrorist activities the Cordons feel safer
walking the streets of Jerusalem at night
than they did the streets of Philadelphia.
That probably says less about th e perceived
quality of life in Philadelphia than it doe s
about the compelling sense of community
and inter-identification that hav e attracted
so many to th e Israeli way of life.
Dr. Cordon's first trip to Israel was on a
1935 tour with a musical group, "The Jeffer sonians," with fellow medical student Morton S. Pearl '36. He next returned one week
after the Six-Day War in 1967 for a twomonth volunteer stint at Hadassah Hospital,
accompanied by his wife who lived with him
in a nearby Nurses' Residence. He treated
non-surgical, non-casualty patients in the
Hospital's clinic until the staff physicians returned to normal duty. After the Yom Kippur
War in 1973 he again volunteered his services, this time working for six weeks at Kaplan Hospital in Rehovot. The Cordons had
become emotionally involved with Israel's
people and fortunes through these visits,
through Dr. Cordon's ham radio contacts and
through Mrs. Cordon's enthusiastic work in
the United States with the United Jewish Appeal and the Jewish Federation of South Jer sey. "We became knowl edgable about conditions in th e country, both the good and the
bad. We wanted to make a change in our
lives, and we wanted to help if we possibl y
could."
The change is a major one, but not as
drastic as it might first appear. The Cordons
sold their home in Haddonfield, New Jersey
and bought a condominium in Jerusalem's
central residential area, a 15-minute walk
from the business district. In terms of comfort and cost it is comparable to those available in center city Philadelphia, and since

they had the furnishings from th eir Had donfield residence shipped over, th e new
home looks remarkably like th e old .
Neither has their diet had to cha nge in a
marked way. Staples, especially fresh fruits
and vegetables are available in abundance,
and th e cost of vital foodstuff s is at this time
subsidized by the government. Imp orted
foods ar e ve ry expensive; a box of U.S. cereal costs mor e than twi ce as muc h as its Israeli competition, whi ch accordi ng to Dr.
Cordon is just as ta sty. Red mea t is expensive and inferior in qu alit y to that found in
th e States, and, with th e exception of frozen
vegetables, prepared a nd convenience foods
do not exist. Casolin e is $1.90 a gallon , but
prices for th e most part are not notably
hi gher than th ey a re in Amer ica; the major
ec onomic differen ce is th e salary scale ,
about two-thirds lower in Israel.
Israelis work a six-day 45-hou r week, and
the work day begin s at eight A.M. Co nsequently people tend to rise and retire earlier
and usually have th eir largest meal in the afternoon. Ent ertaining is gene rally done over
coffee in the lat e aft ernoon; din ner parties
and restaurant dining are not co mmon. Since
entertaining is less formal th ere is more of it,
and the Cordons find th e mix of backgrounds
makes social life in Isra el very stimulating.
The cultural and intellectual life can be stimulating as well, with a vari et y of musical
events, theatre and lectures from wh ich to
choos e. Dr. Cordon not es th at , "Country
clubs ar e unh eard of in Israel. There is one
golf course, but it is only a golf course ." Tennis and socce r ar e th e most pop ular Israeli
sports, and the Cordons find th at there are always opportunities for new aes the tic and
spiritual experiences.
Perhaps th e greatest change for Dr. Co rdon has been occupational. Previously a
full-time practitioner of int ern al medicine,
Dr. Cordon went to Israel with no intention
to retire but with no specific job situa tio n in
mind. He is now Civil Air Surgeon for th e
State of Israel thanks to a lifelo ng avocational interest in aviation medi cin e. Himself licensed as a commercial pilot and an
instrument instructor, Dr. Cordon logged
4500 hours of flying time while in private

practice, including flights to various parts
of the United States, Mexico and Canada.
He had also served for 20 years as senior
Flight Examiner for the Federal Aviation
Administration and had been trained in accident investigation. His new job encompasses these areas but includes others as
well. Naturally th ere is a good deal of administrative detail with which to contend,
and he coordinates a team of specialists
from many fields in dealing with problem s
of passenger tr an sport, health and stan dards
for air crew and ground support people.
D r. Gordon is on boards of enquiry for all
aviation ac cide nts, investi gating the human
fact ors involv ed such as fatigue, emotional
stress, extreme heat, etc. His int ernal medicine background and his own flight experience are useful in evalua ting grounding situations for pilots and air c rews under most
medi cal conditions. He is also conce rned
with agr icultural avia tion, enforci ng safet y
and flight time regul ations for tho se involved in spray ing agricultural che micals.
"The pilo ts think th ey'r e indes t ructible,
and it isn' t easy to mak e th em understand
what th ese che micals can do to th em. "
Working with enginee rs regarding use of
oxygen at 40,000 feet plu s altitudes and th e
effects of pr essurization loss is anothe r responsibili ty of th e Civil Air Surgeon .
In Dr. Gordon's opinion, th er e is a great
deal of int er est in med ical resear ch and
medica l problems in Israel, but not as mu ch
in th e patient himself. Medi cin e is socia lized to a great exte nt, wi th virtually no private pr acti ce as we know it : peopl e simply
ca nnot afford it. Depending on one's will ingness and abil ity to pay, different med ical
plans are availab le, some allowing th e right
to choose one's own ph ysician, so me using
only clinic physicians wi th conside rable
wait ing tim e th e rul e. The qu alit y of ca re is
excelle nt, with all mod em methods available and free ly used . " Medica l men read a
grea t deal," Dr. Gordon notes, " and ma ny
belon g to journal clubs to keep curre nt of
medi cal ad van ces."
Wi thi n th ree years the Gordons, as Jews,
will be gran ted Israeli citize nship under th e
"Law of Return," Since thi s process is au tomat ic, the ir U.S. citi zensh ip ca n be simultaneously retained. Each yea r th ey spend a
month in th e U.S. visiting famil y and
frien ds, and their optio ns ar e op en if th ey
decide not to make th e move a permanent
one. D r. Go rdon no tes that most people
who leave Israel do so for economic rather
than sec uri ty reasons. If peopl e make less of
th e dange r th an might be expec ted it is perhaps because most of tho se now living in Israel either wer e born th er e or have immi grated from countries in whi ch the y could
not live freel y as Jews. " People like us from
th e free world, " .says Dr. Gordon, " have a
cho ice . But most Isra elis come to accept
danger as a part of life, because th ey hav e
no choi ce. Th er e is nowh ere else to go,"

Medical C enter , in the Department of
Cardiac Surgery. Dr . Pharr has been on th e
staffs of Charlotte Memorial Presbyterian
and Mercy Hospitals in North Carolina and
Hampton General Hospital in Newport
News, Virginia. He is certified by th e American Board of Surgery and has been an Instructor in Surgery at Rush Medical Center
in Chicago.
Dr. Thomas J. Schneider, 4212 Oak St.,
Palm Beach Gardens, Fl ., was appointe d
Chairman, Divi sion of Medicine, at St.
Mary 's Hospital in We st Palm Beach . He is
in his fifth year of practice in a 35-man
multi-specialty group in gastroente rology .
" Family loves Florida,"
Dr. GarryH. Wachtel, 7l00S.W. 7th St.,
Plantation, Fl., is practicing in T amarac,
Mar gate, and Lauderdale Lak es with an associate. He and his Wife,Linda hav e three
children .
Dr. William B. Wood writes that his famil y
ha s grown. Th ey now hav e "our third beautifullittle girl, Kaaren Susanna. My practice
in anesthesiology has grown rap idly as has our
clinic dealing with chronic pain problems."
He and his famil y resid e in Mankato, Mn,

1966
Dr, Jo seph B. Doto, Jr., 320 Sinkler Rd.,
W yncot e, Pa., is a Clinica l Assista nt Professor of Anes thes iology at Jefferson.
Dr. Robert H. Kirschner, 6822 S. Euclid
Ave., C hic ago, was a ppointed th e first Ben
Horwi ch Scholar of Medi cal Scie nces at the
Unive rsity of C hicago . Th e a ppoin tment
pr ovides salary and rese arc h support for a
two-year pe riod. He is doing research on
th e st ruc ture of leuk emi a viru s RNA with
funds fro m NC I and ACS.
Dr. Daniel Lovrinic, 17 Brookhill Rd., Conyngh am, Pa., recently passed his orthopaedic Boards. He is in priv at e pr act ice in Haze lton. " Kathy and th e kids are fine,"
Dr. Gerson B, Rothman, T enbyt owne Apt .,
Rt e. 130N., Delran, N.J., has joined th e Radiology Dep artment a t Ran cocas Vall ey
Hospital in Willingboro, New Jer sey.

1967
Dr. Robert M. Friedlander, Litt le Suna pee
Rd., New Lond on, N.H., writes th at his
third child, Reb ecca, was born on Oct ober
25,1975.
Dr. Matthew White is in a group practi ce
with four othe r famil y ph ysician s at th e Naval Hospital in Bremerton, Washington. He
passed his boards in family practi ce and is
now a Fellow of th e Acade my.

1968
Dr. Joel M. Barish , 1988 Calle Madrigal, La
Jolla , Ca ., is p racti cin g gastroentero logy in
San Di ego and his wife is practicing pediatric s. They have a son, Doug, age two.
Dr. Wa yne H. Braverman, 44 Tradd St.,
Ch arl eston, S.C ., wri tes that Lana and he ar e
happily enjoying life in Charleston where he
pra cti ces psych iat ry. He isnow a Diplomate
of th e Boards of Psychia try and Neurology.
Dr. Clifford A. Gordon, 1777 Hamburg
Tpke., Wayne, N.J., is practicing gastroenterology. Hehas two daught ers and anew son.
Dr. Robert A. Jacobs, 2615 N. Vermont
Ave., Los Angeles, is an Assistant Professor
of Pedi atrics at th e USC School of Medicin e. He is also working at Children's Hospital in Los Ange les.
Dr. Joel A. Kaplan, 1175 Gunnison Ct .,
Cla rksto n, Ga ., has been appointed Director of Cardio thoracic Anesth esia at Emo ry
Univers ity Hospital in Atlanta.
Dr. Martina Mockaitis Mar tin, 17 Dar tmouth La., Haverford, Pa., was ce rtified by
th e American Board of Intern al Medi cine in
rheum at ology in 1974.
Dr. Morris L. Orocofsky has been appoint ed staff internist for th e Philadelphia
Psychi atry Center . Dr. Oroeofsky is a Dip loma te of the Ame rican Board of Int ernal
Med icin e. He finished his medical residency
in Jun e, 1975.

1969
Dr. Robert L. Arkus, 5600 S. Willow Dr.,
Ste . 116, Hous ton, is pra cticing int ern al
medicine an d gastroenterology at th e above
address. He and his wife adopted two ch ildr en wh ile in the Air Force in New Mexico,
Lisa and Reb ecca.
Dr. Rich ard C. Gross, 4391 26th St ., San
Francisco, is in his final year of residency in
diagnostic radiology at th e University of
Ca lifornia, San Franci sco Medical School
an d will remain ther e next year on th e junior staff. His wife, Carrol, has received her
Masters degree in Nursi ng from the UCSF
an d is now an Associate Professor of Nursing at San Francisco State University.
Dr. Barry S. Smith, 702 Lexin gton PI.,
Louisville , Ky., passed his specialty boards
an d is now ce rti fied by the Amer ican Board
of Physical Medicine and Rehabilitation.

1970
Dr. John A. Azzato has been appoint ed to
th e staff of the Ort hopaedic Surgery Department at Methodist Hospital. He served
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orthopaedic residencies at the University of
Illinois and Jefferson.

a contributing author to the book "Interruption of Pregnancy. "

Dr. Edward B. Bower,3 McIntosh PI., Ft.
Stewart, Ca., completed his general surgery
residency at Jefferson and is now a surgeon in
the Army for two years. He and his wife and
their two children are living on post at Ft.
Stewart. Before leaving Philadelphia, Dr.
Bower had a one-man art exhibition and reception in the Jefferson Commons Callery.

Dr. Allen C. Richmond, 135 Crosshill Rd.,
Overbrook Hills, Pa., announces the birth of
a daughter, Robyn , September 19. He is
completing a residency in ophthalmology at
Scheie Eye Institute. He and his wife also
have a son, Philip, age four.

Dr. Larry S. Cohen, 16800 N.W. 2 Ave.,
Ste. 204, N. Miami Beach, Fl., announces
th e birth of twin daughters on October 19,
1973. He is in the private practice of cardiology in North Miami Beach.
Dr. Douglas B. Hagen, 1370 Byron Dr. , Salina s, Ca ., has joined Medical Associates of
New Paltz as a family physician. Dr. Hagen
completed his family practice residency at
the Natividad Medical Center in Salinas,
California.
Dr. Steven A. Klein, 8916 Data Point Dr.,
San Antonio, Tx., graduated from an
N.Y.U.-Bellevue residency in obstetrics and
gynecology. He is on the ob-gyn staff at
Wilford Hall Medical Center of the
U.S.A.F. He announces the birth of a son in
De cemb er , 1975, Barak Matthew.
Dr. James R. LaMorgese, 1960 Williamsbridge Rd., Bronx, N.Y., and his wife,
Nanc y, announce th e birth of a son, Robert
Scott, February 9. They have two other
sons, James, III and Brad. Dr. LaMorgese
will complete his residency in neurosurgery
a t Albert Einstein College Hospital, Yeshiva University, in Jun e and enters the Air
Forc e in July.
Dr. Robert M. Lumish, 7106 S.W. 112th PI.,
Miami , finished an infectious disease Fellowship at the University of Pittsburgh and
joined the e pide miology intelligence service of the Center for Disease Control. He
will be stationed with the Dade County
Health Department until June, 1977. He
and his wife, Saundra, expected their second child in March.
Dr.JohnT.Martsolf,307-671 William Ave.,
Winnipeg, Manitoba, is enjoying his stay in
Canada, where he will continue his clinical
genetics training until December,1976.
Dr. Lawrence S. Miller, 1842 Roscomare Rd.,
Los Angele s, has begun a practice of physical
medicine and rehabilitation in Beverly Hills
and at the Cedars-Sinai Medical Center. He is
a Clinical Instructor of Medicine at UCLA ,
and isenjoying California with his wife, Anita, and two children:Justin Todd, four
months and Torrey, 22 months.
Dr. Richard L. Nemiroff, 748 Stonehouse
Rd., has op en ed an office for the practice of
obste trics and gynecolo!,')' in Moorestown,
New Jersey. A Clinical Instructor of Obi
Cy n at th e University of Pennsylvania, he is
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Dr. Martin A. Tobey, 802 Pecan Ct., Belair,
Md ., will complete his duty in the army in
July, after which he will begin a Fellowship
in cardiology at the University of Texas
Southwestern Medical School in Dallas.

1971
Dr. Donald A. Bergman, 305 E. 86th St.,
New York, is in the first year of an endocrinology Fellowship at Mt. Sinai Hospital
where he just finished his internal medicine
residency. He and his wife, Susan, became
parents in June, 1975 with the birth of their
daughter, Melissa.
Dr. Delvyn C. Case, Jr., 430 E. 67th St.,
New York, will complete his Fellowship at
Memorial Sloan-Kettering Cancer Center
in June, 1976 and will move to Portland,
Maine to join a group in the practice of hematology/oncology. He will be on the staff
of the Maine Medical Center and the Tufts
University School of Medicine.
Dr. Harry R. Cramer, 2362 Thompson Ct. ,
Mountain View , Ca ., began a residency at
Stanford Medical Center in July, 1975 after a
three-year tour with th e Navy asa flight surgeon in CorpusChristi, Texas . His wife,
Cayle, is involved in a Master's program at
Stanford.
Dr. Paul M. Fernhoff, 2592 Briarcliff Rd.,
N.E. , Atlanta, and his wife, Deborah, announced the birth of a daughter, Shana Miriam , on May 31 , 1975.
Dr. Bruce M. Fishbane, 21 Strabane Ct.,
Baltimore, will be Chief Resident in orthopaedic surgery at Johns Hopkins in July .
His wife Marsha '72 is on the fulltime clinic
staff at Johns Hopkins after finishing her pediatric training there. She is also a parttime
student at their School of Public Health and
Hygiene. Their daughter, Alissa Michele,
was born on June 24, 1975.
Dr. William C. Hamilton, 23 E. Homestead
Ave., Collingswood, N.J., is a senior orthopaedic resident at Jefferson and expects to enter the service in July, 1976. His second
daughter, Amy, was born in August , 1975.
Dr. David W. Jones, P.O. Box4523, Boulder,
Co. , has been appointed DirectorofEmergency Services at Boulder Community
Hospital.

Dr. Barry R. Klein has complet ed his residency in emergency medicine at the University of Louisville and is now Director of
Emergency Servi ces at Parkridge Hospital
and Pre sident of Emergency Med ical Associates, Chattanooga, Tennessee.
Dr. Gerald M. Klein, U.S. Naval Hospital,
Box 19, F .P.O., New York, passed his Boards
in Radiology in June 1975 and is now
serving a two-year tour in th e U.S. Navy as
Chief of Radiology at th e Navy Medical
Center in Naples, Italy.
Dr. Michael J. Lechman, 819 Montgomery
Ave., A202, Bryn Mawr, Pa. , is in his second
year of surgical residency at Bryn Mawr
Hospital.
Dr. Elizabeth London Rogers , 1904 Elmore
St., Louisville, Ky., is Assistant Professor of
Medicine at the University of Louisville Medical Center, while her husband "is protecting
our country at Fort Knox. Our son, Bradley, is
a healthy, happy 13 months of joy."
Dr. Edward B. Ruby, 468 W . Chocolat e
Ave., Hershey, Pa., announces the bir th of a
baby girl , Alisa Melane, on July 25, 1975.
He is doing a Fellowship in endocrinology
at Hershey Medical Center.
Dr. Augustin J. Schwartz III, 705 N. Olive
Ave., P.O. Box 3167 , W. Palm Beach , Fl.,
has become a Diplomate of th e American
Board of Medical Oncology and a Board
certified medical oncologist. He invit es his
classmates to visit if the y are in the Palm
Beach ar ea .
Dr. Stephen C. Silver, 4082 Wil mington Rd.,
S. Euclid, Oh. , has returued to the Cleveland Clinic as a senior resident in gene ral
surgery after two years as a general surgeon
in the Air Force. He plans to finish in general surgery in 1977 and tak e a Fe llowship
in colon and rectal surgery. " Looking forward to our reunion."
Dr. J. Stanley Smith, Jr., 1139 Loop Dr.,
Harrisburg, Pa., finished a gener al surge ry
residency at the Harrisburg Polyclin ic Hospital and is now doing a Fellowship in
trauma at the Maryland Institute for Emergency Medicine.
Dr. C. Thomas Spigel, 1424 10th Ave., S.E.,
Apt. 2, Rochester , Mi., married Cecelia M.
Mulone on September 13, 1975. "Jim
McBride '71 and Hank Feder '71 were
among the ushers. I started a dermatology
residency at the Mayo Clinic on October I,
and my wife, who is an R.N., started work
at St. Mary's Hospital."
Dr. James O. Van Bavel ,53 W estmoreland
Ave., Longmeadow, Ma., isDirector of the
Psychiatric Inpatient Unit at th e Med ical
Center of Western Massachusetts in
Springfield.
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Dr. Syrek: Emergency medicine often is like general practice.

Dr. Susan J. Syre k ' 68, a n emerge ncy room
ph ysician a t Bryn Mawr H ospital, says that
contra ry to th e television image of th e acc ident ward, ER medicine today ofte n is like
a bi g ge nera l practice. "O f course we d o ge t
hou sehold and auto acc iden t victims and
many true medical eme rge ncies, but we ar e
mor e likel y to tr eat c u t fingers, sprains,
bell y a nd c hes t pains, many chronic conditions. W e e ve n had someo ne come in last
week who wanted hi s ears irrigated."
After a residency in int emalmedicine at
Brvn Mawr, Dr. Syr ek 's accident ward
tr;ining was at Doylestown Hospital , where
ph ysici an s wer e mor e likel y to see a patient
wh o had caugh t his hand in a thresher than
one with a spra ine d hip. Still , some of th e
pr obl ems of eme rge ncy roo m work arc co nst an ts. " It is d iHicult," D r. Syr ek not es, " to
esta b lish a ny rapport with th e patient on a
one- time visit. W e have little back ground
information and less follow-up. This sa me
di stance is ev iden t in our rel ati on sh ip with
th e pat ients' families. It' s a p roblem in
tr eating patients and it has ove rto nes for
our ma lp rac tice vulnerability. If th er e is
somc person al connectio n bet w een doct or
and pati ent, a malpractic e su it is less lik el y
to seem a ttract ive ."
Because a n e me rge ncy roo m has no appo intment book , patient volume can at
tim cs be virtua lly unmanageable. Dr. Syr ek
finds that from May to O ct ob er is her busiesttime , positing that th e lon ger hours of
daylight givc peopl e mor e of a c hance " to
de stroy th em selv es." Bryn Mawr saw 24,<X>o

emerge ncy patients last yea r, with a st aff of
four fulltim e ph ysicians and residents. The
four fulltime sta ffe rs rotate , with each of
three covering an e ight- ho ur shift for a
week and th e fourth with a we ek off. This
puts much responsibility on the one nonresident ph ysician in attendance , and when
th ere is a 20-patient backlog it ca n be a
st res sfu l, hi ghl y pressured position.
This pressure sit ua tion makes the accident ward physician especially vulnerable
to criticism by referral physicians and th e
rest of th e staff. Dr. Syrek feels th ey are oftcn judged from an unfair perspective, b ecause the referral do ctor ha s not seen the
pr e cise condition that th e e me rge ncy room
ph ysician had to tr eat on th e spo t.
For a person who ca n face stress without
ge tt ing flust er ed, howev er, ER work has
some notable advanta ges as well. Mention ed first is th at , unlike privat e practice
th ere is no adm ini stration, and an e igh thour da y is gu a ra nteed. Although th e gro u p
a t Bryn Mawr changes sh ifts weekl y, so that
each ph ysician will work seven days of eac h
e ight- ho ur shift e ve ry month , once one adjust s to th e sche d u le th at full week off each
month becom es a di stinct ben efit . Dr. Syrek
usually insists th at at least tw o da ys of th at
week are hers e nti re ly, and ofte n gocs to
ew York for th e op era she so mu ch enjoys .
The grea te st satisfactions of her work ,
however , are th ose occasional chance opportunities for follow -up, such as with
patients whom she Il<L~ treated previously
who return for another reason. " W he n

someone rem embers us a nd lets us know
that our tr eatment was successful, that every th ing turned out well , it is extremely
rewarding."
Although th e st andard ized hours of an
eme rge ncy room positi on would seem to
make it a lik ely professional choice for a
woman with a family, Dr. Syrek notes that
in this area few women have ente re d th e
field. As a mother of four he rsel f, she feels
that her career obligations hav e made he r
children very indep endent. "S ince our first
ch ild was born wh en I wa s in co llege and
th e second th e we ek b efore so phomo re National Boards in medical schoo l, non e of
th e children has eve r known any other way
of life ,"
A Board-c ertifi ed int ern ist, D r. Syre k
feels that in her pa rti c ular c ircumstance,
wh er e she refers a great m an y of he r
patients to spe ci a lists on th e H ospital staff,
her training in int ernal medi cine, which
ga ve her a b road backgr ound, is p robab ly
mor e valua b le th an a resid ency in the new
eme rge ncy medi cine specialty wo uld have
been. She beli eves, how ever, tha t the adve nt of th c EH specialty will inevitably im provc th e qualit y of e me rge ncy care.
" W h ile th e e mc rgc ncy roo m is an excellen t
ed uc at io nal expe rie nce in eve ryday medicin e for medical stude nts and resident s
alik e , to o oftc n la ck of sta ffing puts th e residents in virtual co mma nd of th e ac ciden t
ward. The ER spe cia lty should ma ke th is
work mor e attractive and bring more fulltime physicians into service."
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1972
Dr. William H. Brubaker, Camp Casey,
Korea , APO San Francisco, completed his internal medicine residency at Presbyterian
Medical Center in Denver. After he finishes
his tour of duty with the army he plans to return to Denver to practice internal medicine.
Dr. Anna M. D'Amico, 2223 E. Prior Rd.,
Wilmington, De., has completed a residency in obstetrics and gynecology at the
Wilmington Medical Center and will begin
private practice in Wilmington.
Dr. Anthony P. DeNoia, 20 Avenue at the
Common, Shrewsbury, N.J., passed his internal medicine Boards in June, 1975 and is
now practicing internal medicine. He and
his wife, Marianne, have a son, Christopher,
one and one -half.
Dr. Philip J. DiGiacomo,Jr.,513 Paddock
Rd., Havertown, Pa., writes that his first
child, Heather , was born July 14,1975. His
wife , Anita, received her B.A. in psychology
from Villanova two weeks before Heather's
birth.
Dr. Gregory J. Edinger, 115 Craven Dr.,
Havelock, N.C ., is serving two years with
the Navy at Cherry Point, North Carolina
after completing a family practice residency at Wilmington Medical Center.
Dr. Richard L. Fieo, 825 Windermere Ave.,
Drexel Hill , Pa., writesofthe birth of adaughter, Megan Ann, on November 5,1975.
Dr. Marsha J. Fishbane, 21 Strabane ci,
Baltimore, finished her pediatric training at
John s Hopkins and is on the fulltime clinic
sta ff th er e. She is also a parttime student at
th eir Sch ool of Public Health and Hygiene.
Her hu sband Bruce '71 will be Chief Resident in orthopaedic surgery at Johns Hopkins in July. Th eir daughter, Alissa Michele,
was born on Jun e 24, 1975.
Dr. Sanford Fitzig, Thomas Jefferson Hospital , Department of Urology, and his wife ,
Elly, announce th e birth of a daughter, Devon
Mer edith, born a t Jefferson Hospital August
22,1975. He isa second-year urology resident
at Jefferson and will join the Air Force after
completing his training next year.
Dr. Gene H. Ginsberg, 1735A Clarion Lp. ,
Cannon AFB, Clovis, N.M., is spending two
yea rs in the Air Force in int ernal medicine.
He and his wife were expec ti ng their sec ond child in March.
Dr. Charles A.Gordon, 51C Glen Mead Dr. ,
Port smouth, R.I., passed his Boards in internal medicine in 1975 and is now at the U.S.
Naval Regional Medical Center in
Portsmouth.
Dr. James T. Hay, 14202 Recuerdo Dr.,
DelMar, Ca., writes that he finished a Iam-
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ily practice residency in July. He will be on
the staff of the Naval Hospital at Camp
Pendleton for the next three years, and has
bought a new house in DelMar.

Dr. Carol A. T. Rivera, Edificio Oliver
#308, Arecibo, P.R., passed her Boards in
internal medicine. She continues in private
practice in Arecibo.

Dr. Philip C. Hoffman, 1468-D, Druid Valley Dr., Atlanta, is spending a U.S. Public
Health Service commission in hospital
epidemiology at the Bureau of Epidemiology, Center for Disease Control, Atlanta.

Dr. James R. Roberts, 85 Bedford St., Forty
Fort, Pa., is finishing a residency in emergency medicine at the Medical College of
Pennsylvania in June. He will take a threemonth trip to Central America by truck th is
summer.

Dr. DavidP. Hughes, 16Williamsbur Manor,
Edwards Rd., Greenville, S.C., writes that his
wife and son, John, are spending a year in
Greenville as part of his orthopaedic residency at Duke University.
Dr. Stanley R. Jacobs, 1321 W ingolrocktng
St., Philadelphia, is coming on staff at Jefferson as an Instructor in rehabilitation
medicine.
Dr. Gail Tenikat Jacoby, 66 Corwin St., Apt.
20, San Francisco, writes that theirdaughter,
Suzanne Nichole Tenikat, was born September 25. "She and our residencies have kept
David and me quite busy. When our residencies are completed in June, we plan to
move to Belmont, California, and will be
practicing on the peninsula, David, in internal medicine and I, in dermatology."
Dr. Mark Josephs is running an emergency
room in Merced, California, near Yosemite
National Park.
Dr. Susan C. Judson, R.D. 3, Box 159, Wil liamsport, Pa., is Boarded in internal medi cine and currently is completing a two-year
hematology Fellowship at Geisinger Medical Center.
Dr. Alex B. Juhasz,93 Brightwood Ave., Pittsburgh, is a third year resident in general surgery at Mercy Hospital in Pittsburgh.
Dr. Myles K. Krieger, 747 NE 6Ist St., Apt .
101, Miami , will complete an otolaryngology residency at Jackson Memorial Hospital
of the University of Miami in June, 1977.
Dr. Helen A. Leibowitz, 1206 Rodman St.,
Philadelphia, is a second-year radiology
resident at Pennsylvania Hospital. Her husband, Paul Hoyer, graduates from Jefferson
this June.
Dr. Charles J. Locke, 465 N. Harlem Ave.,
Oak Park, II., is a third-year surgical resident at Cook County Hospital.
Dr. Robert D. McKay has completed his
graduate medical training at the Mayo Graduate School of Medicine and presently is at
the Naval Hospital in Bethesda, Maryland.
Dr. Rosalie K. Marinari, 149 Briar Ct .,
Marlton, N.J., is finishing a dermatology
residency at Hahnemann in June, 1976. She
will then enter private practice in Cherry
Hill with another physician.

Dr. Anthony R. Rooklin,566 Vallejo St., # 23,
San Francisco, finished his pediatrics residency as Chief Resident at Oakland Chil dren's Hospital in June, 1975. He is now
studying for a Master's degree in public
health and will return to Jefferson to begin a
Fellowship with Dr. Herbert C. Mansman '51
in pediatric allergy and immunology.
Dr. Michael S. Roth, 9845 Wisteria St.,
Philadelphia, is Chief Resident in ob-gyn at
Temple University Health Sciences Center.
He will begin a two-year Fellowship in reproductive endocrinology at th e University
of Miami in July, 1976.
Dr. Marshall A. Salkin, Key W est Naval
Hospital, Key West, Fl., is on the staff of
the above hospital in internal medicine.
Dr. Bruce S. Saltzman, 7860 S.W . 147th St.,
Miami, is practicing anesthesia at Doctor's
Hospital in Coral Gables. He and his wife
have one daughter, Stephanie, two.
Dr. Barton L. Schneyer, 212 Brookley Ct.,
Loring AFB, Me., has completed an internal medicine residency at Mon tefiore Hospital in the Bronx and he and his wife Elin
("and assorted pets") will be at Lorin g AFB
until July, 1977.
Dr. Susan E. Staniels, 1333 Old Gulph Rd.,
Villanova, Pa., is completing a Chief Med ical residency at Jefferson and will begin a
Fellowship at Cardeza in July.
Dr. Thaddeus R. Szydlowski, 885 Easton
Rd., Glenside, Pa., and his wife had a
daughter, Kristen Ann, on August 19, 1975.
He is doing a hematology Fellowship at th e
New Jersey College of Medicine and Dentistry. In July he will begin a gastroenterology Fellowship at Lankenau.
Dr. William M. Wixted, 604 Meado w Rd.,
Pine Hill, N.J., writes that he and his wife,
Jean, now have two sons with the arrival of
Thomas in December, 1975.

1973
Dr. John W. Cochran, 1718 W . Flournoy
St., Chicago, completed his inte rn al medicine residency at Presbyterian-St. Luke 's
Hospital and began a neurology residency
there. His wife, Arlene, will receive her
Master's degree in special education from
the University of lllinois in March .

Dr. Joseph A. Jacobs, 6902 Bonnie Ridge
Dr. , Baltimore, is doing a urology residency
at the University of Maryland. He was married in August , 1975 to Linda Anne Gozzetti, who is getting her M.S. at the University of Maryland in community health
nursing.

1974
Dr. Louis T. Broad, 2991 School House La.,
Oak 14E, Philadelphia, " who has been happily married to the former Andrea Rosenbaum since April, 1975, is proud to announce that he has no children or pets."
Dr. Joel M. Brown, Methodist Hospital of
Dallas, Dallas, is in the second year of a
medical residency at the above hospital. He
has a daughter, Jennifer, age one , and is
buying their first house in Mesquite, Texas.
Dr. John J. Karlavage, 1417A Confederate
Ave., Columbia, S.C., has coauthored a paper on methylphenidate and Gille de la
Tourette's disease that will be published by
the Journal of th e Academy of Child Psychiatry. He has also been accepted by th e
University of Chicago for a psychosomatic
medicine elective.in 1977.
Dr. Scott I. Lampert, 2485 Morosgo PI., Atlanta, Ga ., will begin an ophthalmology
residency at Jefferson in July, 1976.
Dr. Anthony D. Molinaro, Jr., 1927 Queenswood Dr ., York, Pa., is happily married and
in the middle of a three-year family practice residency at York Hospital.
Dr. Martin D. Mollen , 8572#E E. Indian
School Rd., Scottsdale, Az., is presently in
his second year of post graduate training in
internal medicine at the Good Samaritan
Hospital of Phoenix , Arizona. He and his
wife Joan proudly announce the birth of
their first child, Rochelle Ilona, on August
18, 1975. "Also of note , is that Marty became
interested in jogging since in Arizona, and
ran his first marathon, 26 miles, 385 yards
on December 20, 1975 in the Fiesta Bowl
Marathon in Phoenix. He plans to be the
first physician from Arizona to run in the
Boston Marathon this spring: '
Dr. John P. Morton, 624 7th St., Imperial
Beach, Ca. , is practicing family medicine at
the above address, and announces the birth
of a son, Hank, who is now 15 months old.
Dr. James D. Plumb, 1018 Spruce St.,
Philadelphia, is a second-year resident in
Jefferson 's Department of Family Medicine.
Dr. Jay S. Schinfeld, 474 W. 238th St., Apt.
2F, Riverdale, N.Y., is a second-year resident at Albert Einstein College of Medicine. His wife, a recent graduate of Columbia School of Public Health, works for
Planned Parenthood.

Obituaries
George F. Lull, 1909
Died February 7, 1976 at the age of 88.
Dr. Lull attained the rank of major general in the United States Army and from
1943 to 1946 served as Deputy Surgeon
General. He was Secretary General
Manager of the American Medical Association. In addition Dr. Lull served as
Medical Director of Cook County Department of Public Health, President
and Executive Administrator of the Illinois State Medical Society and VicePresident of the Chicago Medical Society from 1970 to 1976. Dr. Lull held a
Master's degree from Harvard University and a Doctor of Public Health from
the University of Pennsylvania. Surviv ing are his wife, Mildred, and a son, Dr.
Lull, Jr., '40.
Herbert C. Oelschlegel, 1911
Died July 21, 1975 at the age of 88. Dr.
Oelschlegel, a family practitioner, resided in Torrington, Connecticut. He
was a past President of the Torrington
Medical Association.
Enrique G. Matta, 1912
Died October 29, 1975 at the age of 90 .
Dr. Matta served as a Municipal doctor
in Puerto Rico for 34 years. In the early
years of his career he was elected
Mayor of his village , a Senator in the
Puerto Rico Senate and a Trustee at the
University of Puerto Rico. He retired in
1944 and devoted his time to his 538
acre coffee plantation and writing. His
son, Dr. Enrique, Jr., graduated from
Jefferson in 1940.
James R. Reuling, 1914
Died December 27,1975 in Windermere, Florida where he had been residing for the past 18 years. Prior to his
move he was an internist in Bayside,
New York. In 1953 Dr. Reuling was
awarded the Will Ross Medal by the
National Tuberculosis Association for
his work in fighting the disease. He was
President of the Queensboro TB and
Health Association and served as President of the national organization in
1947. He also is a past President of the
Queens County Medical Association.
Surviving him are his widow, Roberta,
and two daughters.

Sheldon A. Saunders, 1914
Died April 7, 1975 at the age of 88. Dr.
Saunders was a family practitioner residing in Aulander, North Carolina.
Holbert J. Nixon, 1914
Died December, 1975 at the age of 85.
Dr. Nixon, an obstetrician, pract iced in
Uniontown, Pennsylvania for 50 years.
He served as Chief of the Dep artment
at Uniontown Hospital.
Alexis T. Mays, 1915
Died February 17, 1976. Dr . Mays, a
cardiologist, resided in Brooklyn with
his wife, who survives him.
Horace B. Anderson, 1917
Died January 29, 1976 at the age of 85
in Delray Beach, Florida. Dr. Anderson
specialized in cardiology and pathology
in John stown, Pennsylvan ia. He serve d
as both Medical Direct or and Presiden t
of the Staff of Memorial Hospit al there.
Isidor Hendel, 1917
Died May 14, 1975 at the age of 79. He
was a family practitioner who resided in
New London, Connecti cut.
William B. Fort, 1918
Died Novemb er 19, 1975 in Pompano
Beach , Florida, where he resided since his
retirement in 1959. Dr. Fort was agynecologist in Plainfield , New Jersey and was
senior staff member in that Department
at Muhlenberg Hospital. He had served as
President of the Plainfield Board of
Health and the Plainfield Medical Society. Surviving are his widow, Marion, a
son,a daughter and two stepdaught ers.
John M. Tyson, 1918
Died October 10, 1975 at the age of 81.
Dr. Tyson was an otolaryngologist who
resided in Dubois, Pennsylvania.
Francis C. Hartun~, 1919
Died June 30, 1975 at the age of 88. He
was a general practitioner in the Philadelphia area.
Ira H. Hurt, 1919
Died February 7,1975 at the age of 84.
A general practitioner in Roanoke, Virginia, Dr. Hurt · Iso served as a Dir ect or
of the Shenanr' .ah Hospital for 20
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years. He is survived by his wife , Edith,
a daughter, Phyllis, and a son, Ira, Jr.
Paul A. Bishop, 1920
Died January 6, 1976 at the age of 79.
Dr. Bishop, Professor of Radiology at
the University of Pennsylvania School
of Medicine and its Graduate School of
Medicine, had served as Director of the
Department of Radiology at Pennsylvania Hospital until his retirement in
1962. He served as President of the Staff
from 1951 to 1953. Dr. Bishop was a
Diplomate of the American Board of
Radiology, a former President and Treasurer of the Philadelphia Roentgen Ray
Society and a Vice-President of the
American Roentgen Ray Society. He
was the author of a book and numerous
papers on radiological diagnoses. Dr.
Bishop also served as Secretary of the
Philadelphia Lyri c Opera Company.
Surviving is his wife, Ruth.
Lewis G. Woodson, Jr., 1920
Died May 25, 1975. Dr. Woodson was an
internist who resided in Birmingham,
Alabama.
Wesle y S. Miller, 1922
Died Jun e 3, 1975 at the age of 78. Dr.
Miller was a family pr actitioner in Jeannette, Penn sylvania.

Alfred H. Diebel, 1925
Died February 7, 1976 in Fort Lauderdale where he had been residing since
his retirement. Dr. Diebel, an obstetrician gynecologist in the Philadelphia
area, was a member of the American
College of Surgeons and the American
College of Obstetricians and Gynecologists. His wife, Amanda, survives him.

67. Dr. Helms, a gen eral practit ioner,
resided in Bethlehem, Pennsylvania.
Surviving are his widow, Gertru de, and
two sons and a daughter.

Roy E. Nicodemus, 1927
Died January 3, 1976 at theageof72. Dr.
icodemus served as Director of the Department of Obstetrics and Gynecology
at Geisinger Medical Center from 1930
to his retirement in 1965. He was a Fellow of the American College of Surgeons, a Diplomate of the American
Board of Obstetrics and Gynecology
and a founding Fellow of the American
College of Obstetricians and Gynecologists. At Bucknell, his undergraduate
school, he was President of the Alumni
Association and a member of the Board
of Trustees. Surviving are his wife , Geraldine, a son and three daughters.

Richard H. Fenstermacher, 1937
Died January 7, 1976 at the age of 63.
Dr. Fenstermacher was D irect or of Pathology at the Street Clin ic in Vicksburg, Mississippi. He is survived by his
wife, Mary , and a son.

Marshall Kerry, 1929
Died December 11, 1975 at the age of
77. Dr. Kerry was an anesth esiologist at
the Reading Hospital in Reading, Penn sylvania from 1950 to 1970. He also
served as Director of the Department
ther e. He is surviv ed by his wife.

Maurice Saltzman, 1922
Died February 1, 1976 at the ageof81 .
Dr. Saltzman was an ear, nose and throat
specialist with officesin Philadelphia. He
issurvived by his wife, Sophi e, and two
sons, Dr. Edward], Saltzman '49 and D r.
Herbert A. Saltzman '52.

Russell W. Rummell, 1929
Died October 7, 1975 at the age of 72.
Dr. Rumm ell served as Medical Director of the Youngstown (Ohio) Hospital
Association from 1948 to his retirem ent
in 1966. He was a member of the Ame rican College of Hospital Administrators.

Herman H. Hostetter, 1923
Died D ecemb er 6,1975 at the age of
81. Dr. Hostett er served as per sonal
physician to Milton S. Her shey for
many years and was school physician
for the Milt on Hershey and Derry
Township Schoo l syste ms. A charte r
membe r of the Keystone Area Council
of the Boy Scouts of Amer ica he had received outstan ding service awards from
the Hershey Rot ary Club and Lions
Club. Surviving are his wif e, Sayra, a
son, Dr. Glenn H. Hostetter '60 , and a
dau ght er , Joann e.

David B. Karr, 1930
Died January 7,1976. Dr. Karr, a general surgeon, resided in Chattanooga ,
Tennessee. He served as Vice-President
for his state for the Jefferson Alumni Association. His widow survives him .
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Joseph M. Brown, 1933
Died j anuary 16, 1976. Dr. Brown wasa
gene ral pr actitioner in Sant a Rosa,
Ca lifornia.
David O. Helms, 1936
Died December 30, 1975 at the age of

Lindon L. Davis, 1937
Died November 29, 1975. Dr. Davis
practiced internal medicine in the East
Williston ar ea of New York .

Albertus C. Wyker, 1940
Died November 25, 1975. D r. Wy ker
was a general surgeon pr acti cing in
Pleasantville, Ohio.
John J. Wydrzynski, 1945
Died February 19, 1976 at the age of 56.
Dr. Wydrzynski, a general practitioner,
served on the staffsat Mer cy Ca tho lic
Medical Center and Delawar e County
Memorial Hospital. He is survived by his
wife, Valeria, and three sons.
JosephF. Devenny, 1946
Died Janu ary 24, 1976 at the age of 55. Dr.
D evenn y, a resident of ew tow n Square,
Pennsylvani a, was an obstet ricianlgynecologist and served on the sta ffsof Fitzgerald Mer cy and Riddle Memorial
Hospitals. He was a Clinical Instruct or at
Jefferson. Surviving ar e his wife, Mary
Catherine, a son and daugh ter.
David 1. Biser, 1949
Died December 28, 1975 at the age of
52. Dr. Biser was a psychi atrist/neurologist who wo rked primarily with children at the Children's Rehabi litation
Cent er at St. Agnes Hospital and the
Mental Retardation Institute of New
York Medic al College. He was a resident of Cro ton-on-Hudson, New York.
Joseph B. Shaw, 1960
Died May 1, 1975 at the age of 4 1 in an
accide nt. D r. Shaw was the psychiatrist
for the Dep artment of Correction in
Reading, Verm ont , and also maintained
a private pr acti ce. He is survived by his
wife, Gr etchen , and thr ee children.

Edward L. Bauer, M.D.
1891-1976
Dr. Edward L. Bauer, Emeritus Professor of Pediatrics, died on February 13 at the age of
85. He had served as Chairman of that department from 1926 until his retirement in 1961. It
was Dr. Bauer who introduced modern methods of diphtheria prevention to the Philadelphia area and who served as immunologist for the city, beginning with an appoint ment
to the Department of Public Health in 1918. During his 14 years as Chief Immunologist, he
virtually eliminated outbreaks of diphtheria which at that time was a dreaded and sometimes fatal disease.
Dr. Bauer's contributions to medical literature comprise some 300 articles on children's
and communicable diseases as well as several important contributions to medical textbooks.
Through his writings he contributed greatly to preventive pediatrics which was a relati vely
new concept at the time of their publication. Dr. Bauer also was the author of the Jefferson
history "Doctors Made in America."
The Professor had served on the state's Certified Milk Commission for 25 years and was
Director of Health Services at Girard College for nearly the same length of tim e.
He served as consulting pediatrician to Philadelphia General, Germantown, St. Chri stopher's and Memorial Hospitals and the Children's Seashore House in Atlantic Cit y. D r.
Bauer was a Fellow of the American Academy of Pediatrics and the College of Physicians of
Philadelphia, a past President of the Philadelphia Pediatric Society and a past Chairman of
the Pediatric Section of the Pennsylvania Medical Society.
His son, Dr. Richard D. Bauer, '45 , represents the eighth generation of physicians in the
family , four generations of whom are graduates of Jefferson Medical College. He serve d the
Alumni Association as President in 1941.

Paul D. Zimskind, M.D., Ph.D.
1932-1976
Dr. Paul D. Zimskind, one of the youngest men ever to head a medical department at)efferson Medical College, died Sunday, February 29 after a sudd en illness.
.
Dr. Zimskind, age 44, had been appointed the Nathan Lewis Hatfield Professor of Urology and Chairman of the Department in 1967. His teaching career began in 1964 when he
became Assistant Professor of Urology.
A magna cum laude graduate of Princeton University , he was named a Markle Scholar in
Academic Medicine in 1966. He received his Doctor of Medicine degree from Jefferson in
1957 and a Doctor of Philosophy degree in physiology in 1964.
Several years before his appointment as Chairman, he wrote to his colleagues, in part: "I
continue to derive enormous satisfaction from planning and carrying out resear ch and stimulating and encouraging the research efforts of others. I intend to continue in research and
teaching both for the enjoyment the y afford and because the exclusion of eithe r would not
fulfill my goal of a true academic career."
Dr. Zimskind was a member of approximately 20 professional societies, including the
American Association of Genito-Urinary Surg eons, the American Association for the Advancement of Science, the ational Research Council and the American Urologica l Association. He was the author of 43 scientific papers and 77 presentations throughout the world.
His honors included the Francis W. Shain Surgery Prize while a stude nt at Jefferson and
First Prize, Basic Research Essay Competition, given by the Philadelphia Urological Society
in 1961.
Dr. Zimskind is survived by his wife, the former Gay Mann ; a son, Jeffrey, age 13; and a
daughter, Wendy, age 9. They live in Penn Valley.
He is also survived by his brother, Nathaniel H. Zimskind, a Rabbi; his fath er , Dr . Joshua
N. Zimskind, a 1927 graduate of Jefferson ; and his mother , Sadie.
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Dr. Peter A. Herbut at his May , 1967 inauguration at the Academy of Musi c
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Peter Andrew Herbut, M.D., C.M.
1913-1976
In the summe r of 1939 th ere ca me to Jefferson a yOlmg Canadian physician, graduate of McGill , to complete his training in pat hology und er Virgil Moon. Th e following year he
was appoin ted Assistant Director of the Clinical Laborator ies. Before a decade had passed, he was Professor and
Chairman of the Department, uniting und er one head the
divisions in the Medical College and Hospital. It was a remarkable achieve ment, but Pet er Andrew Herbut was an
extrao rdina ry man. And bigger things wer e ye t to come.
Like he worked he supervised, rigorousl y and almost all
the tim e. Th e department showed improvement from the
start despite the fact that the budget was meager and the
space very cramped. A complete residen cy program was organi zed. Tho se of us who were trained under his tutelage
think back fondly of that time and recollect many amusing
incidents related to long hours of ha rd work, immediate
deadlines, careful photographing of specimens and vacations that would end barely aft er their start. Tardiness and
pro crastination wer e deeply frowned upon. Excellence and
dedi cation were acknowledged quietly, perhaps with a careful smile as a reward, but he would not forget to say many
nice th ings about you behind your back. W e recall how intense was his love for music, particularly for Mozart. Among
the things he planned for the yea rs of retirem ent were writing essays on composers and a definitive history of Jefferson.
He was a fan of sports. The Phillies and the Flyers of Philadelphia were his special love, and he follow ed their games
closely and with charac teristic enthusiasm. And we remember best of all how cha rming were the visits to his home and
how deep was the love he shared with his wife Margaret,
the swee t lady he married a year after he cam e to Jefferson,
and with his dau ght ers Linda and Paula. Years later, his former trainees remain strongly united by that experience, a
bond that undoubtedly arose not merely as an Alma Mater
tie but from the power and magnetism of the man .
He lectured regularly to sophomores, with sonorous voic e
and very , very well organized. Pathogenesis was clearly ou tlined , ste pwise and invariably beginning with " number
one." His voluminous textbook of general pathology was
called "jolly gree n giant" by the class, and the students,
sharp critics that they are, recogniz ed and thanked the outstanding teacher by selecting him to membership in three of
their socie ties, including Alpha Omega Alpha. In 1961 his
portrait was painted upon the wish of th e senior class. At
the weekly clinico pathologic conference and Tumor Clinic,
whi ch we re supe rb and eage rly awaited by the staff, he was
a steadying force because his knowl edge of pathology was
diffuse, his approach very practi cal and his power s of persuasion stro ng. During those years he wrote, longhand, scientific pap ers ga lore and gained national renown among his
peers. Th e first paper in which he was a senior (and only) author was on diabetic glomerulosclerosis, a disord er originally
described by Dr. Paul Kimmel steil, und er whom Dr. Herbut
had his first yea r of training in pathology. Most not eworthy
were his contributions to the cytologic dia gnosis of cance r,
for whi ch he received the Ward Burdick Award, the highest
honor bestow ed by the Ameri can Society of Clinical Pathologists. For a long tim e he was in th e editorial Board of Acta
Cytologica and consultant in pulmonary cytology to the In-

ternat ional Academy of Gyneco logic Cy tology. His research
on substances whi ch inhibit tum or growth, begun some
years lat er , also achieved Widespr ead recognition. He wrote
four textbooks Virtually alone. Th e one on Uro logical Pathology, which was translat ed into Spanis h, is still the only
treatise on th e subjec t. His rep utat ion as an educator of uncommon skill and adm inistrator par excellence led him to
serve as advi sor or consulta nt to a long list of organizations
of sundry natures and intents, including the Nat ional Library of Medicine, the Council of Education of the Com monwealth of Pennsylvania, the Pennsylvania Society for
Advancing Medical Research , and the National Association
on Standard Medical Vocabulary. In 1970, Dr. Herbut was
presented with the Shaffrey Award by the Medical Alumni
of St. Joseph's College, and on that occasion he spoke on
tre nds in medical education.
As a member of th e Executive Faculty, of which he was
Chairman for ten years, Dr. Herbut helped to formulate
many of the plans from whi ch emerged the remarkable
changes that hav e tak en pla ce here over the last two decades . His participation was never casual for he was too
much a man of vigorous det erminati on and, above all, because he was complet ely Jefferson. Those qualities would
bring him to the inner circles of action in planning and development and eventually to the Presidency of the institution. The organization of a College of Gradua te Studies he
supported strongly. His was one of the most compelling
forc es in the creation of the Jefferson-Penn State Program of
accelerated medical education. He backed without equivocation the admission of femal e applicants to Jefferson Medical College. Far more than anyone else he promoted and
brought to fruition the concept of a College of Allied Health
Sciences, and through it univ ersity status for Jefferson. After
that, he kindled the idea to set up gradua te training in
dental sciences and educational pro grams for dental technologi sts. And so he went, constantly seeking ways here and
the re to improve and expand the institution to which he
gave unconditionally all the years of his fruitful life. The
connections that we now have with th e Franklin Institute
and the Philadelphia College of Pharm acy are two more instances of his far-sight ed driv e. He lived to see the realization of ye t another of his stout-hearted proj ects- the almost
total replacem ent of our health ca re facilit ies by a
$100 ,000,000 new Hospital-Clini cal Teach ing Facility. He
was accessible to all the men and women in the University,
at all levels, and invariably willing to lend an ear to our
problems, sugge stions or complaints. Having been first a
memb er of the Facult y, he felt particularly close to its members during his years as President. W e sensed that readily
and appreciated it a lot. He was also close and accessible to
alumni of Jefferson throughout the country and in distant
lands. Th e Alumni Associati on also apprec iated that a lot,
and expressed its thanks by granting him honorary membership in 1974.
Nearly a decade of growth and developm ent . Then, on
the last afternoon of March 1976, suddenly and very unexpectedly Peter Herbut died. Oh , what a heavy loss for Jeffersonl Whence will come such another leader? Forever and
a day will live the memo ry of that man.
Gonzalo E. Aponte, M.D. '52

